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X-Ray Crystallographic and Electron Microscopy Studies on Members 
of the ClyA/ Nhe Family of the Pore-Forming Toxins:  Avian Pathogenic 
E. coli Cytolysin A and B. cereus Non-Hemolytic Enterotoxin  
Abstract 
Escherichia coli cytolysin A (ClyA, also known as hemolysin E, HlyE) is a 
34 kDa cytolytic !-helical pore-forming toxin. The crystal structure of 
soluble monomeric E. coli K-12 ClyA was previously solved at high 
resolution and this showed that ClyA had a novel structure that had not 
previously been seen in the data bank of proteins.   Avian pathogenic E. coli 
(APEC), strain JM4660 ClyA is 75% sequence identical to E. coli K-12 
ClyA and has many significant similarities. However, two significant 
differences between them are that JM4660 ClyA pores are more 
homogeneous when observed by electron microscopy (EM), and JM4660 
ClyA is more thermostable than E. coli K-12 ClyA. Consequently, JM4660 
ClyA could be a good model system to investigate ClyA membrane 
interaction. The expression and purification of JM4660 ClyA was 
successful. Crystals were grown of the pore form, but so far diffract to about 
7 Å resolution.  
Bacillus cereus Nhe is a complex, pore-forming toxin consisting of three 
related proteins: NheA (43 kDa), NheB  (39 kDa), and NheC  (40 kDa). It is 
able to lyse mammalian cells from several organisms including humans in 
both Agar and liquid media and all three components of Nhe are necessary 
for toxicity. NheA has only 22% identity with NheB and NheC and its 
binding is the final stage of pore formation. Nhe proteins have sequence 
identity to B. cereus Hbl proteins. A previous structure solution of HblB 
revealed a structural resemblance to E. coli ClyA. To date, no crystal 
structure of any Nhe protein has been available in either the soluble form or 
in the pore form. Therefore, the project aimed to resolve the crystal 
structures of Nhe proteins in their water-soluble forms. The expression and 
purification of NheA was very successful. NheA was crystallized using 
PEG3350 as a precipitant by the sitting-drop vapour-diffusion method. The 
crystals belonged to space group C2, with unit-cell parameters a = 308 Å, b 
= 58 Å, c = 172.4 Å, ! = " = 90° and # =110° and were estimated to contain 
8 protein molecules per asymmetric unit. The three-dimensional crystal 
structure was solved at 2.05 Å resolution using Multi-wavelength anomalous 
dispersion (MAD) data sets. NheA is a rod-shopped structure. The main 
body is formed by a bundle of four helices, each at least 70 Å long and near 
the end of C terminal there is a extra fifth helix known as !G. NheA has two 
subdomains: the tail domain and the head domain that contains amphipathic 
!/# hairpin. The structure of NheA reveals strong structure similarity to 
ClyA and HblB, which further suggests that Nhe, Hbl and ClyA belong to 
the some novel family of toxins.  
In addition, B. cereus NheB expressed in B. subtilis strain JH642, was 
purified and crystallized. This thesis also presents the initial electron 
microscopy studies involving NheA and NheB pore formation.   
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ARG (R)    Arginine  LYS (K) Lysine 
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ƒ- Atomic scattering factor. 
f!- The dispersive component. 
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Rmerge or Rsym - Mergeing R- factor.  R-factor relating agreement between  
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SAD- Single anomalous dispersion. 
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Protein abbreviations, and biological terms 
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His tag- Hexa histidine-tag. 
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V- Volt. 
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w/v- weight by volume. 
XDS -X-ray Detector Software. 
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Chapter 1:  Introduction 
 
Bacteria are small micro-organisms, typically 1-10 µm in diameter, that are 
found in all environments (Turner et al, 2005). Bacterial pathogens produce 
toxins which destroy and lyse host cells including human and animal cells 
(Andreeva et al, 2006). Schmitt et al, (1999) have defined a bacterial toxin 
as "a soluble substance that alters the normal metabolism of host cells with a 
deleterious effect on the host". Depending on their mechanism of action, 
toxins can be classified into various groups such as membrane damaging, 
affecting protein synthesis, activation of second messenger pathways, 
inhabitation of the production of neurotransmitters, or activation of an 
autoimmune response (Schmitt et al, 1999). 
 
1.1 Membrane damaging toxins 
Pathogenic bacteria are able to lyse cells and damage the membrane of the 
target cells by two main mechanisms (Linder & Bernheimer, 1991). In the 
first mechanism, the cell surface may be enzymatically damaged by 
disrupting a component of the lipid bilayer. One well-characterised toxic 
enzyme is phospholipase, which is able to cleave phospholipids at the 
junction between the charged polar group (head group) and the long fatty 
acyl chains (Titball, 1999). The head group is responsible for stabilizing the 
lipid bilayer of the membrane. Thus, the cell membrane becomes leaky and 
finally lyses.  
In the second mechanism, the toxins insert into the membrane and form 
functional trans-membrane pores (Bhakdi & Tranumjensen, 1991). 
Therefore, this group of toxins is known as pore forming toxins.  This thesis 
mainly focus in two related pore forming toxins from different species of 
bacteria: the first one is Cytolysin A (ClyA) from avian pathogenic 
Escherichia coli, strain JM4660 and the second one is the non-hemolytic 
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enterotoxin (Nhe) from Bacillus cereus, strain NVH 0075/95. 
 
1.2 Pore forming toxins (PFTs) 
Pore Forming Toxins (PFTs) are one of the major groups of bacterial toxins 
(Ludwig et al, 1999) that are able to cause membrane damage. PFTs 
constitute approximately a quarter of all known bacterial protein toxins 
(Aroian & van der Goot, 2007) and are produced by many different 
organisms including both gram-positive and gram-negative bacterial species 
(Rosado et al, 2008) . Gonzalez et al, (2008) have shown that PFTs can be 
essential virulence factors of a pathogen. PFTs are released by pathogens as 
soluble, monomeric proteins (protomers) and then transformed to integral 
membrane proteins (oligomers) to form trans-membrane channels. Thus, 
they must undergo large conformational changes to create new hydrophobic 
surfaces that able to enter the core of lipid bilayer of the host membrane 
(Parker & Feil, 2005). PFTs destroy the plasma membrane by either 
delivering a toxic compound through the pore or disrupting the selective 
efflux and influx of ions through host membranes (Ludwig et al, 2004; 
Tilley et al, 2005) - in other words water diffuses into the cytoplasm, 
causing the cell to swell and burst (Figure 1.1). The ability of PFTs to 
convert, in a controlled manner, from a water soluble to a transmembrane 
form is common in this type of toxins and constitutes one of their most 
significant features (Bischofberger et al, 2009; Tilley et al, 2005). The 
mechanism of pore formation is still not understood totally but all pore 
forming toxins require the following steps: export into the medium, binding 
to the host cell, penetration into the membrane phospholipid bilayer and then 
finally formation of a trans-membrane channel (Menestrina et al, 1995). 
PFTs can be categorized according to their size or to the category of the 
structure of PFTs utilized to insert into plasma membrane (Feil et al, 2010).  
According to the secondary structure that inserts into the phospholipid 
bilayer of the plasma membrane, bacterial pore forming toxins have been 
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Figure 1.1:  Diagram illustrating the mechanism of a PFT lysing host 
cells.  
PFT causes leakage of ions and entry of water into the cell.  
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classified into two divisions (Gilbert, 2002; Tilley et al, 2005) (Figure 1.2): 
!–PFTs, which form helical channels made up of !–helices; and "–PFTs, 
which form " sheet structures such as " barrels. The formation of a pore 
involves three steps: binding to a specific receptor, unfolding of the pore 
forming part of the protein and insertion into the membrane (Tilley et al, 
2005). "-PFTs require refolding during insertion in the membrane so they 
can form transmembrane " barrels. (Tilley et al, 2005). In the two classes of 
PFTs, the hydrophobic amino acids of the protein face the acyl chains of 
phospholipid of the membrane bilayers while the hydrophilic amino acids 
face the aqueous environment of transmembrane channel (Montoya & 
Gouaux, 2003).  
Most PFTs are homo-oligomeric, for example Staphylococcus aureus !-
hemolysin (Montoya & Gouaux, 2003). However, hetero-oligomeric PFTs 
also exist, for example staphylococcal #-hemolysin and the related 
leukocidins, which form binary toxin complexes (Prevost et al, 1995) or 
tripartite PFTs such as non-hemolytic enterotoxin (Nhe) (Granum et al, 
1999; Lund & Granum, 1996), which is one of the subjects of this thesis.  
 
 1.3 An overview of some pore forming toxins  
 1.3.1 Repeats in toxin family (RTX): Escherichia coli !-hemolysin 
(HlyA) 
RTX toxins are featured by a specific structure known as the glycine and 
asparate-rich nonapeptide motif which is near the carboxy-terminal portion 
of the protein (Cortajarena et al, 2002; Goñi & Ostolaza, 1998; Linhartova et 
al, 2010), and which is repeated between 9 to 42 times (Goñi & Ostolaza, 
1998). An additional significant characteristic of the RTX family is that the 
operon comprises four genes hlyC, A, B, and D in transcriptional order 
(Boehm et al, 1990). This means that all genes coding the synthesis, 
activation, and secretion are located in the same operon.  
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Figure 1.2: The classification of a PFT according to the secondary structure that inserts into the membrane: !–PFTs that 
form amphipathic helical channels and "–PFTs that form amphipathic " sheet structures such as " barrels.  
The diagram was drawn by Prof. Pete Artymiuk (Department of MBB/University of Sheffield/United Kingdom).
!–PFT " –PFT 
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The RTX toxins have similar structures that include a receptor domain at the 
C–terminal and a pore forming domain at the N-terminal. The receptor 
domain is dependent on the addition of fatty acyl groups and the binding of 
calcium ions to glycine and asparate in the C-terminal domain. The N- 
terminal domain is predicted to form pores by the insertion of four-
transmembrane !-helical segments into the lipid bilayer. The sequences 
preceding and between these !-helices have strong amphipathic !-helical 
properties and possess membrane-binding features. For that reason, it is 
believed that RTX may be classified as a !-PFT (Stanley et al, 1998). The 
regulation of pore stability is flanked by two regions: a central domain 
containing glycine-rich repeated nonapeptide which binds calcium ions and 
the C-terminal export region (Menestrina et al, 1995).!!
The pore-forming HlyA of Escherichia coli is the best known example of an 
RTX toxin (Cortajarena et al, 2002). This protein is an extracellular toxin 
with a molecular mass of 107 kDa (Cortajarena et al, 2002; Menestrina et al, 
1995) and homologues are secreted by gram-negative pathogenic strains, 
e.g. Escherichia, Proteus, Morganella, Pasteurella, Actinobacillus and 
Bordetella (Cortajarena et al, 2001). In order to lyse cells, HlyA requires 
post-translational modification and this requires two steps:  
1) Intracellular activation by specific fatty acylation of the structure hlyA 
gene product, which requires the association of the hlyC gene product as 
well as an acyl carrier protein.  
2) Then extracellular activation takes place through binding of calcium ions 
(Goñi & Ostolaza, 1998; Stanley et al, 1994). Binding of calcium ions 
lead to the formation of short "–strands known as a parallel "-barrel or 
"–super-helix (Stanley et al, 1998).  
  
1.3.2 Staphylococcus aureus !-hemolysin 
Staphylococcus aureus !-hemolysin (!HL) is a hemolytic protein that 
classified as a "-PFT and has a molecular mass of 33 kDa in its soluble 
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monomeric form and 232.4 kDa on pure lipid bilayers or on biological 
membranes (Gouaux, 1998; Panchal & Bayley, 1995).  
The structure of !HL was determined to 1.9 Å resolution by Song et al, 
(1996), using X-ray crystallography. This showed that the transmembrane 
channel has a mushroom-like shape consisting of a cap domain, seven rim 
domains and a stem domain (Figure 1.3). The pore is a homo-oligomeric 
heptamer with general dimensions of 100 Å x 100 Å and the channel varies 
in diameter from 14 to 46 Å. To span the membrane the stem region in this 
heptameric complex, transmembrane region, uses two " strands from each 
protomer to form a 14-stranded antiparallel " sheet. The "-barrel is 
amphiphatic and contains hydrophilic and hydrophobic residues so that 
when the pore is formed the hydrophilic residues make the lumen of the pore 
whereas the hydrophobic residues interact with the membrane lipid (Feil et 
al, 2010).  
 
1.3.3 Cholesterol-dependent cytolysins (CDCs): perfringolysin O 
(PFO) 
CDCs are a superfamily of pore-forming proteins which are secreted by 
different species e.g. genera Clostridium, Streptococcus, Listeria, Bacillus, 
and Arcanobacterium (Tweten, 2005). CDCs also include the human 
proteins perforin (PF) and the complement membrane attack complex 
(MAC) (Gilbert 2010; Rosado et al, 2008). The formation of oligomeric 
transmembrane pores are dependent on the presence of cholesterol-rich 
membranes in all CDCs (Polekhina et al, 2005).  The significant sequence 
similarity between CDCs (40-80%) suggests that they all have similar 
mechanism of pore formation and 3D structures (Polekhina et al, 2005).  
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Figure 1.3: Ribbon image of the structure of the protein !-
hemolysin heptamer. (A) From the side. (B) From above. Each 
protomer is a different color. The cap domain, seven rim domains 
and stem domain are labeled (Song et al, 1996).  
Produced using PyMol (DeLano and Lam, 2005). 
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The first 3D structure of a CDC toxin was that of perfringolysin O (PFO) 
which was determined by multiple isomorphous replacement (MIR) 
(Rossjohn et al, 1997). PFO is secreted in a water-soluble form by the 
pathogen Clostridium perfringens (Dang et al, 2005). It has a molecular 
mass of 53kDa and is composed of 500 amino acid residues.  
PFO has an elongated rod-shaped appearance (approximately 115 Å ! 30 Å 
! 55 Å) and like the other "-PFTs, the monomeric structure of PFO is rich in 
" sheet and consists of four domains (Figure 1.4): the first domain is 
comprised of an #/" structure which, containing a 7-stranded antiparallel " 
sheet, the second domain has 4 " strands, the third domain consists of an #/ 
"/# three layer structure, and the last domain consist of a "-sandwich 
topology (Rossjohn et al, 1997).  
A consensus model of the PFO pore suggests that the membrane-bound 
oligomer has between 300 Å and 450 Å outer diameter, depending on the 
number of subunits of the pore which varies approximately between 40-50 
sub-units. Side views of the pore show that it forms a mushroom shape, 
between 90 Å and 100 Å in length (Rossjohn et al, 1997).  
 
1.4 Escherichia coli cytolysin A (ClyA)  
Cytolysin A (ClyA) is an #-helical pore-forming toxin. It is a hemolytic 
protein with approximate molecular weight 34 kDa, which was originally 
recognized in E. coli K-12 and is able to produce pores in the cell 
membranes of eukaryotic cells (Wallace et al, 2000). The crystal structure of 
the soluble form showed that ClyA had a novel structure that did not occur 
elsewhere in the data bank of proteins (Wallace et al, 2000). Accordingly, 
ClyA revealed the molecular architecture of a new family of toxins.  
The ClyA protein has a number of names: ClyA (cytolysin A), SheA (silent 
hemolysin A), HlyE (hemolysin E) because the earliest literature referring to 
the gene and gene product was produced by different independent research  
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Figure 1.4: 3D Crystal structure of the PFO monomer. 
The structure is revealed in ribbon representation with the four 
domains (Rossjohn et al, 1997). Produced using PyMol (DeLano and 
Lam, 2005). 
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Groups (del Castillo et al, 1997; Green & Baldwin, 1997; Oscarsson et al, 
1996). Thus the same gene had three names hlyE, clyA, and sheA.  This gene 
is located at position 26.4 min on the E. coli K-12 chromosome (GenBank 
accession no. U57430; (Green & Baldwin, 1997; Westermark et al, 2000). In 
this thesis the name ClyA will be used. 
 
1.4.1 Biological activity of Escherichia coli ClyA 
The biological activity of ClyA can be summarized as follows:   
1) Lysis of mammalian erythrocytes from various organisms, including 
human, horse, sheep, goat, and hen (del Castillo et al, 1997; Oscarsson et al, 
1996; Yadav et al, 2008).  
2) Provoking apoptosis in leukocytes especially in macrophages (Oscarsson 
et al, 1996). Lai et al, (2000) showed that ClyA induced apoptosis in both 
human and murine macrophages showing host cell DNA fragmentation.  
Consequently, it destroys the immune cells of the host organism causing 
tissue damage. Oscarsson et al, (1999) found 0.9 µg/ml of ClyA was 
sufficient to  induce cytotoxicity measured by release of Lactate 
dehydrogenase (LDH). 
3) Induced disruption of the amount of intracellular Ca2+ in epithelial cells by 
induction of slow, intracellular Ca2+ oscillations (Soderblom et al, 2005). 
 
1.4.2 The homologues of Escherichia coli ClyA  
Certain E. coli laboratory strains are considered as non-pathogenic and safe 
organisms (Rowe & Welch, 1994). Despite this long-standing belief there is 
a gene that encodes a hemolytic protein in E. coli K12 (del Castillo et al, 
1997). In fact, it seems that most non-pathogenic E. coli strains carry this 
gene and have the ability to express cytotoxic protein (Westermark et al, 
2000). 
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ClyA is not related to the well-known pore forming E. coli hemolysins of 
the RTX family, e.g. E. coli HlyA (Coote, 1992; Oscarsson et al, 1999; 
Oscarsson et al, 2002). ClyA requires no post-translational processing to 
become active, whereas RTX toxins are created firstly as a protoxin then 
activated to produce mature toxins (Stanley et al, 1994). Furthermore, ClyA 
does not need Ca2+ ions to be translocated to the periplasm to become 
activated, and it does not have sites for conserved fatty acylation or signals 
for C-terminal secretion as RTX toxins do (del Castillo et al, 1997; 
Oscarsson et al, 2002).  
The clyA gene is present in all E. coli strains including pathogenic strains of 
E. coli, O157:H7 (del Castillo et al, 1997), and porcine ETEC (Entero-
pathogenic E. coli) strain 3030-2 (Fernandez et al, 1998) as well as in the 
dysentery causing organism Shigella flexneri (del Castillo et al, 1997), and 
the typhoid fever causing bacteria Salmonella enterica serovars  Typhi and 
Paratyphi (del Castillo et al, 2001). However the gene locus is apparently 
absent in Salmonella Klebsiella pneumoniae or Serratia marcescens (del 
Castillo et al, 1997) and other Salmonella serovars, including Typhimurium 
(Oscarsson et al, 2002).  
These results show that there is a family of ClyA-like hemolysins and they 
are likely to be an important component of these organisms armory of 
toxins. Figure 1.5 summarizes the homologus ClyA proteins from members 
of the family of enterobacteriaceae.   
 
1.4.3 Regulation of ClyA expression 
1.4.3.1 positive regulation of clyA 
The clyA gene is silenced under normal laboratory growth conditions in E. 
coli K-12. The expression of clyA is regulated by both negative and positive 
controls in E. coli. ClyA is expressed during anaerobic growth of E. coli 
when the amounts of oxygen and glucose levels are low. This expression is 
affected positively by the cAMP receptor protein (CRP).  
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                           ++++++++++++++++++++++++ 
K12              MTEIVADKTVEVVKNAIETADGALDLYNKYLDQVIPWQTFDETIKELSRFKQEYSQAASV 60 
O157             MTEIVADKTVEVVKNAIETADGALDLYNKYLDQVIPWQTFDETIKELSRFKQEYSQAASV 60 
S.Typhi          MTGIFAEQTVEVVKSAIETADGALDLYNKYLDQVIPWKTFDETIKELSRFKQEYSQEASV 60 
S.Paratyphi      MTGIFAEQTVEVVKSAIETADGALDFYNKYLDQVIPWKTFDETIKELSRFKQEYSQEASV 60 
APEC             MTN--ADQTVETVKTAIDTADKALDLYNKVLDQVIPWNTFNDTVKELSRFKEEYSQSAST 58 
                 
 
K12              LVGDIKTLLMDSQDKYFEATQTVYEWCGVATQLLAAYILLFDEYNEKKASAQKDILIKVL 120 
O157             LVGNIKTLLMDSQDKYFEATQTVYEWCGVATQLLAAYILLFDEYNEKKASAQKDILIKVL 120 
S.Typhi          LVGDIKVLLMDSQDKYFEATQTVYEWCGVVTQLLSAYILLFDEYNEKKASAQKDILIRIL 120 
S.Paratyphi      LVGDIKVLLMDSQDKYFEATQTVYEWCGVVTQLLSAYILLFDEYNEKKASAQKDILIRIL 120 
APEC             LVGEIKSLLMNSQDRYFEATQVVYEWCGVTTQLLTAYLSLFNEYDEKKASAQKTILIKVL 118 
                  
                                                                         **** 
K12              DDGITKLNEAQKSLLVSSQSFNNASGKLLALDSQLTNDFSEKSSYFQSQVDKIRKEAYAG 180 
O157             DDGITKLNEAQKSLLVSSQSFNNASGKLLALDSQLTNDFSEKSSYFQSQVDKIRKEAYAG 180 
S.Typhi          DDGVKKLNEAQKSLLTSSQSFNNASGKLLALDSQLTNDFSEKSSYFQSQVDRIRKEAYAG 180 
S.Paratyphi      DDGVNKLNEAQKSLLGSSQSFNNASGKLLALDSQLTNDFSEKSSYFQSQVDRIRKEAYAG 180 
APEC             DDGIIKLEKAQQSLHASSQSFNSASGKLIALDSQLANDFDEKSDYFQGQVDKIRKEAYAG 178 
                  
                 ****** 
K12              AAAGVVAGPFGLIISYSIAAGVVEGKLIPELKNKLKSVQNFFTTLSNTVKQANKDIDAAK 240 
O157             AAAGVVAGPFGLIISYSIAAGVVEGKLIPELKNKLKSVQSFFTTLSNTVKQANKDIDAAK 240 
S.Typhi          AAAGIVAGPFGLIISYSIAAGVIEGKLIPELNNRLKTVQNFFTSLSATVKQANKDIDAAK 240 
S.Paratyphi      AAAGIVAGPFGLIISYSIAAGVIEGKLIPELNDRLKAVQNFFTSLSVTVKQANKDIDAAK 240 
APEC             AAAGVVGGPFGLIISYSIAAGVVEGKLIPALKEKLKSVKDFFESLAATVKSANTDIDKAK 238 
                  
 
K12              LKLTTEIAAIGEIKTETETTRFYVDYDDLMLSLLKEAAKKMINTCNEYQKRHGKKTLFEV 300 
O157             LKLTTEIAAIGEIKTETETTRFYVDYDDLMLSLLKEAANKMINTCNEYQKRHGKKTLFEV 300 
S.Typhi          LKLATEIAAIGEIKTETETTRFYVDYDDLMLSLLKGAAKKMINTCNEYQQRHGKKTLFEV 300 
S.Paratyphi      LKLATEIAAIGEIKTETETTRFYVDYDDLMLSLLKGAAKKMINTCNEYQQRHGKKTLLEV 300 
APEC             SKLKDEISVIGDLKTETETTRFFVDYDDLMLKQLQDSATKLILSCNEYQKRHGKKNEQPL 298 
                   
 
K12              PEV 303 
O157             PEV 303 
S.Typhi          PDV 303 
S.Paratyphi      PDI 303 
APEC             WY- 300 
 
                                         
Figure 1.5: Sequence alignment of ClyA proteins.   
Amino acid sequence alignments are shown for ClyA from E. coli K-12, E. 
coli O157, E. coli JM4660 (APEC), Salmonella typhi, and Salmonella 
paratyphi. Aliphatic/hydrophobic residues are colored red; Acidic residues 
are colored blue; basic residues are colored magenta; Hydroxyl, sulfhydryl, 
amine, and G residues are colored green. Conserved residues are shown in 
yellow background. The hydrophobic transmembrane sequence is shown by 
the (*) above the sequence.  The amphipathic (!A1), transmembrane region 
of ClyA-K12, is indicated by the (+) above the sequence. The amino acid 
sequence alignment was generated using ClustalW2 (Goujon, et al. 2010& 
Larkin, et al. 2003) (available on: http://www.ebi.ac.uk/Tools/msa/). 
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The homologous transcription factor of fumarate and nitrate reduction 
(FNR) also positively controlled the expression of ClyA in the absence of 
oxygen (Green & Baldwin, 1997). Homologues from the FNR family such 
as HlyX, which is encoded by the hlyx gene of the pig pathogen 
Actinobacillus pleuropneumoniae, are able to regulate positively a hemolytic 
phenotype on E. coli (Green & Baldwin, 1997; MacInnes et al, 1990; Ralph 
et al, 1998). The anaerobic expression of ClyA can also be controlled by 
Pasteurella multocida ahpA gene or mesA in E. coli (Cox et al, 2000; Hunt 
et al, 2000). Positive regulation of clyA can also be induced by Salmonella 
typhimurium SlyAST by binding to the clyA promoter region (Oscarsson et 
al, 1996). Other SlyAST homologous proteins such as SlyAEC and MprA 
(also known as EmrR), which have bacterial regulatory function in E. coli 
also activated clyA expression (del Castillo et al, 1997; Ludwig et al, 1995; 
Oscarsson et al, 1996).   
 
1.4.3.2 Negative regulation of clyA 
Two histone-like proteins, IHF and H-NS, appear to control the negative 
regulation of clyA (del Castillo et al, 1997).  H-NS is able to repress many 
genes in E. coli and so it seems that it may indeed repress the hemolysin of 
E. coli K-12 (GomezGomez et al, 1996). It was shown that a mutant lacking 
H-NS exhibits a hemolytic phenotype (GomezGomez et al, 1996). 
According to DNA bending analysis, the clyA promoter has high intrinsic 
curvature and it was concluded that this represents a control region that may 
be susceptible to H-NS silencing (Westermark et al, 2000).  
 
1.5 The crystal structure of E. coli K 12 ClyA  
1.5.1 Crystal Structure of E. coli K 12-ClyA as monomeric form  
The three–dimensional structure of the ClyA monomer in its water-soluble 
form was solved by using X-ray crystallography at 2.0 Å resolution 
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(Wallace et al, 2000) and the major points are discussed below: 
ClyA belongs to a novel class of bacterial toxins and it is an elongated, rod -
shaped molecule with approximate dimensions 100 Å x 30 Å x 20 Å.  
The toxin mainly consists of a long helical bundle: the main part consists of 
four ! helices:  !A1/ !A2 with distinct kink at residue PRO 36, ! B, ! C, 
and ! F. Each helix is approximately 70-80 Å long and they are coiled 
around each other with a simple up-down-up-down topology (Figure 1.6).  
However, ClyA has significant novel structure elaborations at both ends: 
At the lower end of the ClyA monomer (also known as the tail domain) 
there is a fifth G helix at the C-terminal. The G helix consists of 24 residues 
and is approximately 35 Å long and adds a fifth helix to the bundle and it is 
located in a space between helices A and B. The tail domain also hosts two 
cysteine residues, which are located on the B and G helices and which are 
sufficiently close to form a disulfide bond.  However, the "-sulphydryl 
atoms of two cysteine residues (CYS 87, 285) are separated by 4.1 Å, which 
is longer than the expected 2.2 Å for a disulphide bond. 
Replacement of CYS by SER in ClyA shows that neither is necessary for the 
structure to cause hemolytic activity but the two cysteines seem to contribute 
to the thermostability of ClyA.  The incorporation of a disulphide bond 
within ClyA caused a decrease in hemolytic activity, hence suggesting that a 
disulphide bond may inhibit pore formation by preventing premature 
oligomerisation of ClyA (Atkins et al, 2000).  
Wai et al, (2003) found that most of ClyA in the periplasm was monomeric 
and in an oxidised form, whereas ClyA exported in outer-membrane vesicles 
(OMVs) was oligomeric and present in the reduced form.  This led to further 
speculation that oligomerisation to form active pores is dependent on redox 
status (Wai et al, 2003). In spite of this, another research group Eifler et al, 
(2006) found that the redox state of ClyA had no effect on oligomerisation 
or activity of ClyA as they found ClyA remained monomeric in any case of 
redox state and that both forms of ClyA, reduced and oxidised, have similar  
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Figure. 1.6: The 3D crystal structure of monomeric soluble E.coli K-12 
ClyA consist of four !–helices (!A, !B, !C and !F), two Cysteine residues 
(black circles), and ! ß-hairpain in the head domain. The C and N terminal 
and !G helix in the tail domain are labelled (Wallace et al, 2000). Produced 
using PyMol (DeLano and Lam, 2005). 
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activity against horse erythrocytes (Eifler et al, 2006). 
The second novel elaboration, the upper end (also known as the head 
domain) of ClyA consists of a short ß hairpin (the "ß tongue") flanked by 
two shorter helices D and E. The ß tongue packs between helices C and, F. 
The ß hairpin contains the main hydrophobic region on the ClyA surface. 
Hence, Wallace et al, (2000) suggested that the ß tongue interacts with lipid 
membrane. 
Wallace et al, (2000) stated that the most significant region of the amino 
acid sequence of ClyA is between residues 177 and 203, which are 
hydrophobic. In addition, there is a shorter hydrophobic region from 
residues 89 to 101. It has been suggested that the longer hydrophobic region 
in ClyA plays an important role in the insertion of toxin into cell membranes 
and it was predicted as transmembrane helix.  
 
1.5.2 Models for pore formation 
Wallace et al, (2000) proposed a conservative preliminary, octameric model 
for pore formation after describing the 3D crystal structure of ClyA. It was 
proposed that the flat face of the head domains “! tongue” would interact 
with the hydrophobic lipid bilayer with no major conformational change to 
allow ClyA to form a pore.  
By using cryo-electron microscopy and single particle analysis Eifler et al, 
(2006) visualized the oligmeric pore structure at 12 Å resolution. This 
showed the ClyA pore form appeared to be an assembly of 13 monomers of 
ClyA. They suggested that the head domain “! tongue” of ClyA could form 
a 26-stranded ! barrel cap structure during membrane insertion. However, in 
direct contradiction of this, Tzokov et al, (2006) showed the pores appeared 
to the pores consist of 8 ClyA subunits. 
Both Eifler et al, (2006) and Tzokov et al, (2006) found that the pore 
assemblies are much longer than the soluble ClyA structure (Wallace et al, 
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2000) which suggested that conformational changes of ClyA monomers 
must take place. 
Hunt et al, (2008) also showed that there are rate limiting conformational 
changes when ClyA forms a pore and they proposed that conformational 
changes of ClyA are expected when the protein binds to the lipid bilayer of 
the plasma membrane. 
 
1.5.3 Crystal Structure of ClyA E. coli K 12 pore form  
After the conflicting hypotheses of octameric (Tzokov et al, 2006) and 13-
meric (Eifler et al, 2006) pores, it is now widely accepted that a 12-meric 
pore is produced in E. coli ClyA K12. This is a result of the publication of 
the crystal structure of the detergent-solubilized soluble pore form of ClyA 
(Mueller et al, 2009), the first crystal structure of a membrane-bound  !-PFT 
and second of any membrane-bound PFT.     
The 12-meric pore structure has been determined by X-ray crystallography 
to 3.3 Å resolution and it shows that the ClyA monomers undergo large 
conformational changes before oligomerization can occur (Mueller et al, 
2009).  The assembled ClyA pore forms a hollow cylinder in the membrane 
and measures up to 130 Å in height, an inner diameter of 70 Å and outer 
diameter of 105 Å (Figure 1.7). Mueller et al, (2009) reported that huge 
conformational changes occur in the conversion of the ClyA monomer to the 
protomer, with more than half the residues being affected and the head 
domain being completely rearranged!"In fact the content of ! helices in the 
ClyA pore form increased from 79% to 83% compared with the soluble 
form.  
The protomers are arranged in a parallel head to head orientation and in 
contrast to the four main helices (!A, !B, !C, and !F) that were observed in 
the water-soluble form of ClyA, the pore form of ClyA consists of a three !-
helix bundle (!B, !C, and !F) in each protomer there is a large translocation 
of helix !A, whose N-terminal end forms a constriction at top of the pore. 
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Figure 1.7: Ribbon image of the structure of the dodecameric 
transmembrane ClyA-K12 pore form (Mueller et al, 2009).  
(A) From the top, (B) From bottom, and (C) from the side. Each protomer is 
a different color. The protomers are oriented head to head and parallel to the 
symmetry axis of the pore. Produced using PyMol (DeLano and Lam, 2005).  
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At the bottom of the pore, !G at the C-terminus flanks the three helices in 
the outside of the pore.  
The protomers are tied together by the formation of a network of a 25 
hydrogen bounds and 13 salt bridges between each pair of protomers in the 
pore. 
To summarize the mechanism of the rearrangements of the body of the ClyA 
molecule to allow the conformational change to occur caused by membrane 
insertion (Mueller et al, 2009) (Figure 1.8): 
1. The ß-tongue associates with the lipid membrane. 
2. The ß-tongue spontaneously inserts into the membrane due to its strong 
hydrophobic character. This disrupts the hydrophobic core of the head 
region and causes the 2 flanking helices (!D and !E) to straighten out and 
refold to become transmembrane ! helix region as previously suggested by 
Hunt et al, (2008). As a result, !D with ß1 becomes a helical extension to ! 
C, and ! E with ß2 becomes an extension to !F.  
3. Helix !A2 becomes an extension to !B, converting the body of the 
protomers from a 4 to a 3 helices bundle. However the amphipathic !A1 
relocates by approximately 180°, resulting in a repositioning of its N 
terminus by more than 140 Å and then attaching to the membrane. Thus, 
distinct kink in the soluble form between !A1 and !A2 at residue PRO 36 
becomes now part of the turn between !A1 and the extended !B of the 
protomer. 
4. !F moves into the position previously occupied by !A1. Then the 
oligomerization of protomers can begin. 
5. The !A1 helix is now lying at the membrane surface, and closing of the 
pore causes !A to buckle and form an iris-like interlocking region, which 
keeps the pore open. The helices then wedge up to form a hole in the 
membrane.  
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Figure 1.8: Conformational changes between the monomer and 
protomer forms of ClyA-K12. (A, C) the soluble form, and (B, D) the 
protomer in the pore form. In (C) the numbered arrows summariz the order 
of the rearrangements of the body of ClyA molecule proposed to allow the 
conformational change that occurs on membrane insertion (Mueller et al, 
2009). Ribbon images in (A, B) Produced using PyMol (DeLano and Lam, 
2005).  
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The pore assembly structure fits fairly well in the electron microscopy 
envelope (Figure 1.9). Extra density at the lower edge of the microscopy 
envelope represents lipids and detergent. 
 
1.6 Comparison of Avian pathogenic E. coli strain (APEC) 
JM4660 ClyA with E. coli K-12 ClyA 
ClyA was first discovered in E. coli K-12, but alignment of the encoded 
APEC ClyA with E. coli K-12 ClyA revealed 75% identity in their amino 
acid sequences and this protein will be used in this project.  
APEC ClyA isolate (JM4660) encodes a gene, which has 71% identity at the 
nucleotide level to clyA (Reingold et al, 1999). The isoelectric points (IP) 
proved to be the same for both K-12 ClyA and APEC ClyA proteins (5.14), 
together with similar molecular weights of 34.6 kDa for APEC ClyA and 
32.2 kDa for the E. coli K-12 ClyA.  
There was an error in the published APEC ClyA sequence (Reingold et al, 
1999). Wyborn et al, (2004) reported that at amino acid 188, JM4660 ClyA 
sequence encodes aliphatic neutral amino acid Glycine (GLY or G; GGG 
codon) instead of the polar hydrophilic charged amino acid Arginine (ARG 
or R; AGG codon) that was shown by Reingold et al, (1999). Residue 188 is 
in the hydrophobic !-tongue of ClyA and would have had serious 
implications for the interaction of ClyA with cell membranes (Figure 1.10) 
if it had been an ARG. APEC ClyA contains 76 other correct amino acid 
substitutions as reported by Reingold et al, (1999) when compared to the K-
12 ClyA (Wyborn et al, 2004).  
Both K-12 ClyA and APEC ClyA have similar properties, being active 
against red blood cells. However, APEC JM4660 ClyA may be 
advantageous to study due to its higher thermostability (consistent with the 
fact that birds have a higher core temperature than mammals). In addition 
APEC ClyA is more homogenous as the estimation of the native molecular 
mass; K-12 ClyA presents as mixture of monomers, dimers, and superior  
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Figure 1.9: Single particle electron microscopy derived envelope of the 
ClyA pore assemblies.  
(A)  One of a big problem with the ClyA monomer structure is that the pore 
assemblies are much longer than the soluble ClyA structure, which means 
that the conformational changes must take place.  
(B) The dodecameric transmembrane ClyA-K12 (Mueller et al, 2009) 
assembly structure fits fairly well in the electron microscopy envelope after 
conformational changes take place. The diagram was drawn by Prof. Pete 
Artymiuk (department of MBB/University of Sheffield/United Kingdom). 
B 
A 
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APEC1           MTN--ADQTVETVKTAIDTADKALDLYNKVLDQVIPWNTFNDTVKELSRFKEEYSQSAST 58 
APEC2           MTN--ADQTVETVKTAIDTADKALDLYNKVLDQVIPWNTFNDTVKELSRFKEEYSQSAST 58 
K12             MTEIVADKTVEVVKNAIETADGALDLYNKYLDQVIPWQTFDETIKELSRFKQEYSQAASV 60 
                 
 
APEC1           LVGEIKSLLMNSQDRYFEATQVVYEWCGVTTQLLTAYLSLFNEYDEKKASAQKTILIKVL 118 
APEC2           LVGEIKSLLMNSQDRYFEATQVVYEWCGVTTQLLTAYLSLFNEYDEKKASAQKTILIKVL 118 
K12             LVGDIKTLLMDSQDKYFEATQTVYEWCGVATQLLAAYILLFDEYNEKKASAQKDILIKVL 120 
 
 
APEC1           DDGIIKLEKAQQSLHASSQSFNSASGKLIALDSQLANDFDEKSDYFQGQVDKIRKEAYAG 178 
APEC2           DDGIIKLEKAQQSLHASSQSFNSASGKLIALDSQLANDFDEKSDYFQGQVDKIRKEAYAG 178 
K12             DDGITKLNEAQKSLLVSSQSFNNASGKLLALDSQLTNDFSEKSSYFQSQVDKIRKEAYAG 180 
 
 
APEC1           AAAGVVGRPFGLIISYSIAAGVVEGKLIPALKEKLKSVKDFFESLAATVKSANTDIDKAK 238 
APEC2           AAAGVVGGPFGLIISYSIAAGVVEGKLIPALKEKLKSVKDFFESLAATVKSANTDIDKAK 238 
K12             AAAGVVAGPFGLIISYSIAAGVVEGKLIPELKNKLKSVQNFFTTLSNTVKQANKDIDAAK 240 
                 
 
APEC1           SKLKDEISVIGDLKTETETTRFFVDYDDLMLKQLQDSATKLILSCNEYQKRHGKKNEQPL 298 
APEC2           SKLKDEISVIGDLKTETETTRFFVDYDDLMLKQLQDSATKLILSCNEYQKRHGKKNEQPL 298 
K12             LKLTTEIAAIGEIKTETETTRFYVDYDDLMLSLLKEAAKKMINTCNEYQKRHGKKTLFEV 300 
                  
 
APEC1           WY- 300 
APEC2           WY- 300 
K12             PEV 303 
 
 
 
 
 
 
Figure 1.10: Amino acid sequence alignment of ClyA-K12 and APEC 
ClyA.  
APEC1 ClyA was determined by Reingold et al (1999); APEC2 ClyA was 
corrected by Wyborn et al (2004). The ClyA K-12 sequence is used as the 
reference sequence. The correct APEC ClyA (APEC2) sequence encodes 
the aliphatic neutral amino acid Glycine (GLY or G) (Wyborn et al 2004) at 
residues 188 instead of the polar hydrophilic charged amino acid Arginine 
(ARG or R) as incorrectly reported by Reingold et al (1999). The original 
APEC1 ClyA sequence is coloured in red. The amino acid sequence 
alignment was generated using ClustalW2 (Goujon, et al. 2010& Larkin, et 
al. 2003) (available on: http://www.ebi.ac.uk/Tools/msa/). 
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order aggregates (Atkins et al, 2000) while the most of JM4660 ClyA was 
dimeric in solution (Wyborn et al, 2004). 
 
1.7 Pore formation By E. coli K-12 ClyA and APEC ClyA by 
elecron microscopy 
Electron microscopy of negatively-stained ClyA E. coli K-12 in lipid 
vesicles showed many stain-filled ring-shaped pore assemblies (Wallace et 
al, 2000). They showed that most of the pores are circular shaped structures 
when the pore is viewed from above (Figure 1.11). They estimated that 62% 
of the individual pores had an internal diameter of 42-52 Å and an external 
diameter of 70-90 Å while 36% of them were bigger than this (having an 
inner pore diameter of 55-60 Å and an external diameter of 90-105 Å). Also, 
the pores can be seen as spikes when they are viewed from the side, 
approximately 105 -110 Å long. These observations by electron microscopy 
show that the ClyA E. coli K-12 monomers oligomerize to build channels 
that project from the cell membrane. Pores formed by APEC ClyA were 
more homogeneous than ClyA K-12 ones with an inner diameter 36-41 Å 
(Wyborn et al, 2004). As observed with ClyA E. coli K-12, the side views of 
the APEC ClyA pore assembly can be seen as spikes 90-100 Å long 
(Wyborn et al, 2004). This greater consistency in size means they may be 
more suitable for structural studies.  
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Figure 1.11: Electron micrograph of negative stained ClyA-K12 in lipid 
vesicles.  
Stain-filled rings (R) are apparent in views normal to the membrane. Some 
pores show a central stain-excluding density (E). Side views of the pore 
appear as spikes (S). Scale bar (lower left) represents 200 Å.  
Republished from Wallace et al (2000), with permission from Elsevier. 
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1.8 The first aim of this project  
When my project started in November 2008 using mainly X-ray 
crystallographic analysis, my aim was to grow crystals of the pore form of 
APEC ClyA. I was eventually able to grow crystals of APEC ClyA in the 
presence of detergent that produced low-resolution diffraction to 7 Å as 
described in chapter 4. While these crystallization attempts were on-going, 
the structure of the pore form of E. coli K-12 ClyA, was determined to 3.3 Å 
resolution (Mueller et al, 2009). This structure revealed the 12-meric pore 
structure  (described in 1.5.3). Because of the similarity between K-12 ClyA 
and APEC ClyA, it is very likely that a 12-meric pore is will also be 
produced by APEC ClyA, with the monomers undergoing the same large 
conformational changes before oligomerization can occur.  
However, other oligomeric states and conformations may also possible as a 
result of the variability in pore size which has been observed by EM (Eifler 
et al, 2006; Tzokov et al, 2006) and there is interest in solving alternative 
structure to clarify the following questions:  
 
! The pores appear to exist in two forms: an open pore in mammalian 
that is hemolytic, and a closed pore in E. coli that is not haemolytic (Wai et 
al, 2003). So, what is the appearance of the “closed” form in relationship to 
the open pore (Mueller et al, 2009)? i.e. what are the conformational 
differences between closed and open pores?  
! Does the G-helix move and does its movement contribute to closure of 
the pore?  
! Is there any mobility in ! tongue region in the soluble form?  
Therefore, we attempted to solve the crystal structure of APEC ClyA pores 
with detergents or lipids by X-ray crystallography and EM at higher 
resolution. This would hopefully have helped to answer the above questions 
and could have provided further important details to the understanding of 
pore formation and structure.  
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1.9 ClyA like toxins from Bacillus cereus  
Sequence searches show that ClyA has sequence homologues in E. coli, 
Shigella flexneri and Salmonella typhi and Salmonella paratyphi. The three 
dimensional crystal structure of ClyA had a novel structure that did not 
occur elsewhere in the data bank of proteins, based on searches of the 
structural databases (Wallace et al, 2000). Recently, however the three 
dimensional crystal structure of hemolysin BL component B (HblB) from 
Bacillus cereus was solved (Madegowda et al, 2008). This showed that 
HblB has very strong structure similarity with ClyA even through there is a 
little sequence homology between ClyA and B. cereus toxins (Madegowda 
et al, 2008). In addition, the strong sequence relationship of Hbl with the 
non hemolytic enterotoxin (Nhe) from B. cereus implied a possible 
similarity in structure and function between Nhe and ClyA (Fagerlund et al, 
2008). This showed that E. coli ClyA, Nhe, and Hbl of B. cereus could 
represent a novel super-family of pore forming toxins.  
The next sections provide a context for consideration of the protein that is 
the main focus of this thesis: the Non-hemolytic enterotoxin Nhe protein 
from B. cereus.  
 
1.10 Bacillus cereus 
 B. cereus belongs to the family Bacillaceae. It is a gram positive, rod 
shaped, and spore-forming bacterium, ubiquitous, aerobic or facultative 
anaerobic, motile, widespread in nature including soils (mainly rice paddy 
soil), sediments, meat, egg, dust, natural water, hair of animal, dairy 
products and vegetation (Granum & Lund, 1997; Kramer & Gilbert., 1989). 
It can also be found in drugs, including both topical and oral pharmacetutical 
products (Garcia Arribas et al, 1988). The full genomes have been 
sequenced for B. cereus strains ATCC 14579 (Ivanova et al, 2003), ATCC 
10987 (Rasko et al, 2004), G9241(Hoffmaster et al, 2004).  
Due to the ability of B. cereus to form spores it has strong resistance to 
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extreme environmental conditions such as heat and chemical treatments, as 
well as freezing, drying, dehydration, enzymatic attack and radiation 
(Kotiranta et al, 2000; Setlow & Setlow, 1995). 
 
1.11 Illness caused by Bacillus cereus 
B. cereus is now recognized as a common agent of food- poisoning illness in 
humans. It can cause two different forms of food-poisoning: the emetic and 
diarrheal type (Kotiranta et al, 2000).  
 
1.11.1 The emetic gastrointestinal diseases  
The emetic syndrome was identified early in the 1970s in the United 
Kingdom, being caused by the ingestion of the preformed toxins in food. 
The emetic toxin that is known as cereluide causes nausea and vomiting a 
few hours after ingestion of contaminated food, rarely followed by 
abdominal cramping or diarrhea (Kramer & Gilbert, 1989). Other studies 
have indicated the high toxicity potential of cereluide including 
immunomodulatory and neuro- and hepatotoxic modes of action (Andersson 
et al, 2007; Mikkola et al, 1999; Paananen et al, 2002).  
 
Cereluide is an ionophoric, cyclic dodecadepsipeptide with molecular 
weight 1.2 kDa and consisting of !-amino and !-hydroxy acids (D-O-Leu-D-
Ala-L-O-Val-L-Val)3 (Agata et al, 1994), synthesized by a non-ribosomal 
peptide synthetase, encoded by the ces genes (Ehling-Schulz et al, 2005a; 
Ehling-Schulz et al, 2005b). It is a stable toxin due to its strong resistance to 
low pH (as low as 2), heat and to proteolysis. Therefore, this toxin cannot be 
inactivated in the acidic environment of the stomach or by enzyme 
proteolytic activity in the intestinal tract (Ehling-Schulz et al, 2004; Frenzel 
et al, 2011; Pexara & Govaris, 2010). Frenzel et al, (2011) shows that use of 
commercial polyphosphate blends could control and inhibit cereulide 
synthesis in food, mainly where B. cereus spores cannot be inactivated 
 45 
during processing or preparation steps. 
 
 
1.11.2 The diarrheal gastrointestinal diseases 
B. cereus caused diarrhea was identified in Norway in 1947-1949 (Hauge, 
1955). It is caused by enterotoxins which form during vegetative growth of 
B. cereus in the small intestine of the host organism (Granum et al, 1993). 
The diarrheal syndrome appears 8–16 hours after ingestion and is 
characterized by abdominal pain and watery diarrhea without vomiting or 
fever.  
 
At the present time, at least three different pore forming enterotoxins appear 
to be responsible for diarrheal type and involved in food-poisoning: two 
protein complexes, hemolysin BL (Hbl) (Beecher & Macmillan, 1991; 
Beecher et al, 1995) and non-hemolytic enterotoxin (Nhe) (Granum et al, 
1999; Lund & Granum, 1996), and the cytotoxin K (CytK) (Lund et al, 
2000).  
 
 
1.12 The Bacillus cereus protein enterotoxins 
1.12.1  Bacillus cereus Cytotoxin K  (CytK) 
CytK is a single pore forming cytotoxic protein with a molecular mass 34 
kDa and encoded by cytK. CytK has vascular permeability activity against 
epithelial cells in the small intestine, and causes fluid accumulation in cells 
(Lund et al, 2000). This toxin has been isolated from B. cereus strain 391/98 
that does not contain genes for the other known B. cereus enterotoxins Hbl 
and Nhe (Fagerlund et al, 2004).  This strain was responsible for an acute 
food poisoning in outbreak France (Lund et al, 2000). CytK forms weakly 
anion selective pores in planar lipid bilayers with 7 Å in diameter.  
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The CytK amino acid sequence shows similarity to Staphylococcus aureus 
!-hemolysin toxin and Clostridium perfringens "-toxin (Gouaux, 1998; 
Lund et al, 2000; Steinthorsdottir et al, 2000), which belong to the family of 
"-barrel pore-forming toxins (discussed in section 1.3.2). This suggests that 
CytK may also classified as a "-barrel pore-forming toxin (Lund et al, 
2000).  
 
1.12.2 Bacillus cereus hemolysin BL (Hbl) 
Hemolysin BL (Hbl) is a complex pore forming toxin, consisting of three-
components: Hbl component B which is reported as a binding protein (35 
kDa) to lipid bilayer, and two lytic proteins: Hbl component L1 (36 kDa), 
and Hbl component L2 (45 kDa) (Beecher & Macmillan, 1991).  None of 
these proteins are active individually and all of them are required for 
maximal cytotoxicity (Beecher & Macmillan, 1991; Beecher et al, 1995). 
However, Beecher & Wong, (1997) reported that all the three components 
are able to bind separately to the red blood cells (RBCs) surface in 
experiments where one Hbl proteins was added to RBCs , then washed, then 
the another two Hbl protein caused hemolysis regardless of which Hbl 
proteins was first added.  
 
HblB, HblL1, and HblL2 are encoded by the genes hbA, hbD, and hbC 
respectively and have been cloned and sequenced from the B. cereus strain 
F837/76. These genes are located in the same operon and give a 5.5 kb 
mRNA transcript (Heinrichs et al, 1993; Lindbäck et al, 1999; Ryan et al, 
1997). Lindbäck et al, (1999) indicated that the cytotoxic activity of Hbl was 
decreased by disruption of the hbl operon in B. cereus strain ATCC14579.  
 
Hbl is able to lyse Vero cells, and it has hemolytic activity against some 
mammalian cells such as sheep, bovine and mouse erythrocytes but not 
against human, horse and rabbit erythrocytes (Beecher & Macmillan, 1990; 
Beecher & Wong, 2000). It also caused fluid accumulation in rabbit ileal 
loops (Beecher et al, 1995).  
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Madegowda et al, (2008) solved the 3D crystal structure of Hbl component 
B at 2 Å resolution using multiple anomalous dispersion (MAD) phasing. 
HblB has long !-helical bundle and elongated structure with dimensions of 
90 Å x 40 Å x 30 Å. There are four major helices in the polypeptide chain, ! 
A (GLU 19- LYS 45), !B (ASP 61- ASN 114) with distinct kinks in LYS 
83-VAL 84, !C (GLY 118- ASN 174), and !F (TYR 244- ALA 297) 
(Figure 1.12).  
Like ClyA, HblB has two sub-domains at both ends, which resemble the two 
novel domains in ClyA: 
-The head domain, which consists of an !/ " hydrophobic hairpin, ! 
D (ASP 177- LEU 189) with distinct kinks at LEU 189- GLY 190, !E (ARG 
225- GLN 240) with distinct kinks at LEU 228-GLY 229, and two short 
strands "1 and "2. 
-The tail domain that is made up of !G (LYS 307-LYS 335) at the C 
terminal with distinct kinks at LYS 310- PRO 311.  
Using DALI (Holm & Rosenström, 2010), it was shown that there is a high 
structural similarity between HblB and K-12 ClyA (Figure 1.13) with a Z-
score of 13.7, although sequence alignment showed a limited match 
(sequence identity = 16%) (Figure 1.14) (Madegowda et al, 2008). As well 
as the relationship between HblB and K-12 ClyA in structure, both of them 
possess the same function, which includes pore formation with cytotoxic and 
hemolytic activity (Madegowda et al, 2008) and so may represent a new 
superfamily of pore forming toxins.  
The main difference between HblB and K-12 ClyA is the orientation of the 
head domain. The head domain in HblB is turned downward and makes 
interactions with the tail domain. However the head domain in K-12 ClyA 
turned is turned upward with a only small interaction with the tail domain 
(Figure 1.13)! (Madegowda et al, 2008). This could represent two different 
conformations in the two structures (Fagerlund et al, 2008). 
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Figure. 1.12: The 3D crystal structure of monomeric HblB (Madegowda 
et al, 2008).  
The main body consists of !A, !B, !C, and !F. The head domain has two 
shorter !-helices, labelled !D and !E, with two strands " 1 and " 2. !G is 
located in tail domain.  
Figure was produced using PyMol (DeLano and Lam, 2005). 
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Figure 1.13: Superimposed structures of HblB (cyan) and K-12 ClyA 
(pink). 
 It is clear that the main difference is in the !-tongue region. The !-tongue is 
turned upward and connects with the tail domain in HblB, but it is turned 
downward in ClyA. The image was produced using the Dali server (Holm 
and Rosenström 2010). 
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ClyA            MTEIVADKTVEVVKNAIETADGALDLYNKYLDQVIPWQTFD----------ETIKELSRF 50 
HblB            MMKKIPYKLLAASAFLTLTTTSVVSPVATFASEIQQTNTEDSLSANDVKMKETLQKAGLF 60 
                * : :. * : .      *: ..:.   .: .::   :* *          **::: . * 
 
 
ClyA            KQEYSQAASVLVG----DIKTLLMD---------SQDKYFEATQTVYEWCGVATQLLA-- 95 
HblB            AKSMNAYSYMLIKNPDVNFEGITINGYVDLPGRIVQDQKNARAHAVTWDTKVKKQLLDTL 120 
                 :. .  : :*:     ::: : ::          **:    :::*     * .***    
 
 
ClyA            ----AYILLFDEYNEKKASAQKDILIKVLDDGITKLNEAQKSLLVSSQSFNNASGKLLAL 151 
HblB            TGIVEYDTTFDNYYETMVDAINTGDGETLKEGITDLRGEIQQNQRYAQQLIEELTKLRDS 180 
                     *   **:* *. ..* :    :.*.:***.*.   :.    :*.: :   **    
 
 
ClyA            DSQLTNDFSEKSSYFQSQVDKIRKEAYAG-----AAAG---------------VVAGPFG 191 
HblB            IGQDVRAFGSNKDLLQSILKNQGADVEADQKRLEEVLGSVNYYKQLESDGFNVMKGAILG 240 
                 .* .. *..:.. :** :.:   :. *.      . *               : .. :* 
 
 
ClyA            LIISYSIAAGVVEGKL--IPELKNKLKSVQNFFTTLSNTVKQANKDIDAAKLKLTTEIAA 249 
HblB            LPIIGGIIVGVARDNLGKLEPLLAELRQTVDYKVTLNRVVGVAYSNINEMHKALDDAINA 300 
                * *  .* .**...:*  :  *  :*:.. :: .**...*  * .:*:  :  *   * * 
 
 
ClyA            IGEIKT-------------------ETETTRFYVDYDDLMLSLLKEAAKKMINTCNEYQK 290 
HblB            LTYMSTQWHDLDSQYSGVLGHIENAAQKADQNKFKFLKPNLNAAKDSWKTLRTDAVTLKE 360 
                :  :.*                     :: :  ..: .  *.  *:: *.: . .   :: 
 
 
ClyA            RHGKKTLFEVPEV- 303 
HblB            GIKELKVETVTPQK 374 
                   : .:  *. 
 
 
 
 
Figure 1.14: Amino acid alignment of B. cereus HblB and E. Coli ClyA-
K12.  
Hydrophobic residues are colored red; acidic residues are colored blue; basic 
residues are colored magenta; hydroxyl, sulfhydryl, amine, and G residues 
are colored green. (* Asterisk) shows a fully conserved residue.  
(: Colon) shows conservation between groups of strongly similar properties. 
(. Period) shows conservation between groups of weakly similar properties. 
The hydrophobic transmembrane sequence is highlighted by yellow 
background in ClyA-K12 and grey background in HblB. 
The amino acids sequence alignment was generated using ClustalW2 
(Goujon, et al. 2010& Larkin, et al. 2003) (available on: 
http://www.ebi.ac.uk/Tools/msa/). 
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1.12.3. Bacillus cereus non-hemolytic enterotoxins (Nhe) 
Besides Hbl, another enterotoxin complex known as the non-hemolytic 
enterotoxin (Nhe), represents a major pathogenicity factor involved in the 
etiology of B. cereus diarrheal syndrome.  
Nhe is a complex pore-forming toxin consisting of three proteins (Table 
1.1): NheA (41 kDa), NheB (39.8 kDa), NheC (36.5 kDa) (Granum et al, 
1999) that was isolated firstly from B. cereus strain 0075/95, which lacks the 
hbl genes and cytK gene and was involved in a large food–poisoning 
outbreak in Norway in 1995 (Lund & Granum, 1996). In initial studies Lund 
& Granum, (1999) suggested that a collagenase (105 kDa) was part of the 
Nhe complex but this was later found to be wrong (Granum et al, 1999). 
Sequencing of the nhe operon (Figure 1.15) indicated that it is composed of 
three open reading frames: nheA, nheB, and nheC and it was found that all 
three proteins are required for maximal toxicity (Granum et al, 1999).  
NheC is produced by B. cereus in much lower amounts than NheA and 
NheB, and thus NheC has never been isolated and purified from B. cereus 
supernatant culture. Use of a specific antibody confirmed the presence of 
NheC in lower amounts than NheA and NheB (Dietrich et al, 2005). In 
contrast to the Nhe proteins, Hbl proteins have been isolated from B. cereus 
supernatant culture and all of them appear to present in approximately the 
same amount (Beecher & Macmillan, 1991).  
Because an original study (Lindbäck et al, 2004) on Nhe wrongly indicated 
this toxin did not have hemolytic activity it was misnamed “non-hemolytic 
enterotoxin”. However, further study confirmed the ability of Nhe to lyse 
mammalian erythrocytes from various organisms, including human, horse, 
cat, bovine, dog and pig (Fagerlund et al, 2008) although with less hemolytic 
activity than Hbl. In addition, Nhe has cytotoxic activity against epithelial 
cells, indicated by loss of cellular Adenosine-5'-triphosphate (ATP) and 
LDH release (Fagerlund et al, 2008). To obtain the maximum cytotoxic 
activity the ratio of NheA: NheB: NheC should be 10:10:1 as determined in 
a Vero cells assay and reported by Lindbäck et al, (2004).  
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Table 1.1: Shows the characteristics of Nhe proteins. According to 
http://web.expasy.org/protparam/  (Gasteiger et al, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15: The nhe operon shows the site of nheA, nheB and nheC.  
The numbers illustrate the start and stop point of the three genes. (Granum et 
al, 1999). 
 
 
 
 
 
 
 
Protein Number of 
amino acids 
 
Molecular weight 
(MW) 
 
Theoretical pI 
(isoelectric point) 
NheA 386 43742.5 5.22 
NheB 402 43119.0 6.85 
NheC 359 39877.3 5.91 
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Also, it was noticed that increasing the concentration of NheC inhibited the 
cytotoxic activity. The function of NheC is not clear yet but it may act as 
catalyst by bringing NheA to NheB after binding of NheB to target 
membranes or it may enhance conformational changes (Lindbäck et al, 
2004). However, it has also been reported that NheA and NheB in the 
absence of NheC are necessary and sufficient for formation of large-
conductance channels in rodent pituitary cells (GH4), which are the largest 
channels observed in cell membranes (Haug et al, 2010). However, in 
primate epithelial cells (Vero) addition of NheC is required for forming 
channels (Haug et al, 2010).   
The detailed mechanism behind pore-formation of the toxin is unknown, but 
is presumed to follow a pattern that involves membrane binding, 
oligomerization and finally insertion of the transmembrane regions to form 
the pore. It has previously been shown that NheB is the only component 
which can bind alone to the cell surface of the Vero cells (Lindbäck et al, 
2004) but recently it has been shown that NheC also binds to the membrane 
of Vero cells but NheA lacks this ability (Lindbäck et al, 2010).  
NheB and NheC share 44% sequence identity but NheA has only 22% 
identity with NheB and NheC. To produce cytotoxic activity, it has been 
demonstrated that Nhe requires a specific binding order of the individual 
proteins whereby the presence of NheB and NheC is necessary in the 
priming step, and NheA is required in the final incubation stage of pore 
formation (Lindbäck et al, 2010) 
Nhe proteins have significant sequence homology to Hbl components 
(Figure 1.16) and (Table 1.2) but do not have significant sequence similarity 
to other known proteins. This means that all Nhe proteins and Hbl proteins 
belong to same protein family. Beside sequence similarities NheA and 
HblL2 have no predicted transmembrane region, while NheB and HblL1 
have two transmembrane helices. Finally, NheC and HblB each have one 
predicted transmembrane helix, in the same position of the two proteins 
(Granum et al, 1999) (Figure 1.17).  
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NheC            -MQKRFYKKCLLTLMIAGVATSNAFPLHTFAAEQNVKIQQENAN--------DYSLGPAG 51 
HblL1           -MKKLPFKVLAVATLATFITATNGNTIHVLAQEQTAQEQ----------KVGNYALGPEG 49 
HblB            MMKKIPYKLLAASAFLTLTTTSVVSPVATFASEIQQTNT-----------EDSLSANDVK 49 
NheA            -----MKKTLITGLLVTAVSTSCFIPVSAYAKEGQTEVKT---------VYAQNVIAPNT 46 
HblL2           -----MKNKIMTGFLITSIVTGATIPINTLATPIVQAETP---------------QESID 40 
                       :      : :   :    .  . *                              
 
NheB            LKDAMERTGSNALVMDLYALTIIKQGNVNFG--NVSSVDAALKGKVIQHQDTARGNAKQW 117 
NheC            FQDVMAQTTSSIFAMDSYAKLIQNQQETDLS--KISSINGELKGNMIQHQRDAKMNAAYW 109 
HblL1           LKTALAQTGSHILVMDLYAKTMIKQPNVNLSNIELGSEGAALIKSIHLNQELARINANYW 109 
HblB            MKETLQKAGLFAKSMNAYSYMLIKNPDVNFEGITINGY-VDLPGRIVQDQKNARAHAVTW 108 
NheA            LSNSIRMLGSQSPLIQAYGLVILQQPDIKVN----------AMSSLTNHQKFAKANVREW 96 
HblL2           ISSSLRKLGAQSKLIQTYIDQSLMSPNVQLE----------EVPALHSNQSLIQQDMKEW 90 
                :.  :         :: *      . : ..               :  .*   : .   * 
 
NheB            LDVLKPQLISTNQNIINYNTKFQNYYDTLVAAVD-----AKDKATLTKGLTRLSSSINEN 172 
NheC            LNSMKPQIMKTDQNIINYNNTFQSYYNDMLIAID-----QKDSGKLKADLEKLYADIVKN 164 
HblL1           LDTAKPKIQKTARNIVNYDEQFKNYYDVLEAAVQ-----KKDKTDLKEGISDLITTINTN 164 
HblB            DTKVKKQLLDTLTGIVEYDTTFDNYYETMVDAIN-----TGDGETLKEGITDLRGEIQQN 163 
NheA            IDEYNPKLIDLNQEMMRYSIRFNSYYSKLYELAGNINEDEQSKADFTNAYGKLQLQVQSI 156 
HblL2           SSELYPQLILLNSKSKGFVTKFNSYYPTLKAFVDT----KEDKEGFLDRLEVLQDMATTN 146 
                      ::         :   *..**  :            .   :      *        
 
NheB            KAQVDQLVEDLKKFRNKMTSDTQNFKGDAN------QITSILASQDAGIPLLQNQITTYN 226 
NheC            QNEVDGLLGNLKAFRDRMAKDTNSFKEDTN------QLTAILASTNAGIPALEQQINTYN 218 
HblL1           SKEVTEVIKMLQDFKAKLYDNSTGFKNNVGGPDGQGGLTALLAGNNALIPQLQAEIEKLR 224 
HblB            QRYAQQLIEELTKLRDSIGQDVRAFGSNKD------LLQSILKNQGADVEADQKRLEEVL 217 
NheA            QENMEQDLLELNRFKTVLDKDSNNLSIKAD------EAIKTLQGSSGDIVKLREDIKRIQ 210 
HblL2           QENVQRQINELTDLKSQLDNKLKNLDTDVT-----KAQVALSSDGTGKIDQLKNELLNTQ 201 
                .      :  *  ::  : ..   :  .               .  . :   .  :     
 
NheB            EAISKYNAIIIGSSVATALGPIAIIGGAVV-------IATGAGTPLGVALIAGGAAAVGG 279 
NheC            DSIKKSNDMVI------------------------------AGGVLCVALIT---CLAGG 245 
HblL1           STQTEHFNNVLAWSIGGGLGAFILVAAAIAGGVIIVVTGGTATPAVVGGLAALGAAGIGL 284 
HblB            GSVNYYKQLES------------------------------------DGFNVMKGAILGL 241 
NheA            GEIQAELTTILNRPQEIIKGSINIGKQVFT-------ITNQTAQTKTIDFVSIGTLSNEI 263 
HblL2           KSIQNDLQQIALLPGALNEQGFVIFKEVYNLSKDIIEPAAQTAVAAYNKGKEINNSILEA 261 
                                                                             
 
NheB            GTAGIVLAKKELDN---AQAEIQKITGQVT-TAQLEVAGLTNIKTQTEYLTNTIDTAITA 335 
NheC            --PMIAVAKKDIAN---AEREIANLKDRIS-GAQAEVAILTDVKNKTTNMTETIDAAITA 299 
HblL1           GTAAGVTASNHMNSYNEISKKIGELGMKAD-VASQAVISLTNAKATLTDLYQTVDQAILS 343 
HblB            PIIGGIIVGVARDNLGKLEPLLAELRQTVD-YKVTLNRVVGVAYSNINEMHKALDDAINA 300 
NheA            VNAADSQTREAALRIQQKQKELLPLIQKLS-QTEAEATQITFVEDQVSSFTELIDRQITT 322 
HblL2           EKKAEKEATEKGKSALEIEAAKKAAREEIEKSKQAEIAAAAVTKTKEYDLTKVIDPEKIK 321 
                       .          .                              : : :*      
 
NheB            LQN---------------ISNQWYTMGSKYNSLLQNVDSISP---------NDLVFIKED 371 
NheC            LQN---------------ISNQWYTVGAKYNNLLQNVKGITP---------EEFTFIKED 335 
HblL1           LTN---------------IQQQWNKMGANYTDLHDNIDSMQE---------HKFSLILDD 379 
HblB            LTY---------------MSTQWHDLDSQYSGVLGHIENAAQKA-----DQNKFKFLKPN 340 
NheA            LET---------------LLTDWKVLNNNMIQIQKNVEEGTY---------TDSSLLQKH 358 
HblL2           KTYSAFAEVNKLTAEQRAHLADLEVQNQKFYDLTKNLAVADLQKSMLLIMQNDLHTFANQ 381 
                                     :    . :   :  ::               .   :  . 
 
NheB            LNIAKDSWKNIKDYAEKIYAEDIKVVDTKKA--------------------------- 402 
NheC            LHTAKDSWKDVKDYTEKLHEGVAK---------------------------------- 359 
HblL1           LKAAKQSWSDIHKDAEFISKDIAFTQEAKN---------------------------- 409 
HblB            LNAAKDSWKTLRTDAVTLKEGIKELKVETVTPQK------------------------ 374 
NheA            FNQIKKVSDEMNKQTNQFEDYVTNVEVH------------------------------ 386 
HblL2           VDVELDLLKRYKEDLNLIKNNITKLSTNVDTTDQQSQKDTLRQLKNISSYLEEQVYKF 439 
                ..   .  .  .     : 
 
 
 
Figure 1.16: Amino acid alignment of B. cereus Nhe and Hbl proteins. 
Yellow background indicates a fully conserved residue. Blue background 
indicates conservation between groups of strongly similar properties. Green 
background indicates conservation between groups of weakly similar 
properties. The amino acid sequence alignments were generated using 
ClustalW2 (Goujon, et al. 2010& Larkin, et al. 2003) (available on: 
http://www.ebi.ac.uk/Tools/msa/). 
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Table 1.2 The percentage sequence identity between the Nhe proteins and 
the Hbl portions (Fagerlund et al, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 HblL2 HblL1 Hbl B NheA NheB NheC 
HblL2 - 18 23 23 21 19 
HblL1 18 - 25 18 40 32 
HblB 25 25 - 20 27 25 
NheA 23 23 20 - 22 22 
NheB 21 40 27 22 - 44 
NheC 19 32 25 22 44 - 
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Figure 1.17: Hydrophobicity plots for Nhe and Hbl portions.  
The Kyte-Doolittle hydropathy calculation (Kyte, and Doolittle 1982) is 
used to score the hydrophobic character of the protein. Peaks (with scores 
>1.8; red line) show possible trans-membrane regions.  
NheA and HblL2 have no predicted transmembrane region, while NheB and 
HblL1 have two transmembrane helices. Finally, NheC and HblB each have 
one predicted transmembrane helix.  
Calculated at  (http://gcat.davidson.edu/rakarnik/KD.html). 
 
 
 
 
 57 
Sequence similarity between HblB and NheB, NheC (Table 1.2) has allowed 
generation of 3D homology computer models using HblB as template 
(Fagerlund et al, 2008). The predicated 3D structures are mainly !-helical, 
including four main chains with "- hairpin that flanked by two !- helices.  
As mention before, HblB has strong structural similarities with ClyA (see 
Figure 1.13) although sequence alignment showed only limited match 
between ClyA and the Nhe and Hbl components (Table 1.3). Consequently, 
the strong sequence relationship of Hbl with Nhe implied a possible 
similarity in structure and function between Nhe and ClyA. This showed 
that ClyA, Nhe, and Hbl represent a novel super-family of pore forming 
toxin.  
 
1.13 Regulation of Nhe expression 
Nhe expression is positively regulated by PlcR/PapR quorum-sensing 
system. PlcR is a protein with 34 kDa transcriptional regulator. PlcR 
encoded by the B. cereus plcR gene and control the expression of B. cereus 
cytotoxin, including Nhe, CytK, Hbl, degradative enzymes (phospholipases, 
proteases), and cell-surface proteins (Agaisse et al, 1999; Slamti & Lereclus, 
2002). Activation of PlcR is dependent on the presence of PapR, a small 
signaling peptide around a 48 amino acids and encoded by papR gene, which 
is located 70 bp downstream from plcR. PlcR acts as a quorum-sensing 
effector and exported by the bacterial cell, processed, possibly as a 
pentamer, and then reimported into the cell. Once inside the cell, PapR 
interacts with PlcR to facilitate binding to its DNA targets and activate their 
transcription (Slamti & Lereclus, 2002). It was shown deletion of the plcR 
gene in B. cereus decreased hemolytic activity and virulence of the 
bacterium compared to the wild-type B. cereus strain (Gohar et al, 2002).  
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Table 1.3 The percentage of sequences identity between B. cereus Nhe, Hbl 
proteins and E. coli ClyA-K12 (Fagerlund et al, 2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ClyA HblL2 HblL1 Hbl B NheA NheB NheC 
ClyA - 18 20 20 18 19 20 
HblL2 18 - 18 23 23 21 19 
HblL1 20 18 - 25 18 40 32 
Hbl B 20 25 25 - 20 27 25 
NheA 18 23 23 20 - 22 22 
NheB 19 21 40 27 22 - 44 
NheC 20 19 32 25 22 44 - 
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1.14 The main Thesis aims and objectives 
Experiments from different laboratories around the world, described above, 
shows that the pore forming toxins are an interesting and important proteins 
but that there are many outstanding issues concerning their structures in 
soluble and membrane forms, their mode of action and the roles of lesions in 
biological membranes.  
To date, few studies of Nhe proteins have been available and there is no 3D 
crystal structure for any of the Nhe proteins in either the soluble form or in 
the pore form. Consequently, more studies of pore formation and the hetero-
oligomeric Nhe complex are critical to understand the mechanism of this 
super-family of pore forming toxin. NheA and NheB were are necessary and 
sufficient for pore formation and cell lysis (Haug et al, 2010). According to 
that, we are interested to elucidate the 3D crystal structure of Nhe 
component A and B (NheA, NheB) using X-ray crystallography and electron 
microscopy.  Hopefully this would provide new insights into the structure of 
the pore forming toxins. (DeLano & Lam, 2005)  
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Chapter 2: Theory of X-Ray Crystallography of 
Biological Macromolecules   
 
X-ray crystallography is a technique that is used to determine the three 
dimensional structures of biological samples that are in a crystalline state. It 
has mainly been used to determine molecular or atomic models of small 
molecules or nucleic acids or protein macromolecules. X-ray 
crystallography is unequivocally the most used structural determination 
technique. It surpasses nuclear magnetic resonance (NMR) and Cryo-
electron microscopy by thousands in the number biological structures 
deposited in the Protein Data Bank (Berman et al, 2000). 
This chapter provides a brief overview of the practice and theory of X-ray 
crystallography as a biological macromolecular structure elucidation 
technique and main technique that was used in this thesis. The information 
was mostly taken from (Blundell & Johnson, 1976), (Rhodes, 2006), (Blow, 
2002), (Drenth, 1999) (Rupp, 2010) or otherwise as cited.  
 
2.1 Sample preparations and techniques in protein 
crystallisation  
The major objectives in X-ray crystallography are expression of enough 
quality protein and determining suitable conditions for crystal growth.  
There are no general rules for protein crystallisation experiments; and so 
numerous conditions have to be tried. There are generally three agreed 
stages to proteins’ crystal growth: nucleation, growth or post-nucleation, and 
cessation of growth. Once the nucleus has been formed, protein particles 
move from the bulk of the solution and start to attach and incorporate in 
ordered layers to form a crystal, which can grow to macroscopic dimensions 
(Figure 2.1). 
 
 70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Schematic illustration of a protein crystallisation phase 
diagram.  
The plot shows the protein concentration against precipitant concentration 
during a crystallization experiment. The black circles represent the protein 
and precipitant. As the drop equilibrates with the reservoir solution the 
protein and precipitant concentration will be increased and nuclei can be 
formed, then protein particles move from the bulk of the solution and the 
crystal can be growth. Adapted from Rhodes (2006). 
 
 
 
 
 
 
 
 
! 
! 
" 
Undersaturation    
Metastable     
Nucleation 
 
Precipitate 
 
Precipitant concentration  
Pr
ot
ei
n 
co
nc
en
tra
tio
n 
 
! "#$%&$%'(#!
! "#$%&$%'(#!
 71 
Depending on whether the protein is soluble or a membrane protein some of 
the variables that can affect crystal growth include: pH, temperature, 
detergents, metal, ions, purity, homogeneity, protein concentration and the 
presence of numerous additives and their concentrations. Optimising each of 
these parameters can take a very long time, hence the common use of 
commercial kits to determine initial nucleation and growth conditions.  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
2.1.1 Sample preparation 
Sample preparation is the most important step in order to get protein 
crystals.  High concentrations of protein in the range of 10 mg/ml are often 
ideal. The purity and homogeneity of the sample are of paramount 
importance: up to 95% purity is required. It is usual to purify the protein 
with more than one purification step in order to improve its purity and 
homogeneity.   
 
2.1.2 Crystallisation techniques  
There are many techniques that are used to crystallise proteins, all of them 
aiming at inducing supersaturated solutions of protein macromolecules.  
 
2.1.2.1 Batch technique 
The batch technique is probably one of the first protein crystallisation 
techniques developed in 1930s. This technique involves adding a protein 
precipitant to large volume (about 1 ml) of highly concentrated protein until 
a slight opalescence was observed (Rayment, 2002). This technique fell out 
of favour because of its high requirement for large volumes at high protein 
concentration.  
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2.1.2.2 Vapour diffusion methods 
The vapour diffusion method became popular in early 1960s and is still the 
most commonly used method today. The method involves mixing the 
protein and crystallisation solution in a one to one ratio and placing the 
mixture in a sealed environment close to a reservoir of a precipitant. 
Because the concentration of the crystallisation mixture is lower than that 
the reservoir, water/solvent normally diffuses out from the sample into the 
reservoir. This leads to increase in the concentration of protein and the 
precipitants, which causes the protein to come out of the solution. The 
vapour diffusion method is performed as either hanging drop or sitting drop  
(Figure 2.2).  
 
2.1.2.2.1 Hanging drop method 
Because of the large number of conditions one needs to screen in order to 
grow protein crystals, vapour diffusion methods are designed use small 
quantities to conserve samples. The hanging drop is performed on a pre-
siliconised coverslip (Figure 2.2 A). Normally, 1 to 10 !l of purified protein 
solution at high concentration are mixed with crystallisation solution in 1:1 
ratio. This mixture is then placed on the clean pre-siliconised coverslip, 
which is then inverted and placed above a small well containing 500 !l to 1 
ml of the crystallisation buffer. 
 
2.1.2.2.1 Sitting drop method 
Obviously trying to load each crystallisation buffer and mixing it with the 
protein in 1:1 ratio for hundreds of crystallisation conditions and placing 
them one by one on coverslips is very time consuming. With the sitting drop 
method (Figure 2.2 B), sample loading is automated and can be handled 
using crystallisation robots. The principles of sitting drop are similar to 
those of hanging drop except that the 1:1 mixture is loaded in a depression 
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of a micro-bridge. Similar to the hanging drop method, the container is 
airtight sealed with grease, oil or transparent sticky tape.   
 
2.1.2.3 Dialysis 
The dialysis method is commonly used with a "dialysis buttons". The 
dialysis button’s well is loaded with a protein sample and then covered with 
a dialysis membrane. It is then placed in a small container. The precipitating 
solution is then added. The selectively permeable membrane covering the 
dialysis button only allows passage of precipitating solution into the protein 
sample. As the concentration of precipitating solution increases inside the 
membrane, nucleation can occur, leading to protein crystal growth. The 
precipitating solution can be changed over time to a fresh one. The container 
is usually sealed airtight with grease. 
 
2.2 Protein crystal mounting 
The crystal must then be mounted so that it can be exposed to an X-ray 
beam. The quality of crystals can be judged by sharp diffraction patterns at 
large angles emanating from X-ray beam. Protein crystal mounting is a 
delicate step that needs a great degree of care. Crystals are normally 
mounted in their mother liquor, the solution in which the crystal growth took 
place. This is very important to avoid the crystals cracking or disintegrating; 
rendering them useless for data collection and also to keep them hydrated. 
Crystal used to be mounted in sealed capillary tubes (see below) but now 
one of the commonly used techniques of mounting crystals is to freeze them 
in a loop.  
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Figure 2.2: Schematic illustration of vapour diffusion protein 
crystallization methods. 
(A) The hanging drop method and (B) the sitting drop method that used in 
this thesis.  
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2.2.1 Room temperature mounting 
During the early days of protein crystallography, when cryogenic techniques 
were not fully developed, crystals were mounted using capillary tubes. The 
protein crystal was slowly and gently drawn into the capillary tube and 
droplets of mother liquor were introduced on either side and the tube was 
then sealed. The capillary tube was then mounted on a goniometer head, 
which controls the crystal’s orientation in the X-ray beam (Figure 2.3).  
The biggest problem associated with collecting diffraction data from protein 
crystals mounted at room temperature is radiation damage. This means that a 
lot of crystals were needed to collect enough data for structure 
determination. To overcome this problem crystals can be soaked in 
cryoprotectants and then be cooled to liquid nitrogen temperature.  
 
2.2.2 Cryogenic mounting (Cryocrystallography)   
Cryo-crystallography was introduced to minimise radiation damage to the 
crystals. This technique, which is commonly applied these days, involves 
introducing a stream of nitrogen gas at 100 K or plunging the crystal into the 
liquid nitrogen. The liquid nitrogen leads to solvent vitrification of the 
disordered liquid phase. The major drawback for this technique is that the 
liquid nitrogen can lead to formation of ordered ice crystals, which can 
disrupt the protein crystal and lead to poor diffraction data. To overcome 
this problem, cryoprotectants are introduced into the mother liquor to 
prevent ice crystal formation. Commonly used cryoprotectants include 
glycerol, low molecular weight polyethylene glycol (PEGs), ethylene glycol 
and 2-methyl-2, 4-pentanediol (MPD). It is necessary to optimise the 
freezing stage and/ or the type/concentration of cryoprotectants as both can 
degrade the protein crystal.  
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Figure 2.3: Room temperature mounting. 
The protein crystal was drawn into the capillary tube and droplets of the 
mother liquor were introduced on either side and then sealed. The capillary 
tube was then mounted on a goniometer head, which controls the crystal’s 
orientation in the X-ray beam. 
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2.3 X-Ray generation 
X-ray crystallography can generally be described as a visualisation method 
for macromolecules that are in the crystalline state. In order for any object to 
be visualised, it needs to scatter light. The electromagnetic radiation of 
visible light, which has a wavelength of 400 to 700 nm, cannot produce 
images of individual atoms of proteins because they are much smaller than 
this. The typical bond length of atoms in proteins is 0.15 nm. X-rays are 
electromagnetic radiation and useful in elucidating atomic structures of 
proteins because they have a wavelength of 10 to 0.01 nm and are easy to 
produce. When X-rays are used at a wavelength of 0.1 nm (1 Å), they can 
resolve chemical covalent bonds and show the positions of atoms.  
In most crystallographic structural biology laboratories, X-rays are produced 
by rotating anode tubes (Figure 2.4), but more intense X-rays are produced 
by electron synchrotrons (Figure 2.5). Whichever way the X-rays are 
produced and for whatever purpose that are intended to be used for, there are 
three main requirements to produce X-rays: an electron source, the 
acceleration of the electrons and the target that will eventually produce X-
rays upon interaction with the electrons.  
 
 2.3.1 Rotating anode tubes 
X-rays are generated by bombarding a metal target with electrons that have 
been produced from a heated filament (usually a tungsten filament) and 
propelled through an electric field. An X-ray tube is just a sealed container 
with an anode at one end and a cathode on the other end, maintained in a 
vacuum. The cathode is heated, which allows the electrons to be released 
and propelled through the electric field towards the anode. The anode is 
normally made of copper, molybdenum, or chromium. Copper is normally 
preferred due to its high heat conductivity. When electrons are released from 
the cathode, if they have sufficient energy, will knock off electrons in the 
target metal. The electronic shells of atoms are designated K, L, M, N, O, P, 
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and Q; starting from the innermost shells outwards. The energy level 
spacing of the metal target produces specific wavelengths that are typically 
characteristic of that particular metal.  The lower the atomic number, the 
longer the emission lines of the metal. When electrons are knocked out from 
the innermost K electronic shell, and then are replaced with the electrons 
from L electronic shells, a K! emission is observed. When the electrons in 
the K shell are replaced by electrons from M shell, a K" emission is 
produced. In crystallography a single source of X-rays is desirable. This is 
normally achieved by filtering the weaker K" emissions e.g. using graphite 
crystals or Ni for copper emissions. 
 
2.3.2 Synchrotrons 
Synchrotrons are the most powerful sources of X-rays. They produce much 
more intense X-rays ranging from 0.5 Å to 1.8 Å in wavelength. They are 
very expensive compared to rotating anode tubes. X-rays are produced by 
accelerating electrons in a vacuum, which are travelling near the speed of 
light, in storage rings. These rings consist of straight and curved parts much 
like a polygon, which can go up to 1.5 km in circumference. At each corner 
of this polygon, powerful electromagnets are placed. Intense radiation is 
produced either by bending magnets or with the help of insertion devices 
such as Wigglers or Undulators. These devices change the trajectory of the 
electrons, which leads to production of X-rays (Rhodes, 2006; and Rupp, 
2010). This is achieved by alternating magnetics placed in north and south 
poles adjacent and opposite to each other. The X-rays are emitted 
tangentially to the direction of the electrons circular path around the 
synchrotron. These X-rays are filtered so that only monochromatic X-rays of 
specific wavelength are allowed to reach the protein sample on the 
beamline.  
Synchrotron radiation has the major advantage of having a tuneable 
wavelength, which is a very useful property for phase determination using 
Multi-wavelength Anomalous Dispersion (MAD) or Single -
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Anomalous Dispersion (SAD). Further, due to the intensity of X-rays, the 
exposure times are greatly reduced, hence huge amount of data can be 
collected before the protein crystals are completely damaged due to 
radiation. This also allows collecting data from almost any size of crystals 
and in some instances even from the crystals that showed poor diffractions 
pattern when using Rotation anode tubes.  
 
2.4 X-Ray scattering 
The interaction of X-rays with the electrons in protein crystals leads to 
scattering. The scattered waves are normally 180º out of phase to the 
incident wave, although they maintain the same wavelength. Two major 
types of scattering that can occur are:  
1) Thomson scattering, also commonly known as elastic or coherent 
scattering. This kind of scattering is characterised by no change of energy 
between the incident beam and the scattered beam, although its direction 
may be changed. This kind of scattering is very useful to X-ray 
crystallography because when the incident X-ray photon collides with an 
electron in the crystal, the resultant oscillations produce radiation of 
frequency identical to that of the incident wave as the electron returns to its 
original position.  
 
2) The other kind of scattering is inelastic scattering, also known as 
Compton or incoherent scattering. This kind of scattering leads to loss of 
energy; therefore the scattered wave has less energy and a changed 
wavelength.  
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Figure 2.4: A Rigaku Micromax 007 copper rotating anode generator 
used in our lab. 
 X-rays come from the left from a rotating anode source (not shown), and 
emerge through a metal collimator (1) to strike the crystal, which is placed 
in a cryoloop on the goniometer (2). An image plate detector (3) captures the 
reflections. The crystal is kept frozen by a stream of cold nitrogen gas 
coming from a liquid nitrogen supply (4). 
 
 
 
 
 
 
 
 
 
1 
4 
2 
3 
 81 
 
 
 
Figure 2.5: Aerial view of Diamond Light Source, the UK’s national 
synchrotron facility, in south Oxfordshire. Image courtesy Diamond Light 
Source.  
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2.4.1 Atomic scattering  
The incident X-ray beam is scattered by the electrons around an atom. An 
atom with Z electrons (its atomic number) will be expected to scatter X-rays 
Z times as strongly as a single electron. The atomic scattering factor f is 
defined as the ratio between the amplitudes scattered by an atom and by a 
single electron (Hammond, 2009). The atomic scattering factor can be 
plotted against sin!/" for a particular atom. The higher the resolution (or the 
bigger the angle !), the smaller is the atomic scattering factor. The atomic 
scattering factor for the entire atom is a description of the individual 
scattering contributions of each electron expressed as;  
   !!
! 
" = """#$%&"'#"•###$
$
$  
where # is the electron density, r is the distance from the centre of the atom 
and S is the scattering vector.  The amplitude of the scattering vector is 
expressed as  
                                      |S| = (2 sin !/") 
 
The atomic scattering factor is commonly affected by the atomic 
fluctuations caused by temperature changes. Atoms are not at a fixed 
position at all the time, but they are vibrating with respect to changes in 
temperature.  Hence at higher diffraction angles, the scattering factor is 
greatly reduced due to these thermal vibrations. These thermal vibrations are 
corrected using the temperature factor (Debye-Waller temperature factor) or 
B-factor either at low resolution using isotropic temperature factor 
corrections or at near to atomic resolution with the anisotropic B-factor 
refinement. The B-factor can also explain variation due to static disorders  
(different conformations in different unit cell) as well as thermal 
fluctuations. 
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2.4.2 Unit cell scattering (Structure factors) 
In order to determine the three-dimensional structure of a protein confined in 
a unit cell, the three key factors (direction of the beam, amplitude and 
phases) associated with each scattered or diffracted beam must be 
determined. The unit cell is the smallest group of molecules, which can be 
repeated in three dimensions by translation to produce a crystal lattice. Thus 
to determine the scattering amplitudes in the unit cell, it requires summing 
up all the amplitudes from all atoms within that unit cell, taking into account 
the phases and direction of the scattered waves. For a unit cell made up of n 
atoms located at position rj in the unit cell, where j is an integer from 1 to n 
(1, 2, 3, …n) and r is the distance between the origin and atoms, the sum of 
diffraction of the unit cell is described as:  
                                         
 Where F(S) is the structure factor, S is the scattering vector and 2!r.S is the 
phase difference between the scattered wave at position r and the origin.  
 
2.4.3 Molecular scattering 
Similarly as described for unit cell scattering, the structure factor for 
molecular scattering is the sum of all structure factors originating from 
scattering of individual atoms given as: 
                                     
 
Thus the scattering of X-rays by each atom gives structure factor of 
molecular scattering G (S), where  is the phase difference between 
scattered waves at position rj and the origin in a molecule.   
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2.4.4 Crystal scattering  
Protein crystals are ordered arrays; hence they can amplify the scattering 
factor to detectable levels, only if the unit cells in crystals scatter in phase 
with respect to one another. The phase difference between adjacent unit cells 
in one dimension is described by 2!a.S where a represents the shift in 
position with respect to the origin between the unit cells. The ordered arrays 
of unit cells will only scatter in phase if 2!a.S is equal to 2!h, in other 
words when a.S = h, where h is an integer.  
Thus in three dimensions, the following Laue conditions are met: 
a.S = h 
b.S = k 
c.S = l 
 h, k and l being integers. The h, k and l represent discrete reflections from 
the set of planes and each atom in the unit cell. Hence they describe the 
reciprocal lattice of the diffraction pattern of the unit cell.  
Taking the positional vector of rj from molecular structure factor, the 
fractional coordinates in the unit cell can be expressed as (axj, byj, czj). This 
gives the structure factors for the unit cell with regard to the Laue conditions 
as:  
                              
 
Here it basically means xj, yj, and zj are the fractional coordinates of the jth 
atom in the unit cell. Thus the diffraction pattern of any crystal can be 
elucidated from this equation given the positions of all atoms in the unit cell. 
Indeed, the amplitude that is measured experimentally is the scattered X-ray 
of each of these reflections set, h, k and l. Since experimentally the 
measured reflections are h, k and l sets, the two most important pieces of 
information for protein structure determination (determining an electron 
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density map), the structure factor amplitudes and phases, can be represented 
in a single equation as;  
                F (hkl) = |F(hkl)|ei!(hkl)
 
The structure factor amplitude is represented by |F(hkl)| and the phases by 
!(hkl). Thus, once the amplitudes and phases are determined, the electron 
density map of the protein can be obtained, but in X-ray crystallographic 
data collection the phases are lost. This is because the intensities of the 
diffraction pattern recorded on films or counters are proportional to the 
square of the amplitudes. Therefore all the phase angle information of the 
diffracted X-rays are lost. This is a major problem in X-ray crystallography. 
 
2.5 Bragg’s law 
Bragg’s Law, which won W. L. Bragg and W. H. Bragg with the Physics 
Nobel Prize of 1915, describes the X-ray diffraction of crystalline materials. 
As described in 2.4.2 a crystalline state is made up of ordered arrays of 
atoms periodically repeating themselves to form a lattice. The crystalline 
state can reflect incident X-rays as if it is a mirror. In order to understand 
Bragg’s Law, let us consider two incident X-rays at angle " on atoms Z and 
B separated by distance d (Figure 2.6). Assuming that the interference is 
constructive, and therefore the phase shift is a multiple of 2#, then the 
Bragg’s Law is simply defined as n! = 2dsin", where n is an integer, $ is the 
wavelength of the X-rays, d is the distance between the diffraction and " is 
the angle of incidence of the incoming X-rays (Blow, 2002), this is shown in 
(Figure 2.6).   
When the two incident waves are travelling in phase and parallel to each 
other, they will strike atoms Z and B. The first incident beam will strike 
atom Z in the top plane. The second beam will continue travelling and strike 
atom B on the bottom plane. Thus the second beam travels an extra distance 
AB + BC. For the two beams to be in phase, the distance AB + BC is the 
integer number of n$:  
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Thus                   AB + BC = n! 
By taking the interatomic distance d, as the hypotenuse of right–angled 
triangle formed by AB and the diffracting beam, the distance AB becomes: 
                         AB = d sin" 
Since AB = BC, AB+BC= 2AB, and 
                                                          n! = 2AB 
Combining the two gives the Bragg’s law, n! = 2dsin".  
Thus x-ray diffraction is observed when the interplanar distance (d), the 
incidence angle (") and the wavelength of the incident X ray (!) are satisfied 
as stated in the Bragg’s Law.   
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Figure 2.6: The incident X-rays are scattered by atoms Z and B, which 
are in interplanar distance d.  
AB and BC are each equal to dsin!. AB +BC = an integral number of 
wavelengths, the path difference between the red and blue lines is 2AB, 
which is equal to 2dsin!.  Thus the diffraction takes place. i. e. when  
2dsin!= n" which is Bragg’s law. 
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2.6 Data collection 
The phase of diffracted X-rays cannot currently be measured but their 
position and intensity can. There are generally two main detectors used 
widely in X-ray crystallography at present: image plate detectors and 
Charged Coupled Device (CCD)-based detectors.  
 
2.6.1 Image plate detectors  
These are the most commonly found detectors in most X-ray laboratories. 
They are coated with a thin layer of inorganic phosphor (BaFBr) on a flat 
base. The top layer of the inorganic phosphor is doped with europium 
(Eu2+). When the incident X-rays from the protein crystal strike the image 
plate, the Eu2+ is excited to a metastable Eu3+. Reversing the metastable Eu3+ 
to Eu2+ using red laser light of 633 nm wavelength releases radiation of 390 
nm wavelength. The intensity of the emission at 390 nm wavelength is 
proportional to the quantity of the X-rays absorbed by europium, which 
gives a good dynamic range and uniform sensitivity across the image plate. 
The emission of metastable europium is detected by a photomultiplier, 
which reads the diffraction patterns and forms the diffraction image. Image 
plate detectors have two major disadvantages of having a long readout dead 
time of up to two minutes and low sensitivity. Thus they are not ideally 
suited to synchrotron experiments, which require very quick readout time; 
otherwise the crystals will end up damaged from radiation. 
 
2.6.2 CCD cameras 
All synchrotron X-ray data collection throughout this thesis was conducted 
by using Charged Coupled Device (CCD)-based detectors. These are the 
commonest detectors found at synchrotrons, but are rarely available in the 
in-house X-ray laboratories. The CCD-based detectors are made up of a 
scintillator screen, a fibre optic taper and CCD chip. The scintillator screen 
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has a phosphor used to convert X-rays to visible light/photons. The light 
photons are then transferred by the fibre optics to the CCD chip, where they 
are digitised. CCD detectors have a major advantage of quick readout times; 
hence they are available for use immediately after the exposure. 
 
2.7 Data processing  
Once the diffraction patterns have been collected from the protein crystals, 
they are processed by various programs to extract information, including 
intensities and locations of reflections. The process of data processing from 
diffraction data involves space group assignment, unit cell parameters, 
refinement, integration of the intensity values, sorting, and scaling. There 
are many programs that are used to process the diffraction data such as 
MOSFLM/iMOSFLM, (Leslie, 1994), X-ray Detector Software (XDS) 
(Kabsch, 2010), HKL2000 (Otwinowski & Minor, 1997) and SCALA 
(CCP4, 1994). The XDS, iMOSFLM and CCP4 programme suites were 
used in this thesis.  
 
2.7.1 Autoindexing  
Indexing is the first step of processing any image data set, usually by 
autoindexing. During autoindexing, the space group of the crystal lattice and 
unit cell dimensions are determined. Autoindexing can be done with spots 
from one or multiple images. Two images that are 90o apart are usually a 
good starting point.  
 
2.7.2 Refining crystal parameters and dataset integration 
After indexing the data, the final refined matrix is used by iMOSFLM to 
predict the reflection positions. Prerequisite to this prediction is accurate unit 
cell dimensions, which are obtained during indexing. The refinement is 
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normally done before integration, although if it’s done after integration, then 
the data need to be reintegrated. The integration involves calculating 
estimates of the reflection intensities and determining the standard errors 
from the raw data. Integration is performed by either summation or profile 
fitting. The result of this process is a single *.mtz file that is used in 
subsequent data processing. 
 
2.7.3 Sorting, scaling and data merging  
The reflection indices (h,k,l) assigned by iMOSFLM during data integration 
are assorted in numerical ascending order using the programme SORTMTZ 
(CCP4, 1994). The file generated from SORTMTZ (CCP4, 1994) is 
analysed with SCALA in order to scale and merge the data. SCALA 
calculates the scale factor between each image with respect to a specific 
image of the data set. It tries to put all the images into a common 
observation scale. This scale is used as a diagnostic tool for analysis of data 
quality and to check if the data collection was satisfactory.  
SCALA outputs a series of statistics, which are used to assess the data 
quality with increasing resolution. The main indicators are: Rsym or Rmerge, 
which is the agreement between symmetry equivalent reflections, I/!I; 
which is the ratio of intensity to standard deviation of the intensity; and the 
completeness.  Both Rmerge and Rsym are given by:  
                   
 
 
Where Ii(hkl) is the ith measurement of reflection hkl and  is the mean 
value of the n equivalent reflections. The summation is come out over all N 
independent reflection in the data set.  
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I/!I provides details of the signal to noise ratio of the data, which should be 
greater than one for highest resolution data shell. Theoretically how much of 
the possible data to a given resolution has actually been collected is given by 
the completeness. This should be at least 90% of completeness to a given 
resolution.  
In the higher resolution shells the data become weaker and I/!I becomes 
less. This means that the agreement between equivalent reflections becomes 
poores and therefore Rsym becomes bigger.  
 
2.8 The phase problem and its solution in X-ray 
Crystallography 
The biggest challenge in X-ray crystallography is to determine phases, 
which are needed together with the intensities of reflections to elucidate the 
electron density map. If a similar structure already exits then Molecular 
Replacement (MR) can be used. Otherwise the phases must be obtained 
experimentally using Multiple Isomorphous Replacement (MIR) or Single 
Isomorphous Replacement (SIR) or Multi-wavelength Anomalous 
Dispersion (MAD) or Single -wavelength Anomalous Dispersion (SAD). 
This can be one of the toughest stages during macromolecule structure 
determination. In this thesis, only MAD was used to elucidate the protein 
structure.   
 
2.8.1 The Patterson function 
The Patterson function, originally proposed by Arthur Lindo Patterson in 
1934 at Massachusetts Institute of Technology, is used to determine atomic 
positions by utilising intensities as coefficients rather than structure factors. 
It is a Fourier transform (FT) of the reflection intensities assuming all phases 
are equal to zero. The Fourier transform used to calculate electron density 
maps, when all phases are set to zero, will be equal to: 
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where u, v and w are Patterson cell coordinates that locate a point on the 
Patterson map.  
The Patterson function is a convolution of electron density with itself. The 
peaks of the Patterson function represent interatomic distance vectors both 
within the same molecule and between different molecules in the crystal. 
Thus if a molecule contains N atoms, then considering only the intra-
molecular vectors, N2 peaks will be observed in the Patterson function. The 
Patterson function is very useful for determining the structures of small 
molecules but not macromolecules like proteins because there are just too 
many atoms however it can be used to locate a small numbers of heavy 
atoms bound to a protein. The Patterson function is very useful in other 
phasing techniques such as MR to perform the rotation and translation 
functions, and in both MAD and MIR for locating heavy atom positions of 
derivative crystals.  
 
2.8.2 Multiple isomorphous replacement (MIR) 
Multiple isomorphous replacement experiments determine phases by 
comparing scattering from two almost identical protein crystals, except that 
one has one or more strong scattering centres. The strong scattering centres 
are made up of heavy atoms. These atoms could be naturally be part of the 
protein like its natural ligand/substrate or introduced into the protein through 
co-crystallisation or soaking of the crystal with heavy atoms. Typical heavy 
atoms that are used include Hg2+ ions which are used to bind thiol groups, 
uranyl salts which bind between carboxyl groups in Asp and Glu, Pb binds 
to Cys, PtCl42- anions bind to His and tryptophan binds to Hg(OAc)2. When 
these heavy metal ions bind to the protein crystal’s asymmetric unit, it is 
referred as a derivative crystal, while a metal free protein crystal is called a 
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native.  There are several criteria that define heavy-atom derivative crystals 
such as isomorphism, which generally means that the presence of the heavy 
atom does not disturb the protein structure or crystal packing. Isomorphism 
further implies that the unit cell dimensions of the derivative and native 
crystal are the same. A second criterion is that there must be detectable and 
measureable changes of reflection intensities from which phases can be 
determined.  Finally, it is important that the derivative crystal is able to 
diffract to a fairly high resolution, although not necessary as high as the 
native, but just enough to extract important information.  
Considering that the reflection amplitude of native protein is given as |FP| 
and that of the derivative as |FPH|, then the difference in amplitude (|FPH|– 
|FP|) approximate to the amplitude of a heavy atom alone (|FPH – FP|). 
Computation of the diffraction pattern of (|FPH – FP|)2, will give the 
diffraction pattern of the heavy metal alone. The structure factor of the 
derivative can be defined as the sum of: 
                                     FPH = FP + FH 
This equation allows to solve the phases of FP and FPH using the Harker 
construction. See Figure 2.7 and 2.8 for phase solutions using isomorphous 
replacement. 
 
2.8.3 Multi-wavelength anomalous dispersion (MAD) 
Multi-wavelength Anomalous Dispersion (MAD) (Rhodes, 2006; and Rupp, 
2010) was used to solve the protein structure in this thesis. The reason for 
choosing this technique and not MIR is that in MIR several crystals are 
required, and in addition lack of isomorphism is usually very common 
between heavy metal ion derivatives and native crystals. MAD has the 
advantage that non-isomorphism is not a problem, and only one crystal is 
required.  
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Figure 2.7: The vector diagram illustrates the relationship between 
native and derivative scattering factors.  
The ultimate aim of phase determination is to determine the unknown phase 
!P of each reflection. Colour key: the structure factor whose phase is lost 
(the native protein) is green. The structure factor of protein heavy atom 
derivative is blue and the structure factor of heavy atom is red.    
Taken from http://www.ruppweb.org/ accessed on 20 September 2011. With 
permission from Bernhard Rupp.    
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Figure 2.8: Phase determination. 
(A) for single Isomorphous Replacement ; (B) for Multiple Isomorphous 
Replacement. Colour key: the structure factor whose phase is lost (the native 
protein) is green. The structure factor of protein heavy atom derivative is 
blue and the structure factor of the heavy atom is red. Purple arrows indicate 
phase solution. Taken from http://www.ruppweb.org/ accessed on 20 
September 2011. With permission from Bernhard Rupp. 
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2.8.3.1 Anomalous scattering  
Anomalous scattering can be defined as absorption of photons by heavy 
atom when inner shell electrons undergo transition to a higher energy level 
or get ejected totally from the atom. When the excited electron returns to the 
inner shell a new x-ray photon is emitted but with a different amplitude and 
phase to the incident x-ray. This is what is called anomalous scattering.  
At the wavelength where the photon has enough energy to throw the 
electron out of its orbital, there is a quick change in the absorption factor, 
commonly referred to as the atom’s absorption edge. All elements exhibit 
anomalous scattering when the X-ray wavelength is near the atom’s 
absorption edge. However, the X-ray wavelength used in protein 
crystallography is not near the absorption edge of the majority of atoms that 
compose the proteins such as oxygen, nitrogen and carbon and so these 
atoms do not contribute to the anomalous scattering. Sulphur does 
anomalous scatter but selenium does so more strongly. That is why 
selenomethionine is used instead of the normal sulphur-containing 
methionine. X-rays can be tuned at the synchrotron to the specific 
absorption energy of selenium to collect anomalous datasets.  In order to 
incorporate the phase and amplitude of the anomalously scattered wave, the 
atomic scattering factors are expressed with real and imaginary parts as 
follows: 
                    
where fo is the usual atomic scattering factor for wavelengths far from the 
absorption edge, !f" is the real number correction of the amount by which 
the normal scattering is reduced, f''  is the imaginary component.  
f0-! f" is often known as f" and is called as the dispersive component while f'' 
is called the anomalous component.  
These values can be determined experimentally by an X-ray fluorescence 
scan of the protein crystal itself on the synchrotron before data collection.  
This allows us to select wavelengths at which anomalous scattering will be 
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optimal for structure determination. The datasets are collected at the peak, 
the inflection point and remote wavelengths, with the peak providing the 
highest value of f!!, which is also the maximum intensity (Figure 2.8).  
 
2.8.3.2 Friedel’s law  
Friedel’s law states that a pair of reflections h,k,l and -h,-k,-l have the same 
structure amplitudes and that their phases have opposite sign (Blow, 2002). 
This holds true when anomalous scattering is not involved because the 
heavy atom structure factors FH(h,k,l) and FH(-h,-k,-l) have the same 
magnitudes. The anomalous component of the scattered wave from the 
heavy atom is always at 900 to the advancing non-anomalously scattered 
wave (Figure 2.9). The law breaks down because the atomic scattering 
factors have to take into consideration the anomalous scattering factor 
(Figure 2.10).  
 
2.8.3.3 Phasing 
During anomalous scattering, the difference in scattering intensity  (Ihkl and 
I-h, -k, -l) and amplitudes (|Fhkl| and |F-h, -k, -l|) is called the Bijvoet difference. 
The Bijvoet difference can be used to determine anomalous scattering due to 
the heavy atom alone in FPH. The position of the heavy atoms in the unit cell 
can be determined by using a Patterson map. The peaks obtained from the 
Patterson maps can be used to calculate the amplitudes and phases of the 
atomic structure factors.  From these phases and amplitudes, by constructing 
the Harker diagram, the phases of the original reflections can be deduced 
geometrically (Figure 2.11A). The anomalous scattering depends on the 
wavelength of the incident beam. Using a single wavelength, it is possible to 
deduce two different reflection phases. More phases can be obtained by 
taking measurements at multiple wavelengths. Each of these wavelengths 
will provide more vectors on the Harker diagram.  When circles are drawn 
around the Harker diagram, they will intersect at a point that allows 
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deduction of the Fp phase (Figure 2.11B). Normally, two wavelengths are 
enough to determine the phases, but in most cases three datasets are 
collected at different wavelengths. The first two datasets are collected at the 
peak and inflection point wavelengths. At these points the contribution of f!! 
and f! to structure factor scattering is at its maximum and minimum 
respectively (Figure 2.11C).  The third dataset is collected at the remote 
point where both of f!! and f! are very small. Having three datasets provide 
the best possible phasing power.  
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Figure 2.9: A heavy atom scattering factor fH at two different 
wavelengths.  
At wavelength !N it scatters normally. At wavelength !A there is an 
anomalous scattering component fH!! which the phase is 90° in advance of 
the normal component, and also the normal component of the scattering is 
reduced to f"H. Taken from Blow (2002). 
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Figure 2.10: Diagrammatic representation of Friedel’s law and 
anomalous scattering.  
(A) is the normal scattering whereby the reflections along the Bragg plane 
have equal structure amplitude but opposite phases.  
(B) is anomalous scattering due to the presence of heavy atom (grey). The 
anomalous scattering contributes to overall the structure factors (FPH); hence 
the reflections are no longer in phase.  
Similar in (C) the anomalous scattering has caused changes to the phases, 
with the reflections observed along the horizontal axis. Taken from 
http://www-structmed.cimr.cam.ac.uk/Course/Basic_phasing/Phasing.html 
accessed on 21st September 2011. With permission from Randy J. Read. 
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Figure 2.11: MAD phasing. 
 (A) Is the Argand diagram of three datasets collected at different 
wavelengths taken at inflection point !1, peak !2 and remote !3. The 
scattering vector due to the protein is shown in black and is the same at all 
wavelengths. (B) Is the Harker construction of the three wavelengths from 
(C). (C) Is a typical absorption curve for an anomalous scatterer. The FPH 
structure factor scattering is a combination of the protein crystal, dispersive 
and anomalous scattering from the remote point !3, shown for clarity.  Draw 
from the origin FH, whose magnitude and phase was determined from 
Patterson functions then double circles are drawn at each wavelength of 
radius FPH (+) and FPH (-) centred at the end of their f!! contribution to the 
scattering.   
The intersection of circle with one another can be seen at a single point 
which gives an estimate for the phase of Fp. Taken from Taylor (2003; 
(http://dx.doi.org/10.1107/S0907444903017815). With permission from 
IUCr. 
C 
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2.8.4 Molecular replacement (MR) 
Another method of determining phases is by using molecular replacement 
(MR). This method requires the existence of a previously solved protein 
structure that has some similarity to the unknown protein. MR can be done 
by using a program called PHASER (McCoy et al, 2007). MR requires first 
that the model protein to be rotated into the some orientation as the unknown 
protein in the unit cell. Generally, this rotation function is done by using 
Patterson maps of the known and unknown proteins. The correct positioning 
within the unit cell then requires a translational step.  
The rotation function involves comparisons of the unknown Patterson map 
to the Patterson map of the known protein or phasing model in different 
orientations. The Patterson maps are overlapped and oriented in steps 
through three dimensions. At each orientation, the program calculates the 
structure factor amplitudes of the unknown protein and compares them with 
the known protein structure factor amplitudes until the maximum overlap is 
found. The maximum overlap or similar orientations are taken as rotation 
function solutions for the unknown protein.  
The translational function is generally a positioning process of the correctly 
oriented protein in the asymmetric unit. The protein needs to be translated 
into the correct co-ordinates, x, y, z, axis to find the exact position where the 
protein lies in the unit cell. Normally this process is straightforward if there 
is single copy in the asymmetrical unit, but multiple copies of the target 
protein or flexible domains can take a very long time to process as each 
copy will need to be oriented. Otherwise, MR is the quickest method of 
determining phases than any other experimental methods 
 
2.9 Calculation of electron density  
When all is said and done and the phases have been determined to their very 
best, it’s time to examine the image of the structure in the form of the 
electron density map. The relationship between the structure factors (F) for 
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reflection hkl and electron density (!) at the atomic position r is given by the 
following equation; 
                              
 
where 2!r.S is the phase difference between the scattered wave at position r 
and the origin, and S is the diffraction vector of the refection indices hkl. 
Thus defining the position r with actual fractional cell coordinates x, y, and 
z, and substituting the r.S of the phase difference with (hx + ky + lz) for 
volume V of the unit cell, the above equation becomes 
                  
 
F(hkl) is the structure factor with amplitude of |F(hkl)| and phase !(hkl). The 
relationship between the amplitude and the phase in three dimensions is 
given as F(hkl) = |F(hkl)| ei!(hkl). Thus for every fractional coordinate, x, y 
and z in the unit cell, the electron density ! (x,y,z)  can be calculated from 
the structure factor F as follows:  
                    
which is an inverse Fourier transform of the structure factor F(hkl) for the 
three-dimensional experimentally derived electron density map. The electron 
density is calculated in all combinations of h, k, and l as indicated by the 
summation sign.  
 
2.10 Phase improvement 
Regardless of which method is employed to determine phases, the initial 
electron density maps always contain some errors. This can make the first 
maps poor in quality and very difficult to interpret. This is the main reason 
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why programs have been developed to modify the electron density maps 
through improvement of the phases. These programs include solvent 
flattening, non-crystallographic symmetry (NCS) averaging and histogram 
matching (Rhodes, 2006; Rupp, 2010; Taylor 2003; and Taylor 2010).  
 
2.10.1 Non-crystallographic symmetry (NCS) averaging 
Non-Crystallographic Symmetry (NCS) arises from internal symmetry 
within a protein crystal that does not form part of the overall symmetry of 
the crystal. The NCS is characterised as local regions in the asymmetric unit 
with similar electron density. These local regions arise from multiple copies 
or subunits of a molecule. Thus, the asymmetric unit in NCS is made up of 
more than one identical molecule. These local regions of electron density 
can be used in NCS averaging to improve phases. The NCS operators can be 
obtained by a native Patterson function, heavy atom positions, real space 
correlation and self-rotation function, using both rotation matrices and 
translation vectors. The NCS averaging improves the signal to noise ratio 
and the overall quality of the electron density map. The more identical 
objects there are in the asymmetrical unit, the better is the improvement to 
the electron density map.   
 
2.10.2 Solvent flattening 
Solvent flattening is one of the most successful methods of improving the 
electron density map. In a protein crystal, more than 50% of its content can 
be made up of solvent. These solvent regions are highly disordered 
compared to the protein regions. Because of this lack of order in the solvent 
region, the electron density map shows fewer features. The solvent 
flattening procedure sets a mean electron density value for the solvent region 
while the protein regions are left unaltered.  The resultant electron density 
distribution in the solvent areas is used to calculate structure factors, and the 
new phase angles can be used to improve the electron density of the map. 
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There is still uncertainly as to exactly which regions of the electron density 
map really represent the solvent so one needs to be very cautions not to 
assign protein regions as solvent areas; therefore a generous boundary must 
be placed around molecules.  By flattening the solvent areas, the phases are 
improved and the protein regions density map is improved. This processing 
can be repeated a number of times to improve the maps.   
 
2.10.3 Histogram matching 
In histogram matching the electron density as observed (from lowest to 
highest recorded density) is used to construct the histogram, which is then 
compared to the ideal histogram of previously refined structures. This 
method assigns every electron density value within the asymmetric unit and 
compares it to the predicted distribution of electron densities when the 
protein is observed at this resolution. This takes into account the B-factors, 
the overall scale, the resolution and all other important parameters that can 
be expected to be observed at that resolution. Hence, deviations from the 
expected features on the map are attributed to poor phasing angles, which 
have to be adjusted to modify the electron density map.  
 
2.11 Structure refinement 
The refinement of the protein structure is necessary to improve the phases 
and the geometry of the model. This is achieved by modifying the molecule 
to improve the correlation between the observed (|Fobs|) and calculated 
(|Fcalc|) structure factor amplitudes. During the initial stages of phase 
improvement, there are many details of the structure that are missing or 
assigned incorrectly. These include missing atoms, disordered regions, 
solvent molecules and poor coordinates and B-factors.  
The key in structure refinement is to maximise the ratio of unique 
observations recorded to the number of the refined parameters. The higher is 
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the resolution, the more are parameters that will be needed to be refined, 
because there are many reflections at higher resolution.  
 
2.11.1 Monitoring the progress of refinement  
Refinement is a cyclic process and can go on forever. Therefore it is 
important to monitor the fitness of the refined model along the way so that 
one can know when to call it. Monitoring the refinement progress can help 
to detect some inherited or systematic errors in the model. The R factor 
measures the fitness of the model and it is defined as the ratio of the sum of 
differences between observed and calculated structure amplitudes to the sum 
of observed structure amplitudes. Every stage of the refinement should lead 
to a decrease in the R factor. Its values depend on the resolution, the order in 
the crystal, the diffraction data, B-factors etc.  The R factor is expressed as:  
          
 
 
The major problem with the R factor is that is does not take into 
consideration the biases in the refinement data. For example, over-fitting or 
addition of water molecules can reduce the R factor, while the overall model 
is not improved. The a second free R factor is introduced to provide 
unbiased structure refinement data therefore, the data is divide into two part, 
the working set which is used in refinement and is about 95% of the data and 
the free R set 5% of the data. These are used to calculate Rwork and Rfree 
respectively. The free R factor is calculated from the test set or free R flag 
that was set aside from the beginning i.e. these reflections were not used 
during the refinement process. This test set is a randomly chosen 5% 
intensities. They can be randomly generated using UNIQUE (CCP4, 1994) 
programme. The free R factor measures how the model predicts a subset of 
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measured intensities that were not included in the refinement. The free R 
factor is expressed as;  
                                   
   
The hkl!T is the reflections from the free R set. R factor and free R factor 
should decrease at approximately the same rate towards end of the 
refinement, although it is normal at the beginning of structure refinement for 
the Rfree to be 2-5% higher than the R factor, depending on the resolution. It 
is common to find most crystallographers using both Rs during structure 
refinement progress. In the end of any refinement with an improved R 
factors, the model must be stereochemically and conformationally 
reasonable and should be validated before depositing it to the databanks.  
 
2.11.2 Model validation 
The working R factor and free R factor cross validate the model and show 
the fitness of the model. The model needs to be stereochemically and 
conformationally valid. It must not contain inverted amino acids i.e. D-
amino acids. The model also needs to show that all peptide bonds are planar 
and nonproline peptides bonds are trans, unless a cis conformational is 
followed by proline due to a specific local conformation constrains. The 
backbone conformational dihedral angles phi (!), psi (") and omega (#) 
should be within the allowed regions as determined from the Ramachandran 
plots in the case of ! and ". Normally these parameters are expected to 
improve during the refinement progress. As they are not restrained like bond 
angles and bond lengths during refinement, they are very good indicator of 
the model quality.  The MOLPROBITY program (Chen et al, 2010) and 
PROCHECK (Laskowski et al, 1993) analyses were used to validate the 
protein structure in this research project.  
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Chapter 3:  Materials and Methods 
 
This chapter will describe the experimental procedures used during the 
course of this project. 
 
3.1 Strains, plasmids and antibodies  
Bacterial strains, plasmids, and primary antibodies used throughout this 
study are listed in the (Table 3.1).  
 
3.2 Chemical suppliers and equipments 
The majority of chemicals and equipment used in this thesis were general 
products and are commonly available from a variety of companies.  
Chemicals were purchased from BDH Laboratory Supplies, Poole, England; 
Fisher Scientific UK Ltd., Leicestershire, UK; Bio-Rad Laboratories, Inc., 
CA, USA; Sigma-Aldrich, St. Louis, MO, USA; Invitrogen Corporation, 
CA, USA; Qiagen, Hilden, Germany; and GE Healthcare, Freiburg, 
Germany.  
All lipids were purchased from Avanti Polar Lipids, Inc., Alabama, USA 
and detergents from Glycon Bioch. GmbH, Germany. 
 
3.3 Microbiological Methods 
3.3.1 Growth media and conditions: Luria-Bertani (LB) 
Bacterial strains were routinely grown in sterilised Luria-Bertani (LB) 
medium (Sambrook & Russell, 2006) .     
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                                        LB medium  LB-agar 
Tryptone    10 g /L   10 g /L 
Yeast extract    5 g /L     5 g /L 
NaCl     10 g /L    10 g /L 
Bacteriological agar        -                           15 g /L 
All media were sterilised by autoclaving.  The appropriate antibiotics were 
added to LB-agar after cooling to 40-45 °C and LB agar was poured into 
Petri dishes and allowed to set.  Plates were kept at 4 °C and used within one 
month. 
 
3.3.2 M9 Minimal medium 
Bacterial strains were grown in M9 minimal medium when this medium was 
required (Larsson 2009). 
         Stock concentration Volume added 
5x M9 salts*                 -                          200 ml 
MgSO4                1 M       2 ml 
Glucose                                 20% (w/v)               20 ml 
CaCl2                1 M    0.1 ml 
Sterile deionised H2O                  -                up to 980 ml  
*5x M9 salts have been added to deionised H2O to a final volume of 1 litre: 
Na2HPO4.7H2O 64 g 
KH2PO4  15 g 
NaCl   2.5 g 
NH4Cl  5.0 g  
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Table 3.1: The bacterial strains, plasmids and primary antibodies that used 
in this thesis.  
 
 
 
 
 
Bacterial Strain, plasmid, or 
antibody Source or reference 
E. coli Bl21 (DE3) 
 (Novagen) 
Lab collection 
B. subtilis strain JH642 
D. Phung and Prof. P. E. Granum (Our 
collaborators in Norwegian School of 
Veterinary Science, Laboratory Animal 
Unit, Oslo, Norway) 
pGS2134 
 pET28a derivative with the APEC clyA 
coding region and kanamycin resistance . 
APEC clyA was inserted between EcoR1 
and Sal1 restriction sites with a thrombin 
cleavage site. 
Prof. J. Green (Department of 
MBB/University of Sheffield/United 
Kingdom) 
PEXP5-CT/TOPO-NheA 
PEXP5-CT/TOPO derivative with the nheA 
coding region and ampcillin resistance. 
nheA was cloned between Topoisomerase 
site 1 and Topoisomerase site 2. 
D. Phung and Prof. P. E. Granum (Our 
collaborators in Norwegian School of 
Veterinary Science, Laboratory Animal 
Unit, Oslo, Norway) 
pDG148-NheB 
pDG148-StuVector derivative with the 
nheB coding region and kanamycin 
resistance. 
D. Phung and P. E. Granum (Our 
collaborators in Norwegian School of 
Veterinary Science, Laboratory Animal 
Unit, Oslo, Norway) 
MAb 1A8 
Primary antibody reactive with NheA 
MAb 1E11 
Primary antibody reactive with NheB 
MAb 2B11 
Primary antibody reactive with NheB 
Dr. Erwin Märtlbauer (Ludwig-
Maximilians-Universitat, Munich, 
Germany), Our collaborators in 
Germany. 
 
MAb 1C2  
Primary antibody reactive with NheB 
D. Phung and P. E. Granum (Our 
collaborators in Norwegian School of 
Veterinary Science, Laboratory Animal 
Unit, Oslo, Norway) 
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3.3.3 Storage of strains and plasmids 
Strains were stored for up to one month on solid media at 4 °C.  For long-
term storage, strains were kept in the form of glycerol stocks in 80 % (v/v) 
sterile glycerol and stored at -80 °C. Plasmids were stored at -20 °C. 
 
3.3.4 Transformation of chemically competent cells 
The transformation is based on (Hanahan, 1983). Chemically competent 
bacteria were thawed on ice before plasmid DNA was added as 
recommended in the manufacturer’s instructions.  Briefly, a 50 µl aliquot of 
competent cells was incubated on ice with ~100 ng of DNA for 30 minutes 
after being mixed gently.  The cells were then heat shocked for 60 seconds 
at 42 °C and a further 2 minutes on ice. 950 µl of LB medium was added 
and the transformation mixture incubated at 37 °C for 1 hour.  The cells 
were pelleted on LB-agar plates, that containing the appropriate selective 
antibiotic. Plates were growth overnight at 37 °C. 
 
3.3.5 Agarose gel electrophoresis 
Agarose gel electrophoresis was used for confirming the presence of the 
APEC clyA insert gene.  Agarose 1% (w/v) was added to 1x TAE and 
dissolved by heating in a microwave oven.  Once cooled to 50 °C, ethidium 
bromide (0.6 µg/ml, final concentration) was added to the molten agarose 
and the gel was poured.  Electrophoretic fractionation was carried out using 
electrophoresis tanks at 100 V for up to 2 hours.  DNA inserts were 
visualised using a UV Itech photodocumentation system. 
50x TAE buffer: 
Trizma® base                            242 g /L 
Glacial acetic acid                    57.1 g /L 
Na2EDTA.2H2O, pH 8.5          37.2 g /L 
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3.3.6 Plasmid sequencing 
Insert gene sequencing was done by DNA Sequencing and Bioinformatics 
GATC Biotech Ltd, Cambridge. 
 
3.4 Protein Methods 
3.4.1 Concentration of proteins 
Where proteins of increased concentration were required for crystallization, 
the concentration of the protein was performed in a 10 kDa or 100 kDa 
molecular weight cut off Centricon centrifugal ultrafilteration device 
(Vivascience) as required.  Centrifugation at 4000 g was carried out at 4 °C 
until the protein solution reached the desired concentration. 
 
3.4.2 Measurement of protein concentration 
Protein concentration was estimated with the Bio-Rad protein assay protocol 
Bradford method (Bradford, 1976) with reagents purchased from BioRad.  
Absorbance was measured at 595 nm using a spectrophotometer.   
 
3.4.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
SDS-PAGE was used routinely throughout this thesis for analysis of 
proteins. SDS-PAGE analysis was performed according to the method 
described by (Laemmli, 1970) using the BioRad Mini Protean 3 system 
according to the manufacturer’s instructions. Gel and buffer recipes used in 
this thesis were taken from ‘Manual of Molecular Cloning (Sambrook & 
Russell, 2006). All SDS-PAGE gels reported in this thesis were 12% 
(acrylamide concentration).  
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12% SDS-PAGE separating gel:    
Acrylamide/ Bis solution              5 ml 30% (w/v)  
1 M Tris-HCl, pH 8.8                   4.69 ml 
10% SDS (w/v)                             125 !l  
Milli-Q water                                2.56 ml 
Ammonium persulphate                125 µl 10% (w/v) 
N,N,N',N'-tetramethyl-ethane-1,2-diamine (TEMED)     12.5 µl  
6% SDS-PAGE stacking gel:  
Acrylamide /Bis solution             1.5 ml 30% (w/v) 
1 M Tris-HCl, pH 6.8                   0.94 ml 
Milli-Q water                                2.6 ml 
Ammonium persulphate               75 µl 10% (w/v)  
10% SDS (w/v)                            75 µl 
TEME                                          7.5 µl  
1x SDS-running buffer:   2x SDS-loading buffer: 
Glycine 14.4 g /L    Glycerol        20% (v/v) 
Tris-HCL 3 g /L     Tris-HCl 100 mM 
SDS  1 g /L      SDS  4% (v/v) 
*Adjust to pH 8.8      Bromophenol blue   0.02%(v/v) 
        "-mercaptoethanol 200 mM 
1x Coomassie blue stain:     Destain: 
Methanol  20% (v/v)              Methanol      20% (v/v) 
Acetic acid  7.5% (v/v)   Acetic acid    7.5% (v/v) 
Coomassie Blue 0.1% (w/v) 
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3.4.4 Western immunoblotting 
3.4.4.1 Chemiluminescence method 
Western immunoblotting was carried out to identify and locate Nhe proteins 
(NheA and NheB). 12% SDS-PAGE analysis for Nhe was removed to a 
nitrocellulose membrane at 80 V for 1 hour. Then, the membrane was 
blocked with 5% non-fat dried milk in TBST buffer for 16 hours at 4˚C with 
shaking.  
The target protein was revealed by primary antibody at 4˚C for 1 hour with 
shaking. After five washes of the membrane by TBST buffer, Secondary 
antibody anti mouse HRP was added. Bound antibodies were detected by 
Chemiluminescence using LumiGLO reagent according to company’s 
procedure. 
 
3.4.4.2 Colorimetric kit method 
Western immunoblotting was carried out to check for the presence of NheB. 
12% SDS-PAGE analysis of NheB was transferred to a nitrocellulose 
membrane at 80 V for 1 hour. Then, the membrane was blocked with 5% 
non-fat dried milk in TBST buffer for 16 hours at 4 ˚C with shaking.  
NheB was revealed by primary antibody 1C2 at 4 ˚C for 1hour with shaking. 
After five washes of the membrane by TBST buffer, Secondary antibody 
biotin-conjugated anti-mouse antibodies from goat (Amersham Biosciences) 
was added. The membrane was washed five times with TBST buffer then 
transferred into mixture solution of streptavidin (Bio-Rad) and biotinylated 
alakaline phosphatase (Bio-Rad). The membrane was developed using 
colorimetric kits AP Color Development Reagent [5-bromo-4-chloro-3-
indolyl phosphate (BCIP) and nitro blue tetrazolium (NBT)] from Bio-Rad 
according to company’s procedure. 
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1x TBST buffer 
1 M Tris HCL pH 7.4               20 ml 
NaCl                                         8 g /L 
Tween20                                   1 ml 
 
 
3.4.5 Protein expression 
In general for the expression of APEC ClyA, NheA and NheB (more details 
of each protein in chapters 4, 5, and 7), aerobic growths of bacteria strains 
were typically cultured in 2L flasks with appropriate antibiotics and shaking 
at 250 or 200 rpm as required. All flasks and LB media were capped with 
foam bungs and aluminium foil then autoclaved before use. Bacterial growth 
was measured by reading the optical density (OD) at 600 nm of 1 ml culture 
samples. IPTG was added (as required) at point 0.6 to 0.8 then the culture 
was incubated at 37 °C for a further hours.   
In case of APEC ClyA, NheA, the cultures of bacteria were harvested at 4˚C 
(15,344 g, 20 minutes) and lysed by sonication. The sonication was 
performed in 3 cycles for 29 seconds at 16-micron amplitude, with cooling 
of the samples between sonication cycles. The lysed bacteria were 
centrifuged at 70000 g for 10 minutes.  
The protocol of (Larsson 2009) it was used for  expression of 
Selenomethionine (SeMet) labelled NheA protein in E. coli . The amino 
acids inhibition methionine biosynthesis, L-Isoleucine (50 mg /L), L-
Leucine (50 mg /L), L-Lysine (100 mg /L), L–Phenylalanine (100 mg /L), L 
–Threonine (100 mg /L) and L–Valine (50 mg /L), were used together with 
L-SeMet (60 mg /L) then IPTG (200 mg /L) was added to induce SeMet- 
NheA in minimal media.  
In case of NheB, it was assumed that the protein would be released from the 
cells into the media, and the NheB was precipitated from the media using 
60% (NH4)2SO4 . 
 118 
3.4.6 Protein purification 
As we are working on three proteins APEC ClyA, NheA and NheB, several 
different types of column chromatography were used throughout this project 
including ion exchange, hydrophobic interaction, gel filtration, and affinity 
chromatography:  
 
3.4.6.1 Ion exchange chromatography 
In ion exchange chromatography, the proteins separate on the basis of ionic 
attraction between molecules of an opposite charge. In this project it was 
used several types of ion exchange chromatography were used (as required): 
HiPrep TM 16/10 DEAE FF (anion exchange column DEAE-Sepharose Fast 
Flow weak anion exchanger) from GE Helthcare, Resource Q (HPLC) 
(strong anion exchanger) from GE Healthcare, and hydroxylapatite (Bio-rad 
Laboratories, Bio-Gel HT  gel).  
Washing the column with an increasing the gradient of salt can elute the 
protein. So the weakly bound proteins will be eluted first, followed by 
strongly bound components.  
 
3.4.6.2 Hydrophobic interaction chromatography 
In this kind of chromatography, the proteins separate based on hydrophobic 
groups on their surface, like ethyl, butyl or phenyl group.  
In the lab, Phenyl-Toyopearl 630S (hydrophobic matrix) from GE 
Healthcare (formerly Amersham) was used.  Ammonium sulphate is used to 
elute hydrophobic binding.  
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3.4.6.3 Gel filtration chromatography 
Gel filtration chromatography is also known as size exclusion 
chromatography or molecular sieve chromatography. Gel filtration separates 
proteins by size and shape. Beads with different sizes of pores are available, 
allowing different size of molecules to be effectively separated.  
In the lab Hi-Load Superdex 200 1.6x60 cm columns GE Healthcare 
(formerly Amersham) it was used.  
 
3.4.6.4 Affinity chromatography: Nickel Nitrilotriacetic acid (Ni-
NTA) Sepharose 
In this kind of chromatography exploits a protein binding to another 
molecule. In Ni-NTA, which was used in this thesis, histidines bind to the 
nickel sites, allowing separation based on the surface concentration of this 
amino acid. The bound protein is released from immobilized ligand by 
increasing the gradient of Imidazole.  
 
3.4.7 N-terminal sequencing of the proteins  
N-terminal sequences were done to confirm the amino acid sequences of our 
proteins that we were working on. N-terminal sequences were determined by 
Dr. Arthur Moir (Krebs Sequencing and Synthesis Facility, Department of 
Molecular Biology and Biotechnology, The University of Sheffield, UK) 
using an applied biosystems protein sequencer.  
 
3. 4. 8  Liquid chromatography–mass spectrometry (LC-MS) 
LC-MS was used to measure the level of incorporation of selenomethionine 
(SeMet) in NheA. LC-MS of NheA and SeMet NheA were done by Mr. 
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Simon Thorpe (Department of Chemistry,  The University of Sheffield, 
 Dainton Building,  Brookhill,  Sheffield, UK).  
 
3.5 Three dimensional crystallization trials 
Initial 3D crystallization trials for the proteins (APEC ClyA, NheA, and 
NheB) were performed either in an automated procedure using the Matrix 
Hydra II Plus One crystallization robot (Figure 3.1) or manually via vapour 
diffusion methods (hanging drop and sitting drop) using different 
crystallization screens from Hampton Research (Crystal Screen 1, Crystal 
Screen 2, PEG/Ion, and PEG/Ion 2); Jena Bioscience (JBScreen Membrane 
HTS, JBScreen Classic 1, JBScreen Classic 6), and QIAGEN screens  
(JCSG+ Suite, PACT Suite, (NH3)2SO4 Suite, Classics Suite, pH Clear)  
were utilized at 7 ºC and 17 ºC.  
Optimization of promising conditions was performed in 24-well Linbro 
plates (Hampton Research) using varying concentrations of proteins, 
precipitant concentration, temperature, pH, or by adding additives. 
 
3. 6 Cryoprotection of crystals 
Crystals of the proteins (ClyA, NheA, and NheB) that were suitable for 
diffraction were picked and soaked in a cryoprotectant solution, before 
freezing in a nitrogen stream at 100 K. Several different cryoprotectants 
were initially screened: PEG-400, ethylene glycol, sucrose and glycerol. 
Diffraction of cryoprotectant solution was assessed on our in-house source 
at 100 K using the Rigaku Micromax 007 copper rotating anode generator,  
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Figure 3.1: The Matrix Hydra II Plus One crystallization robot used in our 
lab. 
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which produces X-rays at a wavelength of 1.542 Å to identify the most 
suitable cryoprotectant. 
 
3. 7 Data collection and processing 
For producing high quality data collection, synchrotron X-ray beams at the 
Diamond Light Source in Oxford, United Kingdom were used to collect the 
data of the protein native crystals. Diffraction data were indexed and 
integrated using the programme IMOSFLM (Leslie, 1994) in home or XDS 
(Kabsch, 2010) at the Diamond Light Source in Oxford, United Kingdom. 
Scaled using SCALA (Evans, 1997) in CCP4 (CCP4, 1994). This gives an 
*.mtz file containing indices representing intensities (I) and their associated 
statistical errors ! (I), and final data statistics. 
Fluorescence scans of SeMet NheA crystals were collected and anomalous 
data (MAD data) collected using synchrotron X-ray beams at the Diamond 
Light Source in Oxford, United.  
Data were collected for anomalous scattering at three X-ray wavelengths of 
high remote 0.9784 Å, peak 0.9794 Å, and inflections 0.9797 Å.  These 
wavelengths were selected because they determined by a fluorescence scan 
at wavelengths around the theoretical Selenium absorption edge.  
Anomalous data were processed using the same program as native data (see 
above).  
 
3. 8 Structure Determination for NheA 
In this thesis, we able to solve one structure of the protein that we are 
working on, which is NheA.   
The NheA structure was solved by Multi-wavelength Anomalous Dispersion 
(MAD), more details in chapter 6. To carry out phase improvement we used 
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a combination of the SHELX program to locate heavy atoms (Sheldrick, 
2010) and PHENIX to carry out phase improvement (Adams et al, 2010). 
Water molecules and un-modelled regions of electron density were 
interpreted using the program COOT (Emsley & Cowtan, 2004). Refinement 
of the model against the electron density map was performed using the 
program REFMAC (Murshudov et al, 1997). Between rounds of refinement 
the model was rebuilt using the program COOT (Emsley & Cowtan, 2004). 
More details and any other programs used for data analysis or structural 
validation are described in chapter 6 and chapter 7.  
 
3.9 Biochemical protocol 
3.9.1 Hemolysis Assay 
The protocol of (Rowe & Welch, 1994) was used to measure the hemolytic 
activity of avian ClyA. Defibrinated horse and sheep blood was obtained 
from TCS Microbiology (UK). Briefly, purified protein was incubated with 
defibrinated blood in saline Tris- HCL pH 7 (50 mM Tris HCl, pH 7.0. 
containing 150 mM NaCl) for different tome (15 minutes, 30 minutes and 
overnight) at 37 ºC.  The mixture was centrifuged at 1000 g for 1 minute.  
The amount of hemolysis was determined spectrophotometrically by 
measuring hemoglobin release at 543 nm in the supernatants and readings 
were repeated at least three times.   
 
3.10 Electron microscopy studies  
Pore formation was examined using a Philips CM100 transmission electron 
microscope. Micrographs were recorded using a Gatan MultiScan 794 
charge-coupled device camera. 
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3.10. 1 Negative staining protocols 
The protocol of negative staining (Ohi et al, 2004) was used to stain the 
protein samples. Briefly, 3 to 5 µl of sample was loaded on glow discharged 
carbon-coated EM grids for 1 minute. This was then washed with two 50 µl 
drops of deionized water and subsequently stained with two drops of 0.75% 
of Uranyl Formate.  0.75%  (w/v) Uranyl formate solution was prepared in 
boiling dH2O, then filter sterilised, and stored at 4 oC, at pH 7.0.  
 
3.10.2 Immunogold labelling 
3-8 µl of sample from each trial was loaded onto microscope grids for 1 
minute.  Excess sample was removed by blotting on filter paper.  Grids were 
placed face down onto 50 µl drops of BSA (Bovine Serum Albumin) buffer.  
Grids were placed sample side down onto primary antibody drops and then 
were removed and washed three times in 50 µl drops of BSA buffer.  The 
secondary antibody (Anti-Mouse IgG–Gold antibody produced in goat from 
SIGMA ALDRICH) was diluted 1/25 in BSA buffer and grids were again 
added sample side down onto drops. The grids were washed three further 
times in BSA buffer, and prepared for negative staining as normal. 
 
BSA buffer 
Tris HCL pH 7.5        25 mM  
NaCl                          0.5 M 
Ca2Cl                         2.5 mM  
Na3N                         0.005%  
BSA                          5%  
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3.10.3 Cross-linking experiment  
The protocol was modified from (Huysmans et al, 2012). 3-8 µl of sample 
from each trial was loaded onto microscope grids for 1 minutes then cross-
linking was performed using 50 mM glutaraldehyde for 30 min at 25 °C and 
then immunogold labelling was done as described in section (3.10.2).  
 
3.10.4 Lipid prepration  
Method 1: Brain total lipid extract (BL) and E. coli total lipid extract (EL) 
were used which were prepared from lipid film (Avanti Polar lipids). In this 
method it detergent was used to solublize the lipid. The glass vials were 
washed with chloroform/methanol in ratio 1:1 (v/v), and then with pure 
chloroform. Lipid was added to glass vials and the organic solvent was 
evaporated at room temperature. Finally, the lipid was solubilized by buffer 
100 mM NaCl, 2.5 mM CaCl2, 0.005 % Na3N, in the presence of detergent, 
either ß-OG or DDM. 
Method 2: Brain Total Lipid Extract from Avanti Polar Lipids (Stock 
solution of lipid in chloroform  (10 mg/ml) was used. 2 ml of chloroform 
lipid solution was pipetted into a clean glass vial. Then the organic solvent 
was evaporated and the lipid was dried on to the glass walls using a nitrogen 
stream at room temperature. The lipid was re-solubilised in 5ml of buffer 
(25 mM Tris HCL pH 7.5; 0.5 M NaCl; 2.5 mM Ca2Cl and 0.005% Na3N); 
thus the final solution is 4mg/ml lipid in buffer. And then lipid extrusion by 
suspension strongly through pore (we used filter unit 20 µm) with syringe 
about 20 times to encourage liposomes to form. 
 
3.10.5 SEM & TEM for B. cereus strain NHV 0075/95  
Scanning electron microscopy (SEM) and transmission electron microscopy 
(TEM) were used to carry out the first experiments to observe B. cereus 
strain NHV 0075/95.  
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The specimen was prepared according to techniques of (Bozzola & Russell 
1999) by Dr. Christopher J Hill using the Philips XL-20 SEM and the FEI 
Tecnai G2 Spirit TEM in the Department of Biomedical Science, University 
of Sheffield, UK. Electron micrographs were taken using a Gatan digital 
camera. 
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Chapter 4:  APEC ClyA Expression, 
Purification, and Crystallization 
 
This chapter will describe the work on Avian Pathogenic E. coli (APEC) 
ClyA that was carried out in a project in my first year and half of my second 
year. ClyA was introduced in chapter 1, section 1.4. Attempts were made to 
crystallize the protein both in its soluble and its pore form. 
 
4.1  Plasmid sequence and agarose gel electrophoresis 
The APEC ClyA insert was confirmed firstly by restriction analysis using 
EcoR1 and Sal1 restriction enzymes. Gel electrophoresis showed the 
presence of His Tag-APEC ClyA fragment on Figure 4.1 with 950 bp, which 
was the expected size of the His Tag-APEC ClyA insert.  
The insert was then analyzed using the Basic local alignment search tool 
(BLAST) (Altschul et al, 1990) at the National Centre for Biotechnology 
Information http://blast.ncbi.nlm.nih.gov/Blast.cgi. It was clear the APEC 
ClyA insert sequence was 98% identical with the sequence of APEC ClyA 
from avian E.coli (Figure 4.2) which had been deposited in nucleotide 
database with accession number: AF052225. The discrepancies were due to 
undetermined nucleotides and to an erroneous G-R mistranslation in the 
original deposition as pointed out by Wyborn et al, (2004).  
 
4.2 Expression of recombinant His Tag- APEC ClyA 
E. coli strain BL21 (!DE3) was used as the host for His tagged-APEC ClyA 
expression vector, pGS2134.  
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Figure 4.1: Single and double digests of APEC ClyA expression vector.  
Visualised by agarose gel (1%) electrophoresis. Lane 1: hyperladder I; Lane 
2: non-digested plasmid; Lane 3: single digest with EcoR1; Lane 4: double 
digest with EcoR1 and Sal1. Arrowhead shows the expected size of His 
Tag-APEC ClyA insert, which about is 950 bp. 
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Figure 4.2: The APEC ClyA insert was sequenced and then analysed 
using BLAST, (Altschul et al, 1990) http://blast.ncbi.nlm.nih.gov/Blast.cgi. 
BLAST results showed that the APEC ClyA sequence is 98% identical to 
avian E. coli ClyA with accession number AF052225. 
 
 
 
 
 
Insert seq.  265   ATTCATGACCAATGCAGATCAGACAGTTGAAACAGTAAAAACAGCAATAGATACAGCAGA  324 
                   ||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain  ClyA  72    ATT-ATGACCAATGCAGATCAGACAGTTGAAACAGTAAAAACAGCAATAGATACAGCAGA  130 
 
Insert seq.  325   TAAAGCTTTAGATCTCTACAACAAGGTACTAGATCAGGTTATACCTTGGAATACATTTAA  384 
                   |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain  ClyA  131   TAAAGCTTTAGATCTCTACAACAAGGTACTAGATCAGGTTATACCTTGGAATACATTTAA  190 
 
Insert seq.  385   CGATACAGTGAAAGAATTAAGCCGTTTTAAAGAAGAGTACTCTCAATCGGCATCCACATT  444 
                   |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain  ClyA  191   CGATACAGTGAAAGAATTAAGCCGTTTTAAAGAAGAGTACTCTCAATCGGCATCCACATT  250 
 
Insert seq.  445   AGTTGGCGAAATTAAATCACTTCTGATGAATAGCCAAGATAGATACTTCGAGGCGACACA  504 
                   |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain  ClyA  251   AGTTGGCGAAATTAAATCACTTCTGATGAATAGCCAAGATAGATACTTCGAGGCGACACA  310 
 
Insert seq.  505   AGTAGTTTATGAATGGTGTGGAGTGACAACACAATTATTGACAGCCTATCTTTCATTATT  564 
                   |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain ClyA   311   AGTAGTTTATGAATGGTGTGGAGTGACAACACAATTATTGACAGCCTATCTTTCATTATT  370 
 
Insert seq.  565   TAATGAATATGATGAAAAAAAAGCGTCAGCACAAAAAACAATATTAATCAAAGTGCTGGA  624 
                   |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain ClyA   371   TAATGAATATGATGAAAAAAAAGCGTCAGCACAAAAAACAATATTAATCAAAGTGCTGGA  430 
 
Insert seq.  625   TGATGGGATTATTAAGCTCGAAAAAGCACAACAATCACTTCATGCTAGTTCTCAAAGTTT  684 
                   |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain ClyA   431   TGATGGGATTATTAAGCTCGAAAAAGCACAACAATCACTTCATGCTAGTTCTCAAAGTTT  490 
 
Insert seq.  685   CAACTCAGCATCTGGAAAATTAATAGCACTTGATAGCCAGTTAGCTAATGATTTTGATGA  744 
                   |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain ClyA   491   CAACTCAGCATCTGGAAAATTAATAGCACTTGATAGCCAGTTAGCTAATGATTTTGATGA  550 
 
Insert seq.  745   AAAAAGTGATTATTTTCAAGGGCAAGTAGATAAAATTAGAAAAGAAGCATATGCGGGGGC  804 
                   |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Avain ClyA   551   AAAAAGTGATTATTTTCAAGGGCAAGTAGATAAAATTAGAAAAGAAGCATATGCGGGGGC  610 
 
Insert seq.  805   TGCTGCAGGTGTTGTCGGANGGCCTTTTGGTTTAATAATTTCCTACTCAATAGCTGCTGG  864 
                   ||||||||||||||||||| |||||||||||||||||||||||||||||||||||||||| 
Avain ClyA   611   TGCTGCAGGTGTTGTCGGAAGGCCTTTTGGTTTAATAATTTCCTACTCAATAGCTGCTGG  670 
 
Insert seq.  865   GGTTGTTGAGGGGAANCTAATTCCTGCGCTGAAAGAAAAATTAAAGTCTGTCANNGANTT  924 
                   ||||||||| ||||| |||||||||||||||||||||||||||||||||||||  || || 
Avain ClyA   671   GGTTGTTGAAGGGAAACTAATTCCTGCGCTGAAAGAAAAATTAAAGTCTGTCAAAGATTT  730 
 
Insert seq.  925   TTTTGAATNNCTAGCTGCA  943 
                   ||||||||  ||||||||| 
Avain ClyA   731   TTTTGAATCGCTAGCTGCA  749 
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Expression of His Tag-APEC ClyA was performed aerobically in E. coli 
strain BL21 (!DE3) in LB supplemented with kanamycin (100 "g/mL) with 
shaking (250 rpm) at 37 ºC. In order to optimize the concentration of IPTG 
sufficient to induce the His Tag-ClyA, the following concentrations: 100 
"g/ml, 500 "g/ml, and 1000 "g/ml of IPTG were used when the bacterial 
growth reached an OD600 of 0.7.  
As a result, it can be observed from Figure 4.3 that all concentrations of 
IPTG were useful for expression of the protein after 5 hours. The molecular 
weight of expressed protein is the same as expected, which is about 34-35 
kDa. Thus, we decided to use 100 "g/ml IPTG for expression of the 
recombinant protein after 5 hours at 37 ºC in the future. 
Atkins et al, (2000) reported that 3 hours after induction by 100 "g/ml IPTG 
was enough for E.coli K12 strain JM109, which was used as the host for 
GST-ClyA, and we suppose the hosting cells may be responsible for slower 
expression of the protein.   
 
4.3 Purification of His Tag- APEC ClyA 
Cells were harvested by centrifugation for 20 minutes at 4 ºC at 15,344 g. 
The cell pellet was re-suspended in the lysis buffer (30 mM HEPES at pH 
7.4, 300 mM NaCl, 20 mM imidazole at pH 7.4) followed by disruption on 
ice with a sonicator.  
After sonication, the supernatant was loaded on a 5  ml Nickel-Nitrotriacetic 
acid (Ni-NTA) sepharose affinity column chromatography at room 
temperature and equilibrated with lysis buffer.  The column was washed 
with lysis buffer to remove any unbound protein. The recombinant protein 
was then eluted from the column with elution buffer containing 30 mM 
HEPES, pH at 7.4, 300 mM NaCl, 500 mM imidazole at pH 7.4 (Figure 
4.4).  
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Figure 4.3: 12% SDS-PAGE analysis of E. coli strain BL21 (!DE3), 
induced for 5 hours at 37 °C, carrying plasmids for the production of 
His tagged APEC ClyA protein.  
Visualised by staining with Coomassie blue. Lane1: Marker 12 from top to 
bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: supernatant 
(control); Lanes 3, 4, 5: supernatant induction by IPTG (100 !g/ml, 500 
!g/ml, and 1000 !g/ml) respectively.   
 
 
 
 
 
 
 
 
 
 
KDa 
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The fusion protein was then digested with thrombin at 25 °C for 16 hours to 
remove the tag. In order to determine how many units of thrombin are 
enough to release the APEC ClyA from its His-tag, a sequence of 
concentrations of thrombin was used (1 unit/mg, 3 units/mg, 5 units/mg, 7 
units/mg and 10 units/mg). We found one unit of thrombin per one mg of the 
protein was sufficient to release APEC ClyA from its His-tag (Figure 4.5). It 
was supposed that thrombin recognises the consensus sequence L-V-P-R-G-
S in the tag (Figure 4.6), cleaving the peptide bond between R and G. 
However, N-terminal sequencing analysis of APEC ClyA digested with 
thrombin protease revealed that thrombin also cleaved at site M-G-R-G-S. 
As a consequence of this cleavage site, APEC ClyA has an additional four 
residues (GSEF) fused to the N-terminus of the protein (Figure 4.6) rather 
than 19 as originally expected.     
Cleaved APEC ClyA was applied to a calibrated superdex200 gel filtration 
column pre-equilibrated with 50 mM Tris HCl, at pH8, 0.5 M NaCl (Figure 
4.7). Purified APEC ClyA had a band molecular mass of 33-34 kDa and was 
approximated to be !95% pure and homogeneous by SDS-PAGE (Figure 
4.8) and LC-MS mass spectrum analysis (Figure 4.9). Data from LC-MS 
show the molecule weight of the protein is 35405 Da. This MW is in 
agreement with the expected MW from cleaving APEC ClyA at the first 
position (marked as red underline in the APEC ClyA sequence in Figure 
4.6).  
N-terminal sequencing of the sample confirmed it was APEC ClyA. Protein 
concentration was estimated with the Bio-Rad protein assay protocol 
(Bradford method) and concentration of the protein was performed in a 10 
kDa molecular-weight cutoff of the Centricon centrifugal ultrafilteration 
device. APEC ClyA was concentrated to different protein concentrations (5 
mg/ml, 7 mg/ml, 10 mg/ml and 18 mg/ml) before crystallization trials. 
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Figure 4. 4: 12% SDS-PAGE analysis of Ni-NTA purified APEC ClyA.  
Visualised by staining with Coomassie blue stain.  Lane 1: Marker12 from 
top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: cell 
extract after induction (100 !g/ml of IPTG); Lane 3: unbound proteins; 
Lanes 4, 5,6,7,8 and 9 the fractions collected from the Ni-NTA column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: 12% SDS-PAGE analysis for APEC ClyA protein cleaved 
using different concentrations of thrombin.  
Visualised by staining with Coomassie blue stain.  Lane1: Marker12 from 
top to bottom: 66, 55, 36, 31, 21, 14, 10, 3.5, and 2.5 kDa; Lane 2: cell 
extract after induction (100 !g/ml of IPTG); Lane 3: loading sample Ni-
NTA; Lanes 4, 5, 6, 7, and 8 a series units of thrombin (1 unit/mg, 3 
units/mg, 5 units/mg, 7 units/mg and 10 units/mg), respectively.   
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        10         20         30         40         50         60  
FCLTLRRRYT MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFMTNA DQTVETVKTA  
 
        70         80         90        100        110        120  
IDTADKALDL YNKVLDQVIP WNTFNDTVKE LSRFKEEYSQ SASTLVGEIK SLLMNSQDRY  
 
       130        140        150        160        170        180  
FEATQVVYEW CGVTTQLLTA YLSLFNEYDE KKASAQKTIL IKVLDDGIIK LEKAQQSLHA  
 
       190        200        210        220        230        240  
SSQSFNSASG KLIALDSQLA NDFDEKSDYF QGQVDKIRKE AYAGAAAGVV GGPFGLIISY  
 
       250        260        270        280        290        300  
SIAAGVVEGK LIPALKEKLK SVKDFFESLA ATVKSANTDI DKAKSKLKDE ISVIGDLKTE  
 
       310        320        330        340  
TETTRFFVDY DDLMLKQLQD SATKLILSCN EYQKRHGKKN EQPLWY   
 
 
Figure 4.6: Primary sequence of insert APEC ClyA (accession ID: 
AF052225_1) blue colour, His-tag (green colour), Cleaving site (red colour). 
The thrombin could be has two cleaving sites as confirmed by N-terminal 
sequence; shown in red colour (the first position of cleavage site marked by 
red underline).  
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Figure 4.7: 12% SDS-PAGE analysis of APEC ClyA, released from His 
tag by thrombin cleavage after gel filtration.  
Visualised by staining with Coomassie blue stain. Lane1: Marker12 from 
top to bottom: 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: cell extract 
after induction (100 !g/ml of IPTG); Lane 3: loading sample an Ni-NTA 
column; Lanes 4, 5, 6, and 7 the fractions collected from gel filtration after 
thrombin cleavage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: 12% SDS-PAGE analysis of the purification of APEC ClyA 
protein. Visualised by staining with Coomassie blue stain. Lane1: Marker12 
from top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: 
cell extract before induction; Lane 3: cell extract after induction (100 !g/ml 
of IPTG); Lane 4: loading sample on Ni-NTA; Lane 5:  APEC ClyA cleaved 
by 1 unit/mg of thrombin; Lane 6: loading sample on gel filtration. 
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Chart 4.9:  LC- MS peptide analysis of APEC ClyA (20 !g).  
Highlighted peaks indicate mass weight of APEC ClyA.  
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4.4 3D Crystallization trials of cleaved monomeric APEC 
ClyA 
More than 5000 crystallization trials for monomeric Cleaved APEC ClyA 
were preformed manually or by automated setup via vapour diffusion 
methods (hanging drop and sitting drop, respectively). Different 
crystallization screens were utilized at 7 ºC and 17 ºC with different protein 
concentrations (5 mg/ml, 7 mg/ml, 10 mg/ml and 18 mg/ml).  
No usable crystals were observed from 3D crystallization trials of 
monomeric APEC ClyA. However, microcrystals were seen in some 
conditions: precipitated discs with tiny needles projecting from them; a very 
heavy circular drop with some small rectangular crystalline material as well 
growth of small crystals in 0.1 M Succinic acid at pH 7; and fused plates-
like crystals in 0.1 M Bicine at pH 9, 0.3 M MgCl2, 25% PEG2000, 15% 
Glycerol. There is a summary of these results in Figure 4.10. Attempts were 
made to optimize these conditions to obtain large crystals but no crystals 
formed. 
Chemical modification of APEC ClyA by lysine methylation was attempted 
using an alkylating agent, formaldehyde, and the reducing agent, 
dimethylamine borane complex, as described in a previous study (Walter et 
al, 2006). Needle microcrystals were obtained (Figure 4.11) in 70% MPD 
and 0.1 M HEPES pH 7.5. Methylation is expected to add +14 Da to the 
molecular mass per methyl group added.  The difficulty here was that mass 
spectrum analysis of methylated APEC ClyA (Figure 4.12) shows several 
different states of lysine methylation and some evidence of lower molecular 
weight species than the 35402 Da of unmodified APEC ClyA.  Accordingly, 
the solution becomes heterogeneous, which may have an effect on 
crystallization trials, since one of the most significant factors in 
crystallization is homogeneity of the sample (Qiu  & Janson, 2009). 
Microcrystals were obtained but could not be optimized.  
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Figure 4.10:  Crystallization hits for cleaved monomeric APEC ClyA.  
 (A) Microcrystals; (B) Discs of precipitate which have tiny needles 
projecting from them; (C) Heavy circular drops with some small rectangular 
crystals, which did not diffract; (D) Small crystals; (E) Fused plate-like 
crystals. 
 
 
 
 
 
 
 
2 M (NH4)2SO4; 
0.01MCoCl2; 
0.1 mM MES pH 6.5; 
ClyA 10 mg/ml, 17˚C  
0.1 M Tris HCl pH 8.5,  
8% PEG 8000.  
ClyA 18 mg/ml, 17˚C.  
 
 
1% Tryptone; 0.05 M HEPES pH 
7; 12% PEG 3350; ClyA 
10mg/ml; 17˚C. 
 
0.1 M succinic 
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12% PEG 3350 
ClyA10 mg/m;  
17 ˚C. 
0.1 M Bicine pH 9; 
0.3 MgCl2; 25% 
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Glycrol; ClyA 10 
mg/ml 
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Figure 4.11: Growth of needles after chemical modification by Lysine 
methylation of APEC ClyA in 70% MPD, 0.1 M HEPES AT pH 7.5. ClyA 
10 mg/ml, 17 ˚C.  
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Figure 4.12:  LC- MS peptide analysis of APEC ClyA (20 !g) after chemical modification by Lysine methylation. MW of 
unmodified APEC ClyA would be around 35402 (Red star). 
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4.5 3D Crystallization trials of non-cleaved monomeric APEC 
ClyA 
Tags in recombinant proteins change the solubility of the protein or increase 
the aggregation of the pure protein (Carson et al, 2007). Therefore many 
crystallographers suppose that tags hinder crystallization and therefore 
cleaving and removing the tag before screening for crystallization conditions 
can be very important (Carson et al, 2007).   On the other hand, the tag may 
be sometimes helpful or even required for crystallization.  (Tajika et al, 
2004) determined the structure of PH0828, a hypothetical protein from 
Pyrococcus horikoshii OT3, where the His tag on a long C-terminal helix 
protrudes outside the molecule and packs with another molecule about the 
crystallographic two-fold axis.  
The considerations discussed above suggested making some crystallization 
trials of the His tagged-APEC ClyA. The same protocol of expression and 
purification was used except thrombin was not used for cleaving. Thus the 
purified APEC ClyA contained a 46-residue linker (FCLTLRRRY 
TMGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSEF) at the N 
terminus (see Figure 4.6).  
Non-Cleaved monomeric APEC ClyA crystallized in the initial 
crystallization screen (pH clear) in condition C3 [0.1 M MES at pH 6 and 
5% PEG 6000] using a protein concentration of 8.5 mg/ml at 17 ºC, after 3 
weeks. This condition was optimized and the best rectangular shaped crystal 
were obtained in condition 0.1 M MES at pH 6 and 12% PEG 6000 and 0.1 
M MES at pH 7.5 and 12% PEG 6000 after 7 weeks at 17 ºC by using 
protein concentration 10 mg/ml (Figure 4.13).  
Crystals were cryo cooled at 100 K using mother liquor plus 20% 
ethyleneglycol as the cryoprotectant.  The crystals were tested in house on a 
MAR345 image plate using 1.542 Å wavelength X-rays generated by a 
Rigaku Micromax 007 copper rotating anode generator.  
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Figure 4.13: Rectangular shaped crystals for non-cleaved monomeric 
APEC ClyA.  
The crystals were growth in 0.1 M MES at pH 6 and 12% PEG6000 using 
10 mg/ml of protein 17 ˚C. Scale bar: 100 !m. 
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Two initial diffraction images separated by 90° were collected, with each 
image a 1° oscillation over a 30 minutes exposure but only diffracted to very 
low resolution. The crystals were kept then tested by synchrotron radiation 
but the diffraction did not go beyond 15 Å. 
 
4.6 Crystallization of membrane protein 
It was decided to attempt to crystallize APEC ClyA in its membrane-
associated pore form. The crystallization of membrane proteins is classified 
into three common methodologies (Smyth et al, 2003):  
- 2D crystallization: this is used in electron microscopy (more details in 
chapter 9).  In 2D crystals the membrane protein molecules are ordered in a 
single lipid bilayer. 
 
- Type I 3D crystallization: this type of crystal is built up of the layers of 
2D crystals in the third dimension. 
 
- Type II 3D crystallization: in this type, membrane proteins are 
crystallized within a detergent micelle. Detergent-solubilized protein 
molecules interact together by the hydrophilic part of the protein (protruding 
from the detergent-covered hydrophobic part of the protein transmembrane 
regions). 
In this project, for crystallization of APEC ClyA pore form (transmembrane 
protein), 2D crystallization trials for EM (as described later in chapter 9) 
were attempted, as well type II 3D crystallization trials for X-ray 
crystallography as described below.  
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4.7 3D Crystallization trials of APEC ClyA pore form 
(transmembrane protein) 
3D crystallization trials for the APEC ClyA pore form were set up using 
three types of detergents separately:  dodecyl maltoside (!-DDM), n-Decyl-
maltoside (DM), octyl !-D-glucopyranoside (!-OG).  
To produce APEC ClyA pores the protein was diluted to 0.2 mg/ml and 
incubated separately with 0.1% of detergent (DM, !-DDM, OG) and 2 mM 
dithiothreitol (DDT) for 16 hours at 4 ºC.  The complex was concentrated to 
6-7mg/ml and then it was set up for crystallization trials.   
Commercial membrane protein screens from Jena Bioscience were used to 
set up initial crystallization conditions. Small protein crystals were observed 
in A7 [20% PEG500, 50 mM Tris HCl at pH 8.5 and 100 mM MgCl2], and 
B1 [10% PEG2000, 50 mM Tris HCl at pH 8.5 and 300 mM MgCl2] using 
DDM-protein complex at 17 ºC. 
Promising crystallization trials were optimized.  The best conditions were 
found in different concentrations of PEG 400 (11-15%), 50 mM Tris HCl at 
pH 8.5 and 100 mM MgCl2. Crystals were also seen at different 
concentrations of PEG 2000 (8-10%), 50 mM Tris HCl at pH 8.5 and 300 
mM MgCl2 by mixing 5 µl of protein complex solution with 5 µl of reservoir 
solution and equilibrating against 1ml reservoir solution. Most of the crystal 
growths took two months. It was noticed that the crystals have a variety of 
forms (tetragonal shaped crystals, hexagonal shaped crystal with dimensions 
~ (80 "m x100 "m x1000 "m), cubic shaped crystal with dimensions ~ (200 
"m x 200 "m x 200 "m), wedge-shaped crystal with dimensions ~ (200 "m 
x100 "m x 300 "m), pentagonal shaped crystal with dimensions ~ (50 "m x 
200 "m x 300"m); and plates look like crystal (30 "m x 40 "m x 300 "m). 
these crystals have a different qualities (Figure 4.14).  
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Figure 4.14: APEC ClyA pore form crystals.  
There were multiple crystalline forms, with a variety of quality and 
dimensions in different concentration of PEG 400 (11- 15%), 50 mM Tris 
HCl at pH 8.5 and 100 mM MgCl2. Scale bar: 100 !m. 
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4.7.1 Cryoprotection  
In order to optimize the cryoprotectant conditions, different concentrations 
of glycerol, ethylene glycol, Sucrose, and PEG400 were mixed separately 
with reservoir solution.  It was found that all the crystal forms started 
dissolving immediately after soaking in most cryoprotectant agents and the 
best result was obtained by mixing PEG400 with reservoir solution.  As a 
result, PEG400 was used as the cryo-protectant agent, and for X-ray 
diffraction testing the crystals were immersed in cryoprotectant solution 
continuing 30% PEG400, 20 mM Tris HCl at pH 8.5, 20 mM MgCl2, 0.1% 
DDM for two hours then flash cooled in a stream of liquid nitrogen cooled 
to 100 K.  
 
4.7.2 X-ray diffraction 
Diffraction was tested for all crystal forms on the in-house source at 100 K 
using a Rigaku X-ray generator with a Mar345 detector. All crystal forms 
diffracted to very low resolution (around 20 Å) and only the hexagonal 
shaped crystals diffracted to beyond 15 Å. These crystals were kept and later 
they were tested with synchrotron X-ray beams at the Diamond Light Source 
in Oxford, United Kingdom but most of them diffracted to 12 Å resolution.  
 
4.8 Techniques for maximizing diffraction 
To test whether the cryo-protectant was damaging the crystals it was found 
that all APEC ClyA pore crystal forms also did not diffract when tested at 
room temperature without freezing. (For more details see chapter 2, section 
2.2.1).  As well, there was no improvement in the diffraction when very 
freshly grown crystals were freshly cooled.  
Two methods were used to attempt to improve the diffraction of APEC 
ClyA pore form crystals: crystal annealing and crystal dehydration.  
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4.8.1 Crystal annealing 
Crystal annealing can be considered as a technique that lies between room 
temperature mounting and cryo-crystallography. This technique involves 
rounds of room temperature mounting, cryogenic data collection, transfer to 
cryoprotected mother liquor at room temperature and then again data 
collection under cryogenic conditions. Thus, crystal annealing is generally a 
freeze, thaw, freeze processes; and during its inauguration it was greeted 
with a lot of skepticism (Newman, 2006). Nevertheless, this technique has 
been shown sometimes to improve crystal packing and resolution (El Omari 
et al, 2011; Harp et al, 1998). Alternatively, instead of transferring the 
crystal into the cryoprotected mother liquor, the cold stream of gas coming 
from liquid nitrogen can be blocked for few seconds to thaw the crystal and 
then allowed to flow again during data collection until the quality of the data 
improves. This method has a major advantage over dipping the crystal in the 
mother liquor at room temperature because the latter can change the crystal 
orientation during remounting while the former does not suffer from this 
problem.  
Some of the APEC ClyA pore form crystals were frozen in a stream of 
liquid nitrogen, and then warmed them up for 2-3 seconds, and finally re-
frozen again. No improvement was observed in the diffraction. 
 
4.8.2 Crystal dehydration 
The main purpose of protein crystal dehydration is to reduce the solvent 
content of the crystal. The gradual increase in precipitant concentration 
technique was used (Heras & Martin, 2005). This technique can be 
considered as a continuation of the hanging or sitting drop techniques once 
the protein crystals have been observed. After the crystals have been 
observed, they are transferred from one crystallisation reservoir to another 
with a gradual increase in precipitant concentration using the same 
crystallisation technique. This allows the solvent content of the crystal to 
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decrease as water vapour diffuses out of the crystal to the highly 
concentrated reservoir solution, which can improve crystal packing quality. 
The advantage of this method is the crystals can be reproduced since the 
humidity is controlled during the dehydration process. Even through 
dehydration alone has been observed to improve the crystal quality (Sam et 
al, 2006) though improvement in crystal packing and shrinkage of the 
lattices, a combination of crystal annealing and dehydration has also been 
shown to produce very good data (Newman, 2006). 
Here, the dehydration technique was used by transferring APEC ClyA pore 
form crystals gradually in to a higher concentration of PEG400  (15%, 17%, 
19%, 21%) for one to two minutes at each concentration prior to immersing 
in cryo-protectant. However the crystals deteriorated (Figure 4.15). 
Generally, was found that annealing and dehydration methods did not 
improve the quality of the data of APEC ClyA pore form crystals but it is 
unclear why some protein crystals respond to these techniques but others do 
not. 
 
4.9 Heavy metal soaking  
The initial strategy to solve the phase problem prior to the SeMet expression 
was heavy metal soaking to produce heavy metal derivatives for multiple 
isomorphous replacement. Normally, Heavy-metal derivative crystals which 
are produced in this way diffract less well than native crystals. However, in 
some cases the heavy-metal derivative crystals have an improved resolution 
limit. For example the resolution limit of MscL protein crystals, a 
mechanosensitive ion channel from Mycobacterium tuberculosis, was 
improved from 7 to 3.5 Å after soaking in heavy-metal (Chang et al, 1998; 
Heras & Martin, 2005). It was believed that binding of heavy atoms to MscL 
protein stabilized a unique orientation of the crystals (Chang et al, 1998).   
Some native APEC ClyA pore form crystals were transferred into drops of 
cryoprotectant solution continuing 30% PEG400, 20 mM Tris HCl pH 8.5,  
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Figure 4.15: APEC ClyA pore form crystals deteriorate after 
dehydration.  
These crystals were obtained from condition 14% PEG 400, 50 mM Tris 
HCl at pH 8.5 and 100 mM MgCl2 then transferred gradually in to higher 
concentration of PEG400  (15%, 17%, 19%, 21%) prior to immersing in 
cryoprotectant. The crystals became worse.  
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20 mM MgCl2, 0.1% DDM supplemented with 2 mM of Ethyl 
Mercuryphosphate (EMP) and 2 mM Ethylmercurithiosalicylic acid, sodium 
salt (C9H9HgNaO2S), separately for three hours then frozen in a stream of 
liquid nitrogen cooled to 100 K. The Mercury compounds helped to improve 
the resolution limit of the APEC ClyA pore form crystals from 15-10 Å to 8-
7 Å using synchrotron radiation (Figure 4.16). The beamline fluorescence 
detector showed that the heavy atom was present in the crystal.  
Mercury interacts strongly with free sulfhydryl groups of cysteine residues 
(the native ClyA sequence has two cysteine residues) to form covalent S-Hg 
bonds. It is assumed that this covalent modification could have improved the 
crystal packing quality.  
 
4.9.1 X-ray diffraction of APEC ClyA pore derivative crystals 
The X-ray diffraction patterns of the best APEC ClyA pore form crystal 
diffracted to 8-9 Å (Figure 4.16 A) but the data were fielded for processing 
due to low -resolution limit. The exposure time was 1 minute per image and 
the crystal-to-detector distance was 779.2 mm at wavelength 0.9795 Å. 
The second best APEC ClyA pore form crystal data was collected on the 
Diamond synchrotron light source to 7 Å resolution (Figure 4.16 B). A total 
of 900 images were collected with an oscillation angle of 0.2°, the exposure 
time was 0.5 second per image and the crystal-to-detector distance was 
446.9 mm at wavelength 1.009 Å. The collection of the data strategy was 
optimized using MOSFLM (Leslie, 1994), then were processed by XDS 
(Kabsch, 2010). APEC ClyA pore form crystal belonged to space group 
C222, with unit-cell parameters a = 195.8 Å, b = 358.3 Å, c = 194.4 Å. The 
data-collection and processing statistics are listed in Table 1.  
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Figure 4.16 A: The X-ray diffraction patterns of an APEC ClyA pore 
form crystal.  
X-ray diffraction pattern of an APEC ClyA crystal that had been soaked in 2 
mM EMP collected to 8- 9 Å resolution using beamline I02 at Diamond light 
source. The exposure time was 0.60 s, the crystal-to-detector distance was 
779.2 mm, wavelength 0.9795 Å and the oscillation range per image was 1°. 
The diffraction image was collected on an ADSC Q315 CCD detector. 
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Figure 4.16 B: X-ray diffraction patterns of an APEC ClyA pore form 
crystal.  
X-ray diffraction pattern of an APEC ClyA crystal that had been soaked in 2 
mM EMP collected to 7 Å resolution using beamline I02 at Diamond light 
source. The exposure time was 0.5 s, the crystal-to-detector distance was 
446.9 mm, wavelength 1.009 Å and the oscillation range per image was 0.2°. 
The diffraction image was collected on an ADSC Q315 CCD detector. 
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Table 4.1: Data collection statistics from the APEC ClyA crystal 
processed in space group C222.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Space group  C222 
Unit-cell parameters (Å, °) 
a=  196.16    b=  358.96   c=  194.78 
!=90   "=90   #=90 
Crystal system Orthorhombic 
 Overall Inner Shell Outer Shell 
Low resolution limit (Å) 81.51 81.51 6.62 
High resolution limit (Å) 6.45 28.87 6.45 
Rmerge 0.081 0.025 1.540 
Total No. of observations 100070 692 6832 
Total No. Unique 14016 164 992 
Mean ((I)/sd(I)) 14.7 27.5 1.2 
Completeness 98.8 87.9 97.1 
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4.10 Matthews number (Vm) calculation 
The Matthews number  (Vm) (Matthews, 1968) was calculated using the web 
page http://www.ruppweb.org/Mattprob/ (Kantardjieff & Rupp, 2003), which 
suggested there are approximately 20 ClyA monomers in the asymmetric 
unit. Since the structure of the pore form of E. coli K12 has 12 molecules in 
the pore (Mueller et al, 2009) (2WCD), this may indicate that there are two 
12 meric pores in the asymmetric unit. Alternatively there may be two 11 
mers or two 10 mers. Assuming 20 meric oligomer the crystals would have a 
solvent content of 48.9% (the Matthews coefficient was 2.4 Å3/Da). In order 
to investigate the possible rotational non-crystallographic symmetry in the 
APEC ClyA pore form crystal the POLARRFN self-rotation function (CCP4: 
Supported Program) analysis was used in the resolution range 7 Å.  For two- 
fold rotation, corresponding to kappa= 180°, there are 5 peaks (Figure 4.17) 
which are the expected crystallographic 2-fold symmetry axes of the space 
group C222, however there is an extra peak (marked X in Figure 4.17) which 
shows evidence of an additional 2-fold axes of non-crystallographic 
symmetry. In 4-fold, corresponding to kappa= 90° there is a further peak 
(marked Y in Figure 4.17) that may indicate non-crystallographic 4-fold 
symmetry. For 12 fold rotation, corresponding to kappa = 30° there is some 
elevated density but no clear evidence for 12-fold symmetry.  A self-
Patterson synthesis was calculated with 50–7 Å resolution data to look for 
pseudo- translational symmetry in the APEC ClyA crystal. However this 
showed only the origin peaks at (0, 0, 0,) and (!, !, 0) which are expected 
from the C222 space group symmetry!" 
While our effort was under way to find high quality pore form crystals to 
acquire higher resolution data, the structure of E. coli K-12 ClyA, which has 
75% amino acid similarity to APEC ClyA, was determined to 3.3 Å 
resolution by the group of Prof. N. Ban in Switzerland (Mueller et al, 2009). 
This structure had a 12-meric pore. Because of the similarity between K-12 
ClyA and APEC ClyA and the very slow progress on APEC ClyA project, it 
was decided to move onto the investigation of the Nhe toxin. 
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Figure 4. 17: Self-rotation function of APEC ClyA that was calculated using the program POLARRFN  in the resolution range 
50 Å – 7 Å. X labelling indicates that additional 2-fold axes of non-crystallographic symmetry. Y labelling indicates that non-
crystallographic 4-fold symmetry.  
X 
X 
Y Y 
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4.11 Biochemical studies on APEC ClyA 
4.11.1 Effect of APEC ClyA on mammalian erythrocytes 
The effect of APEC ClyA on red blood cells (RBC) was assayed using the 
hemolysis assay described by (Rowe & Welch, 1994).  Known 
concentrations (20 !g/ml) of purified APEC ClyA protein were incubated 
for 15 minutes, 30 minutes and 1 hour with defibrinated horse and sheep 
erythrocytes in saline Tris-HCl at pH 7.  The amount of hemolysis was 
determined spectrophotometrically by measuring hemoglobin release at 543 
nm in cell-free supernatants.  The hemolytic activity (100%) was determined 
by incubation of red blood cells in water, in place of buffer and measuring 
the A543 of the supernatant. APEC ClyA has high hemolytic activity against 
both defibrinated horse and sheep RBCs, which was unsurprising since the 
blood comes from similar class of vertebrate (mammalian organisms). 
Hemolytic activity increased with time and 100 % of cell lysis appeared just 
after one-hour incubation with APEC ClyA (Figure 4.18 and Figure 4.19).  
The cell lysis of APEC ClyA is comparable with other groups of pore 
forming toxins, such as E. coli hemolysin (Eberspacher et al, 1989).  
 
4.11.2 Effect of pH on erythrocyte lysis by APEC ClyA 
Certain cytolysins show a dependence on a specific pH for activity such as 
listeriolysin O (LLO), a cholesterol-dependent cytolysin, which has pH-
dependent activity (Schuerch et al, 2005). LLO is active at acidic media pH 
(<6), however the toxin activity is decreased at neutral pH, due to rapid and 
irreversible denaturation of the domain 3 of LLO, this domains usually 
insert into the membrane to form the transmembrane "-barrel pore 
(Schuerch et al, 2005).  
To investigate APEC ClyA activity at different pH values, samples of horse 
blood in saline Tris- HCl at pH 8, pH 7 and pH 5 were incubated with 
purified APEC ClyA (20 !g/ml) for 30 minutes at 37 °C. From Figure 4.20, 
it can be seen that APEC ClyA has high hemolytic activity at both pH 5 and 
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7 with 87% lysis of cells. However, at alkaline pH 8 there was slightly less 
hemolytic activity, which means that altering the pH had little effect on the 
efficiency of APEC ClyA-mediated RBC lysis. This result suggests that 
APEC ClyA is not as dependent on a specific pH for activity as LLO. No 
significant change in APEC ClyA activity was noticed at pH 5, 7, and 8.  It 
was not possible to examine pHs outside of this range due to the instability 
of RBCs.  This result suggests that APEC ClyA is cytolytically active across 
a range of pHs around physiological pH.  It seems that APEC ClyA could be 
effective in numerous locations in mammalian cells, whether it be exposed 
to acidic pH (e.g. the digestive system) or alkaline pH (e.g. the blood, as the 
pH of blood is slightly alkaline).  
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Figure 4.18: Hemolytic activity of APEC ClyA on RBCs with increasing 
incubation time. >?@ Negative control:  RBC with saline Tris-HCl at pH 7. 
 Saline Tris-HCl at pH 7 buffer acts as an isotonic solution that keeps the 
RBCs as a pellet after centrifuging. >A@ RBC with saline Tris-HCl at pH 7 and 20 µg/ml of APEC ClyA: it is 
clear APEC ClyA has high hemolytic activity. An increase in the incubation 
time with APEC ClyA caused an increase in cell lysis shown by the cell 
pellet decreasing in size (!).  >B@ Positive control: RBC with water: It is obvious that water causes full 
cell lysis and hemoglobin was released completely.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19: Hemolytic activity of defibrinated horse blood and sheep 
blood at different times 15 minutes, 30 minutes and 1 hour in saline Tris- 
HCl at pH 7 using 20 !g/ml of purified APEC ClyA protein. 
 
 
Hemolytic activity (%) for APEC ClyA (20 µg/ml) 
Horse blood 
 A            B         C  A            B         C 
15-minute incubations 
30-minute incubations 
1-hour incubations 
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! 
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Figure 4.20: Hemolytic activity of APEC ClyA (20 !g/ml) at different 
pHs on horse blood cells.  
Saline Tris-HCl at pH 7 was used at pH 8, pH 7 and pH 5 for 30 minutes at 
37 °C. 
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Chapter 5:  NheA Preparation and 
Crystallization 
  
This chapter will describe the work involved in the preparation and 
crystallization of native NheA, which including preparation and 
crystallization of selenomethionine incorporated protein for experimental 
phasing (see chapters 6 and 7). 
 
5.1 Expression of NheA and SeMet NheA 
5.1.1 Expression of native NheA 
NheA was expressed in E. coli strain BL21(!DE3) transformed with 
PEXP5-CT/TOPO-NheA vector (see section 3.3.4 for transformation 
protocol).  
The primary culture was grown at 37 ˚C in LB media containing Ampicillin 
(100 µg/ml) with shaking (250 rpm) overnight. 
Six litres of LB liquid media in six flasks was prepared, then ampicillin was 
added to a final concentration of 100 "g/ml. The primary culture was added 
to the secondary culture medium in a ratio of 2:100 (primary: secondary). 
Therefore 20 ml of primary culture was added to each 1000ml of secondary 
culture medium. The secondary cultures were grown at 37 ˚C with shaking 
(250 rpm) until the bacterial growth reached the logarithmic growth phase. 
This was measured when the cultures reached an OD600 of 0.6 to 0.8. NheA 
expression was induced by the addition of IPTG to final concentration of 
200 "g/ml for 20 hour. The nheA gene is under the control of the lac operon 
promoter genes, as is the whole vector inserted into the E. coli. IPTG was 
used to promote the Lac operon promoter site, and therefore induce 
expression of NheA protein (Figure 5.1).  
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5.1.2 Expression of SeMet NheA 
SeMet NheA was expressed in the same E. coli strain as native protein. The 
primary culture was grown at 37 ˚C in LB media containing Ampicillin (100 
µg/ml) with shaking (250 rpm) overnight. Two litres of LB liquid media in 
two litre flasks was prepared, and then ampicillin was added to a final 
concentration of 100 !g/ml. The primary culture was added to the secondary 
culture medium in a ratio of 2 ml primary: 100 ml secondary.  
The cultures of E. coli BL21 ("DE3) were harvested at 4 ˚C (15,344 g, 20 
minutes) and then the pellet was transferred to two litres of minimal media 
containing Ampicillin (100 µg/ml) and supplemented with amino acids that 
inhibit synthesis of the methionine biosynthetic pathway to encourage 
SeMet incorporation (section 3.4.5) and with the bases Adenine (0.50 g/l), 
Guanine (0.50 g/l), Thymine (0.50 g/l), Uracil (0.50 g/l).  The media also 
included MgSO4.7H2O (0.01 mg/ml) and Thiamine (0.004 mg/ml).  Then 
the culture was warmed to 37 ˚C for 30 minutes before induction by 200 
!g/ml IPTG. The culture containing IPTG was left to grow for 24 hours with 
shaking (250 rpm) at 37 °C before being centrifuged (15,344 g, 20 minutes). 
The supernatant containing the liquid media was removed and the pellets 
containing the cells were retained and kept for purification (Figure 5.1).  
 
5. 2 Purification of NheA and SeMet NheA 
5.2.1 Purification of NheA 
The cultures of E. coli BL21 ("DE3) were harvested at 4 ˚C (15,344 g, 20 
minutes) and lysed in 50 mM Tris HCl at pH 8 for sonication. The 
sonication was performed in 3 cycles for 20 seconds at 16-micron 
amplitude, with cooling of the samples between sonication cycles. The lysed 
bacteria were centrifuged at 70000 g for 10 minutes.  
 
 166 
 
 
 
 
 
 
 
Figure 5.1: 12% SDS-PAGE analysis of E. coli strain BL21 (!DE3), 
carrying plasmids for the production of NheA protein.  
Visualised by staining with Coomassie blue stain. Lane1: Marker 12 from 
top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: 
induction of NheA by 200 !g/ml IPTG in LB media for 20 h; Lane 3: 
supernatant (control); Lane 4: induction of SeMet NheA by 200 !g/ml 
IPTG in minimal media for 24 h.    
The molecular weight of the protein should be around 41 kDa (yellow 
pointer). 
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For the purification of NheA the following protocol was used for both the 
native NheA and the SeMet-derivative, with some amendments of the 
protocol for NheA SeMet as explained in section 5.2.2. 
The cell extract was applied onto a 20 ml DEAE sepharose fast flow ion 
exchange column pre-equilibrated with loading buffer (25 mM Bis Tris at 
pH 5.8). Un-bound proteins were washed from the column using the same 
buffer. The fractions were run on a 12% SDS polyacrylamide 
electrophoresis gel for analysis (Figure 5.2). Western immunoblotting was 
carried out to identify and locate NheA (as described on section 3.4.4.1). 
Consequently, the western immunoblotting result (Figure 5.3) confirms the 
presence of NheA in the fractions.  
Fractions were chosen for the least amount of contaminants and loaded onto 
a Hydroxylapatite Chromatography (HA) Column followed by elution with 
a linear gradient of 0 to 0.25 M Na3PO4 at pH 6.8 (Figure 5.4). 
 The eluted protein concentration was measured using a spectrophotometer 
to measure the OD at 595nm. The fractions with highest protein content 
were then loaded onto a Hi load Superdex 200 gel filtration column, which 
was pre-equilibrated with 50 mM Tris-HCL at pH 8.5 and 0.5 M NaCl 
(Figure 5.5). The fractions were run on a SDS PAGE for analysis along with 
a sample from each step in the purification to allow comparisons. N- 
terminal sequencing of the sample confirmed it was NheA.  
 
5.2.2 Purification of SeMet NheA 
For purification of the selenomethionine labeled protein the protocol was 
essentially the same, but with the following amendments: 
• The eluted proteins from the anion exchange chromatography were cut 
with 2 M - 2.5 M of (NH4)2SO4 for 2 hours at 4 ˚C, after spinning down the 
solution at 70000 g for 10 minutes.  
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Figure 5. 2: 12% SDS-PAGE analysis of DEAE sepharose column 
purification for NheA.  
Visualised by staining with Coomassie blue stain.  Lane1: Marker12 from 
top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: 
pellet; Lane 3: cell extract; Lane 4: to lane 13 the fractions collected from 
the DEAE sepharose column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 3: Western immunoblot of 12% SDS-PAGE analysis of DEAE 
sepharose for NheA.  
Visualised by chemiluminescence method. The primary antibody MAb 
1A8 was used. 
Lane 1: Marker Nexus View 20 kDa Dual Color from top to bottom: 140, 
120, 100, 80, 60, 40, and 30 kDa; Lane 2 cell extract; Lane 3 to 14 fractions 
from DEAE sepharose for NheA. 
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Figure 5.4: 12% SDS-PAGE analysis of a Hydroxylapatite 
Chromatography (HA) purification for NheA. 
 Visualised by staining with Coomassie blue stain.  Lane 1: Marker12 from 
top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: HA 
load (after DEAE sepharose); Lane 3: to lane 15 the fractions collected from 
the HA column. 
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Figure 5. 5: 12% SDS-PAGE analysis of purification for NheA.  
Visualised by staining with Coomassie blue stain.  Lane 1: Marker12 from 
top to bottom: 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: Cell extract; Lane 
3: After DEAE sepharose column; Lane 4: After HA column; Lane 5: After 
gel filtration column 
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• Four chromatographic steps were used: the first step was DEAE sepharose 
column fast flow ion exchange (Figure 5.6). Then gel filtration and 
hydroxylapatite chromatography were applied in the reverse order compared 
to native protein (Figure 5.7, and Figure 5.8), and an additional anion 
exchange chromatography step on a Resource Q column HPLC was used as 
a final polishing step for purification of the SeMet-derivative NheA to 
remove small contaminant proteins (Figure 5.9).  
 
5.3 Properties of pure NheA protein 
The purified NheA was homogeneous with molecular weight approximately 
41 kDa shown by SDS–PAGE, which is near to the expected weight.  
To prepare an NheA sample for crystallization, the buffer in the sample was 
exchanged with 10 mM sodium phosphate at pH 6.8 using a 0.5 ml ZebaTM 
Desalting Column (Thermo Sciencific). Protein concentration was 
determined by the Bradford method.  Both native NheA and SeMet-
derivative NheA were concentrated in a Centricon centrifugal ultrafilteration 
device with a 10 kDa molecular-weight cutoff membrane to 10.5 and 9 
mg/ml, respectively, before setting up crystallization trials.  
 
5.4 Mass spectrometry analysis for NheA and SeMet NheA 
The amino acid sequence of NheA (Figure 5.10) shows the existence of 
seven Methionine residues. Theoretically, when replacing Methionine by 
Selenomethionine the molecular weight of NheA should rise by 
approximately 47 Dalton per Selenomethionine.  Native NheA and SeMet 
NheA were examined by liquid chromatography–mass spectrometry (LC-
MS) to investigate the incorporation of SeMet in NheA. LC-MS analysis of 
SeMet NheA confirmed approximately, 100% incorporation of the 7 
Selenomethionines in NheA and no evidence for oxidation to selenoxide as 
the mass peaks are the same breadth as native (Figure 5.11).  
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Figure 5. 6: 12% SDS-PAGE analysis of DEAE sepharose column purification for SeMet NheA.  
Visualised by staining with Coomassie blue stain.  Lane 1: Marker12 from top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 
kDa; Lane 2: cell extract; Lane 3: lane 25 the fractions collected from DEAE sepharose column. 
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Figure 5. 7: 12% SDS-PAGE analysis of gel filtration of purification for 
SeMet NheA. Visualised by staining with Coomassie blue stain.  Lane 1: 
Marker12 from top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 
kDa; Lane 2: gel filtration load; Lane 3 to Lane10: gel filtration column 
fractions. 
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Figure 5. 8: 12% SDS-PAGE analysis of HA of purification for SeMet 
NheA. Visualised by staining with Coomassie blue stain:  Lane 1: Marker12 
from top to bottom: 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: cell 
extract; Lane 3: after DEAE sepharose column; Lane 4: after gel filtration 
column; Lane 5: HA load; Lane 7 to lane 13: HA fractions. 
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Figure 5. 9: 12% SDS-PAGE analysis of Resource Q for SeMet NheA 
purification. Visualised by staining with Coomassie blue stain.  Lane 1: 
Marker12 from top to bottom: 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; 
Lane 2: cell extract; Lane 3: after HA column; Lane 4 to 12: the fractions 
from the Resource Q column. The less contaminated fractions (8-11) were 
collected for further experiments. 
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10         20         30         40         50         60  
    KEGQTEVKTV YAQNVIAPNT LSNSIRMLGS QSPLIQAYGL VILQQPDIKV NAMSSLTNHQ  
 
        70         80         90        100        110        120  
KFAKANVREW IDEYNPKLID LNQEMMRYSI RFNSYYSKLY ELAGNINEDE QSKADFTNAY  
 
       130        140        150        160        170        180  
GKLQLQVQSI QENMEQDLLE LNRFKTVLDK DSNNLSIKAD EAIKTLQGSS GDIVKLREDI  
 
       190        200        210        220        230        240  
KRIQGEIQAE LTTILNRPQE IIKGSINIGK QVFTITNQTA QTKTIDFVSI GTLSNEIVNA  
 
       250        260        270        280        290        300  
ADSQTREAAL RIQQKQKELL PLIQKLSQTE AEATQITFVE DQVSSFTELI DRQITTLETL  
 
       310        320        330        340        350        360  
LTDWKVLNNN MIQIQKNVEE GTYTDSSLLQ KHFNQIKKVS DEMNKQTNQF EDYVTNVEVH 
 
 
 
Figure 5. 10: NheA amino acid sequence.  
 The blue colour shows Methionine positions. 
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Chart 5.11: LC-MS analysis for NheA and SeMet NheA. 
(A) Mass spectrum analysis of native NheA 
(B) Mass spectrum analysis of SeMet NheA. It is clear the molecular weight 
of NheA was increased by roughly 328 Dalton, corresponding to 
changing all 7 Methionines to Selenomethionine. The result also 
indicates the high level of incorporation of SeMet.  
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5.5 3D Crystallization trials for NheA and SeMet NheA 
5.5.1 Initial  crystallization trials for NheA 
Initial protein crystallization trials for NheA were done at 17 ˚C using the 
Matrix Hydra II Plus One crystallization robot, using crystallization screens 
JSCG+ Suite and the PACT screen (Qiagen) and vapour-diffusion (sitting-
drop method).  The initial indication was needles produced in one condition, 
H8 from the JSCG+ Suite [0.2 M (NH4)2SO4 ,  0.1 M Bis-Tris at pH 5, and 
 25% PEG 3350] (Figure 5.12).  
 
5.5.2 Optimization of crystallization conditions for  NheA 
Optimization of the initial hit was performed by reproducing the condition in 
24-well plate format (Hampton Research) using the sitting drop vapour 
diffusion method (as described in section 2.1.2.2). Crystals could be 
reproduced in this format and so further optimisation grids were set up using 
different protein concentrations, PEG-concentrations, PEG molecular 
weights, salt concentrations, pH from 5 to 8, using different buffers. Further 
optimization conditions involved lowering the incubation temperature to 7 
ºC and screening additional buffer components (additive screen). 
The droplet was prepared by mixing 2 µl protein solution and reservoir 2 µl 
solution and then equilibrating against 1 ml of reservoir solution at 17 ˚C 
and 7 ˚C. Long plate-like crystals of native NheA were grown from 0.2 M 
(NH4)2SO4 ,  0.1 M Bis-Tris at pH 5.5, and different PEG3350 
concentration (20-25 %) after 3 days. 
In order to reduce nucleation and create a single crystal for native NheA, 
further optimization of crystallization conditions was attempted. The best 
single crystal (Figure 5.13A) was obtained from the condition 0.2 M 
(NH4)2SO4,  0.1 M Bis-Tris at pH 7, and 22 % PEG3350 after 20 days. The 
crystals had maximum dimensions of 80 !m x 200 !m x 400 !m.  
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Figure 5.12: Growth of needles as the first hit for native NheA crystals 
in 0.2 M (NH4)2SO4, 0.1 M Bis- tris pH 5, 25% PEG3350, NheA 10 mg/ml,  
17˚C. Scale bar: 100 !m.  
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5.5.3 Search for a cryo-condition for the NheA crystals 
Searching for a cryogenic condition for the crystals of a protein is a very 
significant point as this allows the crystals to be cooled to a very low 
temperature, which helps reduce radiation damage. When the crystal is 
exposed to the X-ray radiation, free radicals are generated and easily 
propagate throughout the entire crystal and damage the protein. To 
overcome this problem, a cryoprotectant solution should be chosen very 
carefully.  
Initial searching for cryoprotectants focused on the use of etheleneglycol, 
glycerol, sugar, and low molecular weight PEG solutions.  The best 
cryoprotectant solution is one that forms a glass, with a clear appearance and 
no visible ice ring on diffraction.  
All the cryo-tests were carried out using freshly prepared solutions, which 
were flash-cooled to 100K in a cryo-stream, one-minute exposure, in the 
absence of the crystal. It was found that the best cryoprotectant for the NheA 
crystals was 0.2 M (NH4)2SO4 ,  0.1 M Bis-Tris at pH 5.5,  22% PEG3350, 
and 20% ethyleneglycol.  
 The crystal was flash-cooled in liquid nitrogen at 100 K on the in-house 
source using the Rigaku X-ray generator with a Mar345 detector. The 
crystal showed excellent diffraction in-house to better than 2.4 Å resolution 
(Figure 5. 13 B). The crystal was then stored in liquid nitrogen for data 
collection at the Diamond Light Source in Oxford, United Kingdom for high 
resolution data collection.  
 
5.5.4 3D Crystallization trials of SeMet NheA 
Using a slight variation of the native NheA crystal conditions for SeMet-
NheA, clusters of crystals (Figure 5. 14) were grown in 5 days from 0.2 M 
(NH4)2SO4 ,  0.1 M Bis-Tris pH at 6, and  27% PEG 3350. 
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One crystal of SeMet-NheA was broken apart from a cluster, and then the 
crystal was mounted in a loop and soaked for a few seconds in 0.2 M 
(NH4)2SO4 ,  0.1 M Bis-Tris at pH 6, and  27% PEG 3350 with 20% of 
ethylene glycol. X-ray diffraction was observed in-house to beyond 2.9Å 
resolution using the Mar435 detector. This crystal was saved in liquid 
nitrogen to send to the Diamond Light Source for high resolution data 
collection and to perform fluorescence scans on the crystal and to collect 
anomalous diffraction data.  
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Figure 5.13: (A) A single crystal of native NheA grown in 0.2M 
(NH4)2SO4,  0.1 M Bis- tris pH 7, 22% PEG3350 , NheA 10 mg/ml, 17 ˚C. 
Scale bar: 100 !m.  
(B) Initial X-ray diffraction to 2.4 Å resolution from NheA crystal using 
beamline of Mar345 detector in house.  
An enlarged portion of the image is revealed on the top.
Hexagonal shaped 
crystal 
A B 
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Figure 5. 14: A cluster of crystals of SeMet NheA grown in 0.2 M 
(NH4)2SO4,  0.1 M Bis- tris pH 6, 27% PEG3350 , SeMet NheA 9.5 mg/ml, 
17 ˚C.  Scale bar: 100 !m. 
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Chapter 6:  Experimental Structure 
Determination of NheA by SeMet MAD to 
2.05Å  
 
Attempts were made to solve the structure of NheA by molecular 
replacement using E. coli K-12 ClyA and B. cereus HblB as search models 
but they failed because there was no structure available with sufficient 
(>30%) sequence identity to NheA. Therefore, the structure had to be solved 
independently by multiple isomorphous replacement (MIR) or multiple 
anomalous dispersion (MAD) phasing. This chapter will describe the 
structure solution of B. cereus NheA at 2.05 Å resolution using SeMet MAD 
phases.  
 
6.1 Space group determination and indexing 
Native NheA and SeMet NheA crystals were initially evaluated on the 
MAR345 image plate using 1.542 Å wavelength X-rays generated by a 
Rigaku Micromax 007 copper rotating anode generator in Sheffield. Two 1° 
oscillations separated by 90° with a 30 minute exposure were used to 
initially determine the space group by autoindexing using MOSFLM (Leslie, 
1994). The space group and autoindexing were confirmed at the Diamond 
Light Source in Oxford, United Kingdom using XDS (Kabsch, 2010) by 
testing two images separated by 90° with each image a 0.25° oscillation.  
Both native NheA and the SeMet derivative belong to the monoclinic crystal 
system, which is characterized by unequal lengths of the three axes, a, b, and 
c, and the interaxial angles != " =90°, #$90°. 
The space group of native NheA and NheA SeMet crystals are C2. The 
native NheA crystal had a cell dimensions a=308.67 Å, b=58.17 Å, 
c=172.93 Å, !=90°, #=110.55°, " =90°.  The cell dimensions of the NheA 
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SeMet crystal were a = 307.91 Å, b= 58.73 Å, c= 172.73 Å !=90°, 
"=110.40°, # =90°. 
 
6.2 Data collection and processing 
As described in Section 3.7, the native NheA crystal was flash-frozen in 
liquid nitrogen at 100K and data were collected on the Diamond synchrotron 
light source to 1.79 Å resolution (Figure 6.1).  
A total of 450 images were collected each with an oscillation angle of 0.5° 
but this data was interrupted two times due to technical problems of the 
synchrotron beam so that 199 images were discarded then the same 225° of 
data were recollected completely without interruptions. The exposure time 
was 0.25 second per image and the crystal-to-detector distance was 
259.0 mm at wavelength 0.9686 Å. The strategy for collection of the native 
data was optimized using MOSFLM (Leslie, 1994), then the data were 
processed by XDS (Kabsch, 2010).  
Native data analysis indicated that the data had poor quality at above 2.05 Å 
resolution. The processing of native data at 1.79 Å resolution indicates 
overall "Rmerge" was 0.1 and 1.27 for the outer shell, and "Mean ((I)/ sd (I))" 
was 0.7 for the outer shell, and 5.3 overall. Thus the data was cut off to 
2.05Å resolution. Final data collection statistics are shown in Table 6.1. 
The SeMet crystal was also flash-frozen in liquid nitrogen at 100 K and the 
MAD data collected on the Diamond synchrotron light source. A 
fluorescence scan of the SeMet crystal was taken by Vortex fluorescence 
detector over an energy range of 12.62-12.67 keV, and revealed an 
absorption edge at 12.66 keV that confirmed the presence of selenium in the 
sample (See Figure 6.2) as already indicated by MS (See Figure 5.11). The 
fluorescence data were processed firstly in CHOOCH (Evans & Pettifer, 
2001) to produce a chart illustrating the values of the anomalous scattering 
factors, f' and f'',  which indicated the X-ray energies at points corresponding 
to maximum f' and f'' minimum.  
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 Anomalous data (MAD data) were collected to 2.05 Å resolution (Figure 
6.3) from one NheA SeMet crystal at three wavelengths: high remote 0.9784 
Å, peak 0.9794 Å, and inflection 0.9797 Å. These were chosen near the 
selenium-absorption edge based on the fluorescence absorption spectrum of 
the crystal in order to maximize the f'' component (!1 peak), to minimize the 
f' component (!2 inflection) and to maximize "f` (!3 remote) in order to 
optimize the power of phasing from the incorporated Selenium atoms.   
Anomalous data (MAD data) were collected on the I02 beamline at the 
Diamond Light Source in Oxford, United Kingdom. The diffraction images 
were collected on an ADSC Q315 CCD detector.  A total of 540 images, 
with a 0.5º rotation per image, exposure time of 0.75 second per image and 
with the detector distance set at 225.0 mm, were collected at all three 
wavelengths. The collection of the anomalous data strategy was optimized 
using MOSFLM (Leslie, 1994) and then the data were processed in the same 
manner as the native data. The data collection statistics are shown in Table 
6.1.  
The result of data collection and processing for the anomalous data overall 
"Rmerge" was below 0.1, and around 0.6 for the outer shell. The "Mean ((I)/ 
sd (I))" was between 2.5 and 2 for the outer shell, and over 7 overall. The 
Completeness was over 98% overall. In general these represent reasonable 
indicators for data quality. As well, there was no indication of crystal 
twinning and no indication of radiation damage.   
These data processing statistics are good by the statistics of (Wlodawer et al, 
2008).  The data collection and processing statistics listed in Table 6.1. 
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Figure 6.1: X-ray diffraction pattern of NheA crystal using beamline 
I02 of Diamond light source.  
Diffraction intensities were collected to 1.79 Å resolution but the data 
werecut off to 2.05 Å resolution. The exposure time was 0.25 s, the crystal-
to-detector distance was 259.0 mm, wavelength 0.9686 Å and the oscillation 
range per image was 0.5°. The diffraction image was collected on an ADSC 
Q315 CCD detector. 
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Figure 6.2: Fluorescence scan of anomalous scattering of SeMet NheA at 
three X-ray wavelengths of high remote 0.9784 Å, peak 0.9794 Å, and 
inflection 0.9797 Å. Taken at beams on the Diamond Light Source in 
Oxford, United Kingdom. 
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Figure 6.3: X-ray diffraction pattern from SeMet NheA crystal using 
beamline I02 of Diamond light source.  
Diffraction intensities are visible to 2 Å. The exposure time was 0.75 s, the 
crystal-to-detector distance was 225.0 mm, Peak wavelength 0.9794 Å and 
the oscillation range per image was 0.5°. The diffraction image was collected 
on an ADSC Q315 CCD detector. 
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Table 6.1: The Final data collection and processing statistics of the 
NheA structure in the C2 space groups generated. 
 
 
 
               *Data in brackets are for highest resolution shell. 
Rmerge = !hkl!i|I i " <I>|/|<I>|, where I i is the intensity for the i th 
measurement of an equivalent reflection with indices h,k,l 
 
  
Native NheA  
 
SeMet NheA 
Data collection statistics    
Beamline 
At the Diamond Light 
Source, Oxford, England 
I03 
 
I02 
 
Detectors 
At the Diamond synchrotron 
ADSC Q315R CCD detector  
 
 
The crystal-to-detector 
distance (mm) 
259.0  225.0 
Space group C2 
Cell dimensions   
    a, b, c (Å) 308.67, 58.17, 
172.93 
307.91, 58.72, 172.73 
    #, $, %  (°) 90, 110.55, 90 90, 110.39, 90 
Crystal system Monoclinic 
  Peak Inflection Remote 
Wavelength (Å) 0.96860 0.9794 0.9797 0.9784 
Resolution (Å) 50.2-2.05 
(2.16-2.05) 
29.8-2.05 
(2.16-2.05) 
29.9-2.09 
(2.21-2.09) 
29.9-2.19 
(2.31-2.19) 
No. of observations 504907 (74251) 672961 
(96285) 
629433  
(89066) 
547829 
(76626) 
No. of unique reflections 179016 (26237) 182607 
(26191) 
170815 
(24262) 
148979 
(21012) 
Rmerge 
0.077  
(0.358) 
0.114 
(0.626) 
0.10 
(0.641) 
0.106 
(0.656) 
I / &I 7.5 (2.5) 7 (2) 7.7 (2) 8.3 (2) 
Completeness (%) 98.9 (99.7) 99.6 (98.5) 99.5 (97.6) 99.3 (96.5) 
Mosaicity (°) 0.36 0.4 
Multiplicity 2.8 (2.8) 3.7 (3.7) 3.7 (3.7) 3.7 (3.6) 
Number of molecules in the 
asymmetric unit 
8 
Solvent content (%) 44.3  
Matthews coefficient 
(Å3/Da) 
2.21  
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6.3 Matthews number (Vm) calculation 
The Matthews number calculation allows estimation of the number of 
molecules residing in the asymmetric unit (Matthews, 1968). It was 
calculated using the web page http://www.ruppweb.org/Mattprob/ 
(Kantardjieff & Rupp, 2003). This predicted, based on the unit cell volume 
and the molecular weight of NheA, that there were 12 possible solutions in 
the Vm range considered of which the most probable solutions are between 
6 and 9 molecules in the asymmetric unit (Table 6.2). In order to examine 
the possible rotational pseudosymmetric relationships of NheA molecules in 
the asymmetric unit, a self-rotation function was run from 0° to 180° with a 
5° intervals on ! using POLARRFN (CCP4: Supported Program), but there 
was no non-crystallographic pseudosymmetric rotational symmetry. A self- 
Patterson function was calculated with 50–6 Å, data which showed that 
there are two peaks, one with a height of 61% of the origin at (u, v, w) = 
(0.25, 0.25, 0.0), and another one with a height of 41% of the origin at (u, v, 
w) = (0.5, 0.0, 0.0) (Figures 6.4 A and B) in addition to the origin. These 
indicate that the asymmetric unit of NheA has molecules which are related 
by two different kinds of translational pseudo-symmetry. As result, it was 
suggested that the number of the monomers in the asymmetric unit of NheA 
is a multiple of four, and thus the strongest probability is 8 molecules in 
asymmetric unit with a solvent content of 44% and a Vm of 2.21 Å3/Da 
(Table 6.2; and Figure 6.5 A and B). This value is in the middle of the range 
of those predicted for protein crystals (Matthews, 1968). 
 
6.4 Structure determination of NheA 
As described below, the NheA structure was solved by SeMet MAD and to 
solve the structure and to carry out phase improvement we used a 
combination of the SHELXC, D and E programs to locate heavy atoms 
(Sheldrick, 2010) and PHENIX to carry out phase improvement and 
automated model building (Adams et al, 2010).  
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Table 6.2: Output from the Matthews Probability Calculator at 
http://www.ruppweb.org/Mattprob/ (Kantardjieff & Rupp, 2003).   
This suggested that there were 6 to 9 molecules in the asymmetric unit with 
a Vm of 2.21 A3/Da giving the crystals a solvent content of 44% if there 
were 8 molecules in the asymmetric unit. 
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Figure 6.4: A self- Patterson function shows of NheA crystal.  
There are two peaks, one at (u, v, w) = (0.5, 0.0, 0.0) (A), and another one at (u, v, w) = (0.25, 0.25, 0.0) (B) in addition to origin (0, 0, 0). These 
show that the asymmetric unit of NheA crystal contains molecules, which are related by two different kinds of translational pseudo-symmetry. 
A 
(!, 0, 0) 
(", ", 0) 
B 
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Figure 6.5 A: Output from the Matthews Probability Calculator at 
http://www.ruppweb.org/Mattprob/ (Kantardjieff & Rupp, 2003).   
This suggested that there were 6 to 9 molecules in the asymmetric unit, with 
a Vm of 2.21 A3/Da if there were 8 molecules in the asymmetric unit.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 B: Output from the Matthews Probability Calculator at 
http://www.ruppweb.org/Mattprob/ (Kantardjieff & Rupp, 2003).   
This suggested the crystals have solvent content of 44% if there are 8 
molecules in the asymmetric unit.  
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Because SHELX cannot read the CCP4 *.mtz reflection file format the 
*.mtz file, which was produced from SCALA, was converted to *.sca file 
using SCALEPACK in CCP4 (CCP4, 1994).  SHELXC was used to prepare 
files for SHELXD (Selenium atom location) and SHELXE (phasing and 
density modification). SHELXC does statistical analysis of the input data, 
estimates the heavy atom structure factors and prepares files for the other 
two programs. The SHELXD program solved the heavy atom substructure 
and located 58 selenium atoms using 1000 attempts and then generated a 
*.pdb file with the positions of the heavy atoms. SHELXE calculates phases 
and carried out density improvement over 100 cycles. However, in this case 
SHELXE could not produce an interpretable map. These were indication of 
solvent boundaries between elongated molecules and of presence of helical 
structure but detailed interpretation was impossible (Figure 6.6 A and Figure 
B). Therefore, the *.pdb file from SHELX with the *.sca files of anomalous 
data and native data, were used in PHENIX to carry out phase improvement 
and automated building of the NheA structure. As a result of this autobuild 
eight chains were built and 2754 residues were found.  
Un-modelled regions of electron density were rebuilt using the program 
COOT (Emsley & Cowtan, 2004). Refinement of the model against the 
observed structure factors was performed using the program REFMAC 
(Murshudov et al, 1997). Between rounds of refinement the model was 
rebuilt using the program COOT (Emsley & Cowtan, 2004).  The process of 
rebuilding and refinement was repeated 19 times until no structure 
improvement was possible.  
The result of refinement was a model with a R work of 20% and a R free of 
28% for 176339 unique reflections between 49.85 Å and 2.05 Å resolution. 
The root mean square deviation from the ideal for bond lengths is 0.02 Å 
and for bond angles is 1.7°. There are 1507 water molecules included in the 
final structure. The average B-factor overall is 35.4 Å2 for the protein and 
34.72 Å2 for water. These refinement statistics indicated an acceptable and 
reasonable structure (Branden & Jones, 1990). The final refinement statistics 
for this structure are shown in Table 6.3. 
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Figure 6.6: The map calculated with the initial phases obtained from 
SHELX for the NheA structure at 2.05 Å. The (2Fobs-Fcalc)exp(i!calc) map 
is contoured at 1!. 
(A) Non- inverted solution.  
(B) The map from the inverted hand. 
 
 
 
A 
B 
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Table 6.3: Final statistics for the refined structures of the NheA 
structure in the C2 space groups generated by REFMAC (Murshudov et al, 
1997) 
 
 
 
 
 
 
 
 
 
 
 
 
Rwork =!|Fobs - Fcalc|/!|Fobs| where Fcalc and Fobs are the calculated and 
observed structure factor amplitudes, respectively. Rfree = as for Rwork, but 
for 5% of the total reflections chosen at random and omitted from 
refinement. 
 
 
 
 
Refinement statistics  
Resolution (Å) 2.05 
No. Reflections  176339 
Rwork / Rfree 0.20/0.28 
No. Atoms 22683 
No. Residues 2674 
No. Waters 1507 
Average B values (Å2)  
Protein 35.4 
Water 34.7 
R.m.s deviations  
    Bond lengths (Å) 0.02 
    Bond angles (°) 1.7 
Ramachandran plot  
Most favored regions (%) 96.1 
Additionally allowed regions (%) 3.4 
Generously allowed regions (%) 0.4 
Disallowed regions (%) 0 
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6.5 3D crystal structure of NheA 
The crystal structure of NheA confirmed that the protein has eight 
monomers of NheA in the asymmetric unit as expected from the Matthews 
number (Vm) calculation (Figure 6.7 and 6.8). These molecules were named 
chain A, chain B, chain C, chain D, chain E, chain F, chain G, and chain H. 
Electron density for all the eight molecules was well defined except for the 
residues in the N-terminal regions of all eight molecules in the asymmetric 
unite and in some turns and loop regions.  
PDBePISA http://pdbe.org/PISA (Krissinel & Henrick, 2007) analysis was 
run in order to investigate if there was any evidence for oligomeric 
assemblies in NheA (Figure 6.8). The eight molecules all appear to be 
monomeric (this discussed in more details on section 6.7). The overall fold 
of each monomer within NheA can be viewed in Figure 6.9 A and 6.9 B. 
NheA is a long, elongated, rod shaped structure, with dimensions 95 Å x 40 
Å x 20 Å. Because all eight molecules are essentially identical (see section 
6.6) the description below considers only molecule A, unless otherwise 
stated. Monomer A has been chosen as it is better ordered than others.   
To identify and analyze secondary structures in the NheA protein, the 
PROMOTIF program was used, which is available on 
http://www.ebi.ac.uk/pdbsum/ (Hutchinson & Thornton, 1996; Laskowski, 
2009). The major secondary structure of NheA is ! helix. Figure 6.9 A and 
Figure 6.9 B shows that the main body of NheA consists of a bundle of five 
helices: !A consists of 21 residues (32 Å long; SER 24- GLN 44); three long 
helices: !B1/ !B2 consists of 48 residues (62 Å long; LEU 56 – GLY 104) 
with a distinct kink at residues TYR 95 and TYR 96; !C consists of 57 
residues (82 Å long; GLU 110 - LEU 166) with a distinct kink at residue 
LEU 141; !F consists of 49 residues (73 Å long; SER 326 –ASN 356) and 
!G at the C terminal which consists of 31 residues (44 Å long; SER 326- 
ASN 356). Helix !A, !B, !C and !F or !B, !C, !F, and !G are arranged in 
an anti-parallel bundle in a simple square, left-handed. Up–down topology 
with connecting loops or domains. 
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Figure 6.7: 32 NheA molecules in a unit cell (space group C2) of the 
crystal.  
This figure was generated by PDBePISA http://pdbe.org/PISA (Krissinel & 
Henrick, 2007).  
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Figure 6.8: 8 NheA molecules in the asymmetric unit cells of the NheA 
crystal.  
The figure  (A) shows monomer A (deep blue), monomer B (cyan) monomer 
C (limegreen), monomer D (green), monomer E (yellow), monomer F (light 
orange), monomer G (orange), and monomer H (red). The figure  (B) shows 
the top view of the eight monomers of NheA.  
Produced using PyMol (DeLano and Lam, 2005). 
 
 
 
A 
B 
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Figure 6.9 A: Ribbon representation of NheA monomer.  
The NheA ribbon is coloured from blue to red, from the N to C terminus. 
The !-helical bundle has dimensions 95 Å x 40 Å x 20 Å.  NheA has seven 
!-helices, labeled !A, !B, !C, !F, !G, !D, !E. The structure has two sub-
domains the ‘‘Tail’’ domain, and the “Head” domain, which includes the “ß 
tongue” which consist of two strands ß1 and ß 2. N- and C-terminal are 
labelled.  
This figure was prepared with PYMOL (DeLano and Lam, 2005). 
 
Tail domain  
Head domain  
N terminal  
Helical turn 
!F 
!C 
!G 
C- terminal  
"3 
!D 
!E 
"1 
"2 
!B1 
!A  
!B2 
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Figure 6.9 B: Ribbon representation of NheA monomer showing turns 
in NheA. 
 NheA coloured according to secondary structure: ! helix is red, and " sheet 
is yellow. The turn regions are coloured in green. The two ß strands 
coloured in yellow.  
This figure was prepared with PYMOL (DeLano and Lam, 2005). 
 
 
C 
N 
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The molecule consists of two unusual topology sub-domains which had been 
first recognized in the 3D crystal structure of E. coli K12 ClyA (Wallace et al, 
2000)  and then in HblB (Madegowda et al, 2008) but do not occur elsewhere 
in the Protein Data Bank:  
1) The tail domain, at the C terminal is made up of the fifth helical 
bundle, !G. Helix !G packs between helices !A and !B, and thus forms a 
five -helix bundle for a short region of the structure. Here, it should be 
pointed out that ! A in NheA structure is short, therefore it only a minor part 
of tail domain. However, in the ClyA molecule (Wallace et al, 2000) !A is 
much longer and the 5-helical bundle (!A, !B, !C, !F, and !G) occupies the 
lower half of the structure (Figure 1. 6).  The C terminal ends with a short ß 
strand, ß3, which is formed from 4 residues (VAL 357, GLU 358, VAL 359, 
HIS 360).  
2) The head domain, which includes the  “ß tongue”, is located between 
the 3rd and 4th (!C and !F) helices of the main body and includes two long 
!-helices: !D consists of 24 residues (35 Å long; ASP 172-LEU 195), !E 
consists of 27 residues (38 Å long; SER 243-THR 269), and a very short 
helical turn (ASN 235-VAL 238). This part also contains two ß strands: ß 
strand 1 that consists of 13 residues (40 Å long; GLY 204- THR 216) and ß 
strand 2 that consists of 12 residues (26 Å long; THR 222- LEU 233). These 
form a 3-stranded antiparallel ß-sheet with ß3 from the tail domain (see 
above). 
The major secondary structures of NheA are connected by regions of 
random coil and by turn regions that sometimes contain additional short 
helical segments, giving a structure that over all is 75.8% helix, and 8.4% 
beta strand as classified by the PROMOTIF program (Hutchinson & 
Thornton, 1996). The loop structures contain well-characterized structural 
motifs such as beta turns and gamma turns and there are some residues 
adopting random coli conformations (Table 6.4).   There are 11 " turns, and 
one inverse # turn (Table 6.4).  
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The PROMOTIF program indicates two beta bulges in NheA structure as 
follows: 
1) There is an antiparallel classic ! bulge (GLY 231, THR 232) in !2 strand 
opposite ASN 207 in !1 strand. The classic ! bulge involves extra residues 
on one of ! strand, which cause disruption of the regular hydrogen bonding 
pattern. 
2) There is an antiparallel ! bulge type G1  (ALA 220, GLN 221) before !2 
strand. G1 type ! bulges involve the presence of one residue in the left-
handed " conformation and are mostly found at the ends of ! strands.  
Hairpin structures have been also identified and consist of two antiparallel ! 
strands, !1 (GLY 204-THR 216) and !2 (THR 222- LEU 233) and they 
hydrogen bonded together.  The hairpin in the NheA structure is classified as 
hairpin class 3:5, this class is characterized by presences of type a l ! turn 
followed by a G1 ! bulge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 205 
Table 6.4: The secondary structure elements in B. cereus NheA at 2.05 
Å resolution. Output from the PDBsum http://www.ebi.ac.uk/pdbsum/ 
(Hutchinson & Thornton, 1996; Krissinel & Henrick, 2007; Laskowski, 
2009) (Hutchinson & Thornton, 1996; Krissinel & Henrick, 2007; 
Laskowski, 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start    -   End Secondary structure Number of Residue 
ASN 19 – SER 22 Type l ! turn 4 
LEU 21- SER 24 Type ll ! turn 4 
SER 24- GLN 44 "A helix 21 
VAL 50- MET 53 Type l ! turn 4 
ASN 51 –SER 54 Type VIIl ! turn 4 
MET 53- LEU 56 Type l ! turn 4 
LEU 56 – GLY 104 "B1/ "B2 helix 48 
ASN 105- GLU108 Type l ! turn 4 
ILE 106- ASP 109 Type lV ! turn 4 
GLU 110-LEU 166 "C helix 57 
GLN 167- SER 170 Type lV ! turn 4 
ASP 172-LEU 195 "D helix 24 
GLN 199 ILE 202 Type lV ! turn 4 
GLY 204- THR 216 !1 strand  13 
ASN 217-ALA 220 Type l ! turn 4 
THR 222- LEU233 !2 strand 12 
ASN 235- VAL 238 Short helical 4 
ALA 240- SER 243 Type lV ! turn 4 
SER 243- THR 269 "E helix 27 
ALA 271- GLU 319 "F helix 49 
THR 322- THR 324 Inverse # turn 3 
SER 326 –ASN 356 "G helix 31 
VAL 357 – HIS 360 !3 strand 4 
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6.6 Structure comparison of molecules of NheA 
Most of the residues in the molecule are well ordered and visible in the 
electron density (Figure 6.10, 6.11 and 6.12), with the exception of some the 
N terminal and turn regions in all eight monomers of NheA, where the 
experimental electron density was poorly defined (Figure 6.13 and 6.14). 
This poor density is interpreted as resulting from the inherent flexibility of 
these turns or from disorder in the crystal. Several N-terminal residues are 
missing from electron density maps due to their flexible nature.  Thus, these 
poorly defined residues have been truncated in the model for improved 
accuracy as they are not well represented in the electron density as follows: 
• In monomer A: the 15 N-terminal residues (LYS 1- VAL 15) and the 
residues in turn (ASN217-GLN221), and SER 170 
 
• Monomer B: the 6 N-terminal residues (LYS 1- GLU 6) and the residues 
in turns (GLY 168 –SER 170), (ASN 217-THR 222);  
 
• Monomer C: the 18 N-terminal residues (LYS 1- PRO 18) and the 
residues in turns (GLU108- SER 112), (GLY 168-SER 170), (GLN 218- 
GLN 221);  
 
• Monomer D: the 5 N-terminal residues (LYS 1- THR 5) and the residues 
in turns ASP 109, (168 GLY-GLY 171), (GLN 218- GLN 221); 
 
• Monomer E: the 18 N-terminal residues (LYS 1- PRO 18) and the 
residues in turns (GLU 108-GLU 110), (SER 169 -GLY 171), (ASN 217-
THR 222), (GLU 320-THR 324);  
 
• Monomer F: the 19 N-terminal residues (LYS 1- ASN 19) and the 
residues in turns (GLU 108-SER 112), (GLY 168-SER 170), (GLN 218- 
GLN 221), (VAL 318-GLY 321); 
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Figure 6.10: Example of the final electron density observed for the 
NheA structure (monomer A) at 2.05 Å.  The (2Fobs-Fcalc)exp(i!calc) map is 
contoured at 1! and shown in blue.  The protein is shown in ball and stick 
representation with yellow Carbon, blue Nitrogen, and red Oxygen atoms. X 
symbol represents water molecules.  
 
 
 
 
 
 
 
 
 
 
 
TYR 38/A 
GLY 39/A 
ALA 37/A 
 ILE35/A 
 GLN36/A 
LEU 34/A 
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Figure 6.11: The final electron density observed at the C terminal for 
the NheA structure (monomer E) at 2.05 Å.  The (2Fobs-Fcalc)exp(i!calc) 
map is contoured at 1! and shown in blue.  The protein is shown in ball and 
stick representation with yellow Carbon, blue Nitrogen, and red Oxygen 
atoms. X symbol represents water molecules.  
 
 
 
 
 
 
 
 
 
 
 
HIS 360/E 
VAL 359/E 
VAL 357/E 
GLU 358/E 
ASN 356/E 
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Figure 6.12:  Examples of the final electron density for some side chains 
in the NheA structure at 2.05 Å.   
The (2Fobs-Fcalc)exp(i!calc) map is contoured at 1! and shown in blue.  The 
protein is shown in ball and stick representation with yellow Carbon, blue 
Nitrogen, red Oxygen atoms, and green Sulfur atom. X symbol represents 
water molecules.  
 
 
TRP70/A 
 
MET343/A 
 
LYS64/A 
 
ASP291/A 
 
GLN36/A 
 
ARG251/A 
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Figure 6.13: The final electron density observed at N terminal for the 
NheA structure (monomer B) at 2.05 Å.  
 The (2Fobs-Fcalc)exp(i!calc) map is contoured at 1! and shown in blue.  The 
protein is shown in ball and stick representation with yellow Carbon, blue 
Nitrogen, and red Oxygen atoms. X symbol represents water molecules. The 
arrow shows the electron density was lacking for the N-terminal therefore 
amino acids 1-6 were un-modeled. 
 
 
 
 
 
 
 
 
 
 
 
 
VAL 7/B 
LYS 8/B THR 9/B 
VAL 10/B 
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Figure 6.14: The final electron density observed at type l ! turn regions 
for the NheA (monomer A) structure for loop regions at 2.05 Å.   
The (2Fobs-Fcalc)exp(i!calc) map is contoured at 1! and shown in blue.  The 
protein is shown in ball and stick representation with yellow Carbon, blue 
Nitrogen, and red Oxygen atoms. X symbol represents the water molecules. 
The arrow shows the electron density in this region was poor thus amino 
acids from 217 to 221 were un-modeled.   
 
 
 
 
 
 
 
 
 
THR 216/A 
ILE215 
THR 222/A 
LYS 223/A 
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•  Monomer G: the 18 N-terminal residues (LYS 1- PRO 18) and the 
residues in turns (ASP 109 - GLU 110), (GLY 168 - GLY 171),  (ASN 
217 - THR 222), (GLY 321- ASP 325); 
 
• Monomer H: the 14 N-terminal residues (LYS 1- ASN 14) and the 
residues in turns (168 GLY- GLY 171), (ASN 217- THR 222). 
To investigate whether there are significant differences between the eight 
subunits in the NheA crystal structure, monomer A was superposed onto 
monomers B, C, D, E, F, G, and H.  Monomer A was chosen for comparison 
because overall it is the best-ordered monomer and it is the most complete 
one in the model of the structure.  
Each Chain of monomer A was compared structurally to each chain of 
monomers B, C, D, E, F, and G using LSQKAB (CCP4, 1994) for 
comparing protein subunits in 3D. This was done over the amino acid range 
1-360, and resulted in the overall root mean-square deviations (RMSDs), 
listed in Table 6.5.  The superpositions are shown in Figure 6.15 A and B.  
Each chain aligns very well onto chain A with an RMSD of 0.3 -0.4 Å and 
no indication of any significant differences between monomers, except for 
individual residues in loop region (Figure 6.16). The highest deviation value 
of RMSD was between THR 222 in chain A and chain B which was about 
6.6 Å, but it is important to consider that this residue is located in the psi 
loop regions which is characterized by poor density, and therefore there may 
be differing interpretations during model building. 
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Table 6.5: Output from LSQKAB (CCP4: Supported Program (CCP4, 
1994) showing the average overall RMSD for molecules superposed on 
chain A.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 RMSD Maximum RMSD 
Chain A on chain B 0.3Å between 346 ! 
carbon atom pairs 
6.563 Å   (THR 222) 
Chain A on chain C 0.4 Å between 323 ! 
carbon atom pairs 
1.364 Å (THR 222) 
Chain A on chain D 0.3 Å between 345 ! 
carbon atom pairs 
1.355 Å (THR 222) 
Chain A on chain E 0.4 Å between 322 ! 
carbon atom pairs 
1.731 Å (ASP 325) 
Chain A on chain F 0.3 Å between 323 ! 
carbon atom pairs 
1.340 Å (THR 222) 
Chain A on chain G 0.4 Å between 323 ! 
carbon atom pairs 
1.935 Å (GLU 108) 
Chain A on chain H 0.3 Å between 331 ! 
carbon atom pairs 
1.117 Å (TYR 323) 
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Figure 6.15 A:  Superposition of the C!s of monomer A (red) onto 
monomers B (cyan), C (green), D (yellow), E (blue), F (grey), G (orange), 
and H (light blue) represented as protein ribbons.   
It is clear that the overall folds of all monomers are very similar with low 
deviation. Produced using PyMol (DeLano and Lam, 2005). 
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Figure 6.15 B:  Superposition of the C!s of monomer A (red) onto all eight 
molecules, monomers B (cyan), C (green), D (yellow), E (blue), F (grey), G 
(orange), and H (light blue) represented as protein ribbons.   
It is clear that the overall folds of all monomers are almost identical with low 
deviations. Produced using PyMol (DeLano and Lam, 2005). 
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Figure 6.16: The RMSD in Å (Y- axis) between the C!s of residues of 
monomer A compared to monomers B, C, D, E, F, G, and H plotted 
against residue number (X-axis). 
It clear that there are no really significant differences in RMSD. The maximum 
RMSD value is seen between monomer A and monomer B (6.563, THR 222), 
which is located in a disordered part of the structure. 
Monomer A on monomer B Monomer A on monomer C 
Monomer A on monomer D Monomer A on monomer E 
Monomer A on monomer F Monomer A on monomer G 
Monomer A on monomer H 
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Chapter 7: NheA Structure Analysis 
 
This chapter will describe the analysis of the structure of the NheA protein.  
 
7.1 NheA interfaces, surfaces and assemblies 
In crystals, protein molecules interact together and the molecules arrange in 
orderly lattices to form crystals. It is possible to examine the interactions 
between molecules in the crystals and estimate their binding energy, 
solvation energy, interface area, hydrophobic interactions, hydrogen bonds 
and salt bridges across the interface. If the crystal contacts are large they 
may indicate possible biological assemblies between NheA monomers.  
To investigate the crystal contacts and interfaces in NheA, as well to 
investigate the size of the crystal interfaces, and the energetic factors that 
keep the NheA molecules together and to see is there any evidence for 
oligomeric states in NheA, PDBePISA was used. This is a web tool for the 
analysis of macromolecular interactions, interfaces, surfaces and assemblies 
http://pdbe.org/PISA (Krissinel & Henrick, 2007). The calculation of protein 
assemblies from protein crystallography data on PDBePISA to identify 
significant interfaces is based on the free energy of protein binding which 
includes the free energy of binding and the entropy change. Although 
obviously the free energy consideration is paramount, the difficulty comes in 
accessing the factors that contribute to this -for example if the area of 
displaced solvent is small then the interface is likely to be unstable. Krissinel 
and Henrick (2005) point out that when the complex dissociates, any 
hydrogen bonding sites are likely to be satisfied by new (different) hydrogen 
bonds with the solvent (Krissinel & Henrick, 2005). Analysis of the NheA 
interfaces by PDBePISA did not reveal any specific interactions that could 
result in the formation of stable oligomers of NheA, and the eight molecules 
all seem to be in the monomer form. The results of PISA are shown in Table 
7.1, which gives the details of each interface found between NheA 
 220 
molecules in the crystal. Because there are 8 NheA molecules in the 
asymmetric unit related by pseudosymmetry many pairwise interactions are 
essentially the same.  There are four types of interaction, which can be seen 
between NheA subunits:  
1) The two-fold symmetric back-to-back interface:  this is the strongest 
type of interface, e.g. between chain H and chain G, where 9 hydrogen 
bonds (Figure 7.1) and 8 salt bridges are formed. (Table 7.2 and 7.3). 
 
2) The two-fold symmetric head to head interface, such as that between 
chain C and chain B, in which 4 hydrogen bonds (Table 7.2 and Figure 
7.2). However, no salt bridges are formed. 
 
3) The two-fold symmetric head to tail interface, such as that between chain 
A and chain D, in which 10 hydrogen bonds (Table 7.2 and Figure 7.3) 
and no salt bridges are formed. 
 
4) The two-fold symmetric side by side interface, such as that between 
chain D and chain A, in which 4 hydrogen bonds and 3 salt bridges are 
formed (Table 7.2 and Figure 7.4).  
PDBePISA indicates that none of the interactions are sufficiently extensive 
to suggest NheA is a dimer or oligomer. This is confirmed by gel filtration 
(see figure 5.5), which shows that NheA runs as a monomer. In contrast, the 
soluble form of E. coli ClyA exists in the crystal as a dimer where two 
monomers of ClyA pack together to form a 2-fold symmetric dimer. The two 
subunits interact together to form 10 hydrogen bonds and two salt bridges 
(Figure 7.5). Also these two ClyA monomers orientate in a “head to tail” 
fashion that includes the two major hydrophobic surfaces of each monomer, 
and buries a significant area of the molecule away from the solvent (Wallace 
et al, 2000). Our PISA analysis of B. cereus HlbB (Madegowda et al, 2008) 
indicated that the HlbB interfaces do not reveal any specific interactions that 
could result in the formation of stable oligomers 
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Table 7.1: presents a list of all unique interfaces found in the NheA 
crystal with the number of hydrogen bonds and salt bridges. iNat is the 
number of interfacing atoms, iNres is the number of interfacing residues, !iG 
is the solvation free energy gain on formation of the interface, in kcal/M, 
NHB is the number of potential hydrogen bonds across the interface, NSB is 
the number of potential salt bridges across the interface, NDS is the number 
of potential disulfide bonds across the interface, CSS Sands Significance 
Score, which shows how important for assembly formation the interface is 
(CSS ranges from 0 to 1 as interface relevance to complex formation 
increases). This table is Output from the PDBePISA http://pdbe.org/PISA 
(Krissinel & Henrick, 2007) 
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Table 7.2: Output from PDBePISA http://pdbe.org/PISA (Krissinel & 
Henrick, 2007) shows the hydrogen bonds formed between two monomers 
within the main interface types between NheA molecules in the crystal.  In 
some cases there are multiple bonds between the same side chains, which 
indicated by the square parentheses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
## Monomer H  Distance [Å]  Monomer G 
Type of 
Interfaces 
1  H:ARG 143[ NE ]   3.28   G:ASP 151[ OD1]  
2  H:ARG 143[ NE ]   3.14   G:ASP 151[ OD2]  
3  H:ARG 143[ NH2]   3.32   G:ASN  66[ OD1]  
4  H:ARG 143[ NH2]   3.15   G:ASP 151[ OD2]  
5  H:ASN  58[ OD1]   3.21   G:GLN 136[ NE2]  
6  H:ASN  66[ OD1]   3.39   G:ARG 143[ NH2]  
7  H:GLN 136[ OE1]   2.57   G:ASN  58[ ND2]  
8  H:ASP 151[ OD2]   3.04   G:ARG 143[ NE ]  
9  H:ASP 151[ OD2]   3.16   G:ARG 143[ NH2]  
Two-fold 
back-to-
back 
interface 
##   Monomer C   Distance 
[Å]  
Monomer B  
1  C:GLN 253[ NE2]   3.56   B:THR 214[ O  ]  
2  C:GLN 254[ NE2]   2.77   B:PRO 261[ O  ]  
3  C:THR 214[ O  ]   3.20   B:GLN 253[ NE2]  
4  C:PRO 261[ O  ]   2.97   B:GLN 254[ NE2] 
Two-fold 
head to 
head 
interface 
##   Monomer A   Distance [Å]    Monomer D 
 
 1   A:TYR 100[ OH ]   2.92   D:ASP 242[ OD1]  
 2   A:SER 243[ N  ]   2.96   D:GLN 330[ OE1]  
 3   A:ARG 246[ NH2]   3.24   D:ASN 105[ OD1]  
 4   A:ARG 246[ NH2]   3.15   D:GLY 104[ O  ]  
 5   A:GLN 330[ NE2]   2.51   D:ALA 241[ O  ]  
 6   A:ASP 242[ OD1]   3.08   D:TYR 100[ OH ]  
 7   A:GLN 330[ OE1]   3.08   D:SER 243[ N  ]  
 8   A:GLN 330[ OE1]   3.22   D:SER 243[ OG ]  
 9   A:GLY 104[ O  ]   3.31   D:ARG 246[ NH2]  
 10   A:ALA 241[ O  ]   2.85   D:GLN 330[ NE2]  
 
 
Two-fold 
head to tail 
interface 
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##       Monomer D Distance [Å]      Monomer A  
1  D:THR 224[ OG1]   2.71   A:GLN 167[ OE1]  
2  D:HIS 360[ ND1]   3.12   A:GLU 288[ OE2]  
3  D:THR 214[ OG1]   3.57     A:GLY 171[ N  ]  
4  D:GLU 358[ OE2]   3.10   A:ARG 292[ NH1]  
Two-fold 
side by side 
interface 
Continue table 7.2 
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Table 7.3: Output from PDBePISA http://pdbe.org/PISA (Krissinel & 
Henrick, 2007) shows example of the 8 salt bridges that were formed 
between monomers H and G that form the two-fold back-to-back interface. 
In some cases there are multiple bonds between the same side chains, which 
indicated by the square parentheses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
## Monomer H 
  Distance 
[Å]  
Monomer G 
1 H:ARG 143[ NE ] 3.28 G:ASP 151[ OD1] 
2 H:ARG 143[ NE ] 3.14 G:ASP 151[ OD2] 
3 H:ARG 143[ NH2] 3.15 G:ASP 151[ OD2] 
4 H:GLU 140[ OE1] 3.71 G:LYS  61[ NZ ] 
5 H:GLU 140[ OE2] 3.71 G:LYS  61[ NZ ] 
6 H:ASP 151[ OD1] 3.35 G:ARG 143[ NE ] 
7 H:ASP 151[ OD2] 3.04 G:ARG 143[ NE ] 
8 H:ASP 151[ OD2] 3.16 G:ARG 143[ NH2] 
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Figure 7.1: (1) Example of a two-fold back-to-back interaction between 
monomers H (light blue) and G (orange) in the crystal contacts of NheA. 
(2) The residues involved in this interaction are labelled. The hydrogen 
bonds between H and G are shown by grey dotted lines. Hydrogen bonds 
that are more than 3.4 Å long have not been shown. This interface is 
generated from PDBePISA http://pdbe.org/PISA (Krissinel & Henrick, 
2007) and the pictures were generated using PyMol (DeLano and Lam, 
2005).
ASN 58 
GLN 136 
ARG 143 
ASP 151 
ASN 66 
ASP 151 
ARG 143 
ASN 58 
GLN 136 
1 
2 
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Figure 7.2: (1) Example of a two- fold head-to-head interaction between 
monomers C (hot pink) and B (cyan) in the crystal contacts of NheA.  
(2) The residues involved in this interaction are labelled. The hydrogen 
bonds between C and B are shown by grey dotted lines. Hydrogen bonds 
that are more than 3.4 Å long have not been shown. This interface is 
generated from PDBePISA http://pdbe.org/PISA (Krissinel & Henrick, 
2007) and the pictures were generated using PyMol (DeLano and Lam, 
2005). 
 
THR 214 
 
GLN 253 
 
GLN 254 
 
PRO 261 
 
PRO 261 
 
GLN 254 
 
GLN 253 
 
THR 214 
2 
1 
 227 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3: (1) Example of a two-fold head-to-tail interaction between 
monomers A (brown) and D (green) in the crystal contacts of NheA.  
(2) The residues involved in this interaction are labelled. The hydrogen 
bonds between A and D are shown by grey dotted lines. Hydrogen bonds 
that are more than 3.4 Å long have not been shown. This interface is 
generated from PDBePISA http://pdbe.org/PISA (Krissinel & Henrick, 
2007) and the pictures were generated using PyMol (DeLano and Lam, 
2005). 
1 
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ARG 246 
ASN 105 
GLY 104 
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 243 
GLN 330 
ASP 242 
TYR 100 
TYR 100 
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GLN 330 
ALA  
241 SER 
 243 
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Figure 7.4: (1) Example of a two-fold side-to-side interaction between 
monomers A (red) and D (yellow) in the crystal contacts of NheA.  
(2) The residues involved in this interaction are labelled. The hydrogen 
bonds between A and D are shown by grey dotted lines. Hydrogen bonds 
that are more than 3.4 Å long have not been shown. This interface is 
generated from PDBePISA http://pdbe.org/PISA (Krissinel & Henrick, 
2007) and the pictures were generated using PyMol (DeLano and Lam, 
2005). 
1 
2 
GLN 167 
THR 224 
ARG 292 
GLU 358 
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Figure 7.5: Homodimers of the water-soluble form of ClyA. 
ClyA is a dimer in the crystal and in solution. This dimeric state of ClyA is 
very significant in stabilizing the crystal of ClyA in the soluble form. This 
figure is generated from the PDBePISA http://pdbe.org/PISA (Krissinel & 
Henrick, 2007).  
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7.2 Related toxin structures 
Although the underlying four helix bundle structure is very common and is 
present in a range of proteins, the length of the helix bundle coupled with the 
presence of two subdomains, known as the head subdomain and the tail 
subdomain, led to the conclusion that ClyA family possesses a novel fold 
(Wallace et al, 2000).  
NheA also has the long helical bundle, elongated shape and extra domains. 
Other toxins also have extensive ! helix bundles such as the water soluble 
form of the antibacterial toxin colicin Ia (Wiener et al, 1997), which 
contains two alpha helices, approximately 210 Å long and arranged in a 
elongated ‘‘Y’’ shape (Figure 7.6) with three functional domains: a receptor 
domain, a translocation domain and a pore formation domain. The 
enzymatic membrane damaging, botulinum neurotoxin type A, employs a 
pair of 105 Å long !-helices in the proposed translocation domain (Lacy et 
al, 1998).  Also the elongated shape of NheA is reminiscent of some other 
classes of " pore forming toxins such as aerolysin (Parker et al, 1996), 
perfingolysin (Rossjohn et al, 1997) and staphylococcal LukF (Olson et al, 
1999). As well some membrane-associated proteins involved in membrane 
fusion contain long helical bundles, such as protein HIV-1 gp41 
(Weissenhorn et al, 1997) and SIV gp41 (Caffrey  et al, 1998), influenza 
virus haemagglutinin (Bullough et al, 1994), and mammalian SNARE 
protein (Sutton et al, 1998). However, these proteins do not have significant 
structure similarity to NheA as estimated by the DALI server (Holm & 
Rosenström, 2010), which is used for comparing protein structures in 3D.  
The Dali search revealed only two significant structure similarities, which 
were both expected.  The search gave a superposition of NheA with B. 
cereus HblB (2NRJ) with a Z-score of 24.3, sequence identity 15%, and a 
root mean-square deviation (RMSD) of 3.0 Å between 303 !-carbon atom 
pairs. The superposition between NheA with E. coli ClyA monomeric form 
(1QOY) gave a Z-score of 10.4, sequence identity 8%, and a RMSD of 5.3Å 
between 221 !-carbon atom pairs.  
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Figure 7. 6: 3D Crystal structure of the colicin Ia monomer.  
The structure is shown in ribbon representation with the three domains 
labelled (Wiener et al, 1997). Produced using PyMol (DeLano and Lam, 
2005). 
 
 
 
 
 
 
 
 
 
 
 
Translocation domains 
Channel-forming 
domain 
Receptor domain 
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The superposition of NheA with the E. coli ClyA pore form (2WCD, chain 
C) gave a Z-score of 10.3, sequence identity 11%, and a RMSD of 3.4 Å 
between 198 !-carbon atom pairs All other proteins, gave Z scores less than 
10, which indicates that no very significant fold similarity had been found.  
This result is as expected, because there is a high level of structural 
similarity among the three proteins, B. cereus NheA, B. cereus HblB and E. 
coli ClyA (Figure 7.7), in spite of the lack of sequence homology between 
them (see Table 1.1 and Figure 1.14).  
The main body of all of three proteins consists of four helical chains !A, !B, 
!C, and !F. In addition, all of them have significant novel structure 
elaborations at both ends:  the tail domains and the head domains (the "ß 
tongue"). While the overall topography of the three proteins similar in the 
structure there are some interesting observation to be made:  
Firstly, !A in NheA is shorter than in the other toxins (21 residues; SER 
24- GLN 44; 32 Å long). In ClyA !A is much longer as it consists of 43 
residues (ILE3- ARG 46; 60 Å long) and in HblB consists of 27 residues 
(GLU 19- LYS 45; 41 Å long). Therefore !A in ClyA and HblB is 
considered as part of tail domain and as a result the tail domain is a five 
-helix bundle (Figure. 1.6 and 1.12). However, in NheA the !A becomes 
shorter (Figure 6.9 A) and !A does not occupy the lower half of the 
NheA structure.  
Furthermore, In ClyA a distinct kink is present at residue PRO 36 
(within !A), but this becomes part of the turn between !A1 and the 
extended !B of the protomer of ClyA pore form (Figure 1.7 and Figure 
1.8). HblB has a few distinct kinks, which are located at LYS 83 -VAL 
84 (within !B), LEU189 -GLY 190 (!D), LEU 228 -GLY 229 (!E), and 
LYS 310-PRO 311 (!G). However, in NheA there are the distinct kinks 
within !B at residues TYR 95 and TYR 96 and within !C with distinct 
kink at residue LEU 141.  
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Figure 7.7: The superimposition of NheA (orange) with HblB (cyan) and 
ClyA (pink).  
Dali superimposed the NheA and HblB over 238 !-carbon atom pairs with 
an RMSD of 3 Å; NheA and ClyA over 303 !-carbon atom pairs with an 
RMSD of 5.3 Å.  
This figures were generated using DALI web server (Holm & Rosenström, 
2010) (http://ekhinda.biocenter.halsinki.fi/dali_server/) and PyMol (DeLano 
and Lam, 2005). 
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• The second and the main structural difference is the orientation of the 
head domain with respect to the tail domain. This differs substantially 
between E. coli. ClyA and both B. cereus NheA and B. cereus HblB. 
The head domain is turned downward and interacts with the tail domain 
in B. cereus NheA and HblB, whereas it is turned upward in ClyA and 
forms no interactions with its tail domain (Figure 7.8). The interdomain 
angle for NheA is !20° and HblB is !30°, whereas it is !120° in ClyA.   
The different orientation of the head domain in E. coli ClyA and B. 
cereus NheA, and HblB may indicate that the head domain can reorient 
itself in these toxins. However, it is notable that the eight independent 
copies of NheA in asymmetric unit all have the same orientation. 
 
 In addition the NheA beta tongue is much longer than in the other two 
toxins (ClyA or HlbB). It is approximately 53 Å long in NheA, but it is 
20 Å long in ClyA and 30 Å long in HblB; (Figure 7.8). These 
measurements were done in the program COOT (Emsley & Cowtan, 
2004).  
 
• The third area of dissimilarity is in the type of amino acids in the beta 
tongue. In the beta tongue of HblB the 17 residue hydrophobic segment 
(GAILGLPIIGGIIVGVA) and in the beta tongue of ClyA the 27 residue 
segment (AYAGAAAGVVAGPFGLIISYSIAAGVV) are mainly 
hydrophobic in sequence. They have been identified as transmembrane 
regions (Madegowda et al, 2008; Mueller et al, 2009; Wallace et al, 
2000). In the pore form of ClyA the beta tongue becomes a hydrophobic 
transmembrane " helix (see Figure 1.8) (Mueller et al, 2009). However, 
in NheA the beta tongue of 25 residues is amphipathic (GSINIGKQ 
NFTITIKT IDFVSIGTL). In fact NheA has no predicted transmembrane 
region (Granum et al, 1999). 
 Although NheA, HblB and ClyA do not have significant sequence 
similarity (identities: NheA /ClyA =18%, NheA /HblB =20%, HblB /ClyA 
=20%), they are nevertheless similar in structure, suggesting that once again 
these toxins represent a novel super-family of pore forming toxins and may 
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be have a common mode of pore formation. 
While NheA has no predicted transmembrane region (Granum et al, 1999), 
its elongated amphipathic beta sheet (Figure 7.9 A) is reminiscent of those in 
some other toxins for which structures have been reported, such as 
Staphylococcus aureus !-hemolysin (Song et al, 1996) (see section 1.3 for 
more details), Staphylococcus aureus Leukocidin F (LukF) (Olson et al, 
1999), aerolysin (Parker et al, 1996), and perfringolysin (Rossjohn et al, 
1997). These form pores based on " sheet barrels rather than ! helical 
architectures (see Figure 1.2). These pore forming toxins contains long " 
strands ranging from 93 Å length in aerolysin to 70 Å in perfringolysin, and 
staphylococcal LukF. The hydrophobic residues on one side of the " strands 
face out toward the membrane. However, the hydrophilic ones on the other 
side of the " strands form the pore. 
In S. aureus !-hemolysin it is thought that a short N-terminal " strand acts as 
"latch" to release the " strands that form the " sheet barrels in the oligomeric 
pore (Figure 7.9 B and C) (Song et al, 1996). It is therefore interesting that 
in NheA the short beta sheet at the C-terminal, which is known as "3 in the 
NheA structure (Figure 7.9 A), could possibly similarly act as a "latch" to 
release the beta tongue. Consequently, the questions arise:  Could the NheA 
protein be a " pore-forming toxin? Could it be considered as a link between 
! and " pore forming toxins? And could this member of an !-PFT family 
form a transmembrane "-barrel like S. aureus !-toxin? The NheA structure 
presented here offers a starting point for further biophysical investigations of 
the pore form of the complex to answer these questions. Cleary knowledge 
of the structures of NheB and NheC will be important in this future work.  
 
 236 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.8: Molecular surface view of NheA, HblB and ClyA.  
Red colour indicates the head domains. Calculated inter-domain angles and long distances of the toxins are also depicted. The different 
orientations of the head domain are shown. Downward and upward !-tongue orientations of NheA, HblB and ClyA are labeled. 
Produced using PyMol (DeLano and Lam, 2005). 
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Figure 7.9: Comparison between the amphipathic ! sheet of NheA and 
the transmembrane region in the classic example of a !-PFT.  
(A) The 25 residue long ! sheet of NheA is amphipathic (hydrophobic 
=green  & hydrophilic=blue in diagram). Red region represents the short ß3 
at the C-terminus, which could act as a "latch" to release the beta tongue. 
An enlarged image of the ! sheet of NheA is shown on the top. 
(B) The water -soluble form of staphylococcal LukF and (C) The pore form 
of Staphylococcus aureus "-hemolysin, which has long amphipathic 
transmembrane regions. Produced using PyMol (DeLano and Lam, 2005).
 
 
A 
B C 
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7.3 Electrostatic surface potential of NheA 
The electrostatic surface potential of NheA was calculated using GRASP 
(Nicholls et al, 1991) (Figure 7.10). Examination of the charge distribution 
on the surface of NheA shows that NheA has fairly negative potential in the 
middle of the main body and the head domain. However, positive charge is 
distributed randomly in the body of NheA. The electronegative potential 
surface of NheA may be involved in specific binding to NheB or NheC. In   
the water-soluble forms of ClyA and HblB the negative charge is present 
mostly in tail domain (Figure 7.10 C and B).  
However, it is clear from Figure 7.10 that positively charged LYS and ARG 
amino acids are present randomly in the bodies of all the three toxins, 
NheA, HblB and ClyA. 
The protomer surface of the ClyA pore form is largely lighter color shades, 
which means the molecule is mostly neutral (Figure 7.10 D). On the other 
hand, the protomer surface has slightly negative potential if rotated 180°. 
(Mueller et al, 2009) indicating that the surface of the transmembrane region 
is neutral with a width of approximately 30Å and the inner surface of the 
pore has a mostly negative potential, which reflects the cation selective 
nature of the ClyA pore (Ludwig et al, 1999). ClyA is a homo-oligomeric 
pore forming toxin and needs only one protein to achieve maximum 
cytotoxic activity where both Hbl and Nhe are hetero-oligomeric pore 
forming toxins and require three proteins to obtain maximum cytotoxic 
activity so the structures of Hbl and Nhe may be close to each other than to 
ClyA .  
Although the binding of PFTs to lipid depends mostly on their 
hydrophobicity, it was found that most pore forming toxins are cationic as 
the positive charge residues (LYS and ARG) interact with the negative 
phosphate groups of phospholipids, the major component of cell membrane. 
This electrostatic interaction is increased the binding of hydrophobic core 
into lipid bilayer of the cell membrane (Fuertes et al, 2010).  
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For some pore forming toxins the electrostatic surface potential of the lipid 
bilayer is very important for insertion of the toxin into the membrane of 
target cells. The ion–channel forming toxins such as Colicin la form a 
voltage gated conducting channel through the cell membrane of the target 
bacteria. This toxin requires negatively charged lipids in the target 
membrane at acidic pH (as the pH is reduced below 5.2) to form channels in 
the membrane (Mel & Stroud, 1993).  
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Figure 7.10: Electrostatic surface charge potential diagrams for (A) NheA, (B) HblB, (C) water soluble form of ClyA and (D) 
the protomer of ClyA pore form.  Positively and negatively charged surfaces are shown by blue and red colouring respectively 
according to the scale at the bottom of the diagram. Electrostatic surface charge potential diagrams for each toxin was drawn after a 
180° rotation.  This figure was generated using GRASP (Nicholls et al, 1991). 
180! 
A B 
D C 
180! 180! 
180! 
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7.4 NheA model stereochemistry 
The final model of NheA from the crystal that diffracted to 2.05 Å  
resolution comprised of 2672 residues in the eight molecules in the 
asymmetric unit. The lower numbers of observed amino acids were due to 
absences of these amino acids at N- terminal or loop and turn regions.  
The NheA coordinates were input into PROCHECK 
(http://www.ebi.ac.uk/thornton-srv/software/PROCHECK/) (Laskowski et 
al, 1993) for structure validation and analysis. Ramachandran plots 
(Ramachandran et al, 1963) are shown in Figure 7.11. It is clear that there is 
one residue in the disallowed regions, which is ILE 106 of monomer G. We 
have no explanation of why this residue has !, and " values in the 
disallowed regions as it has reasonably good electron density.  There are 11 
residues in the generously allowed region, and 96.1% in the most favoured 
regions. The main chain and side chain parameters with Chi1-Chi2 plots are 
shown in Figures 7.12, 7.13 and 7.14 and also indicate acceptable geometry. 
These results all indicate that the B. cereus NheA structure is of very good 
quality.  
The NheA structure was also input into the MOLPROBITY program 
(http://molprobity.biochem.duke.edu/) (Chen et al, 2010) to do extra model 
validation by identifying possible steric clashes within the model and 
adjustment of side chain amide rotamers to satisfy optional hydrogen 
bonding interactions. Overall the MOLPROBITY score is in the 97th 
percentile (100% being the best amongst structures of comparable 
resolution). MOLPROBITY reported a low clash score of 7.4 corresponding 
to the 93th percentile. 98% of Ramachandran favored, and 0.35% of 
Ramachandran outliers were reported. 1.45% of side chain conformations 
marked as rotamer outliers with no residues with bad lengths and 0.15% of 
residues with bad angles. 
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Figure 7.11: Ramachandran plot for NheA. 
Produced by the programme PROCHECK (Laskowski et al, 1993). 
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Figure 7.12: Chi 1-Chi 2 plots for various residue types in NheA.  
Number of residues are shown in brackets  favourable conformations lie in 
shaded regions as obtained from an analysis of 163 structures at resolution 
2.0 Å or better, produced by the programme PROCHECK (Laskowski et al, 
1993).  
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Figure 7.13: Main chain parameters for NheA.  Showing all values are 
better than the average for a structure at this resolution.  
Produced by the programme PROCHECK (Laskowski et al, 1993).  
 
NHEA_refine3_19tls_addTLSa-coot-0_refmac1_04.ps
PROCHECK Main-chain parameters
NHEA_refine3_19tls_addTLSa-coot-0_refmac1
1.0 1.5 2.0 2.5 3.0 3.5 4.0
   20
   40
   60
   80
  100a. Ramachandran plot quality assessment
Resolution (Angstroms)%
-ta
ge
 of
 re
sid
ue
s i
n m
os
t f
av
ou
red
 re
gio
ns
1.0 1.5 2.0 2.5 3.0 3.5 4.0
    5
   10
   15
   20
   25b. Peptide bond planarity - omega angle sd
Resolution (Angstroms)
Sta
nd
ard
 de
via
tio
n (
de
gre
es)
1.0 1.5 2.0 2.5 3.0 3.5 4.0
   10
   20
   30
   40
   50
   60
   70c. Measure of bad non-bonded interactions
Resolution (Angstroms)
Ba
d c
on
tac
ts 
pe
r 1
00
 re
sid
ue
s
1.0 1.5 2.0 2.5 3.0 3.5 4.0
  2.5
  5.0
  7.5
 10.0
 12.5
 15.0
 17.5
 20.0 d. Alpha carbon tetrahedral distortion
Resolution (Angstroms)
Ze
ta 
an
gle
 st
an
da
rd 
de
v. 
(de
gre
es)
1.0 1.5 2.0 2.5 3.0 3.5 4.0
  0.5
  1.0
  1.5
  2.0 e. Hydrogen bond energies
Resolution (Angstroms)
Sta
nd
ard
 de
via
tio
n (
kc
al/
mo
l)
1.0 1.5 2.0 2.5 3.0 3.5 4.0
 -2.0
 -1.5
 -1.0
 -0.5
  0.0
  0.5
  1.0 f. Overall G-factor
Resolution (Angstroms)
G-
fac
tor
Plot statistics
Comparison values No. of
                                No. of   Parameter  Typical   Band    band widths       
Stereochemical parameter       data pts    value     value    width    from mean       
a. %-tage residues in A, B, L   2489        96.1      83.2    10.0        1.3    BETTER 
b. Omega angle st dev           2632         5.4       6.0     3.0       -0.2    Inside 
c. Bad contacts / 100 residues     11         0.3       4.7    10.0       -0.4    Inside 
d. Zeta angle st dev            2576         1.9       3.1     1.6       -0.8    Inside 
e. H-bond energy st dev         2168         0.6       0.8     0.2       -1.0    BETTER 
f. Overall G-factor             4185         0.1      -0.4     0.3        1.7    BETTER 
 245 
 
 
Figure 7.14: Side chain parameters for NheA. Showing all values are 
better than the average for a structure at this resolution. 
Produced by the programme PROCHECK (Laskowski et al, 1993). 
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7.5 B value distribution  
Thermal motion means oscillations of an atom around its mean position due 
to temperature. Crystal disorder means the atoms do not occupy the same 
position in every unit cell or in every asymmetric unit (Rhodes, 2006). The 
atomic scattering factor is commonly affected by the variation in atomic 
position caused by the real motion of temperature changes and/or crystal 
disorder. A higher value of B implies a greater uncertainty in the positions 
of atoms. Temperature can cause atomic mobility/fluctuations, that affect the 
B-values (B factors), which also known as "temperature-factor " or "Debye-
Waller factors". 
The average temperature factor for the NheA structure is 35.4 Å2 and for the 
solvent atoms are 34.7 Å2, which means in general the distribution of B-
values is reasonable. The average B factor distribution for the each 
monomer in NheA was shown in Table 7.4. Generally the highest average 
B-value for a whole chain was in monomer H, which is about 42.3 Å2, 
where monomer A has the lowest average B-value for the whole chain, 
which is about 31 Å2.   
From Figure 7.15 and Figure 7.16, it is clear that the main chain has a lower 
B factor distribution than the side chains because the atoms in side-chains 
are expected to have more freedom of movement than the atoms of the main 
chain. Several residues have side-chains with high B factors such as ASP 
109, GLU 110, SER 170 in monomer A; ASP 109, GLU 110, GLN 111 in 
monomer B; ASP 325, GLU 320, GLU 319 in monomer C; TYR 95, GLU 
110, GLN 111 in monomer D; ASN 107, ASP 325, 112 SER in monomer E; 
ASP 115, ASP 325, ASN 107 in monomer F; ASN 105, ASN 105, GLU 108 
in monomer G; ASP 325, ASP 109, GLU 110 in monomer H. However, it is 
believed that the major contributors to the B-values comes from the crystal 
disorder than the thermal motion of the atoms (Rhodes, 2006). This is 
particularly true when crystals are cooled to liquid nitrogen temperature.  
Most of the disordered amino acids, which have high B values, are part of 
coils, turns, bulges or hairpins. As can seen from Figure 7.15 and Figure 
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7.16; residues in turns of each monomer have generally higher B-values 
indicating that turns have a higher degree of mobility than the ! helix or " 
sheets which confirm that regular secondary structure have lower 
conformational mobility than turns (Krishnaswamy & Rossmann, 1990). 
This is expected because the hydrogen-bonded !-helices and "-sheets tend to 
have lower atomic fluctuations than the random turns of a protein (Yuan et 
al, 2003).  
The N-terminal comprising amino acids LYS 1– ASN 23 is not as well 
defined as the C-terminal, especially at the beginning. The electron density 
in this region is weak, and more a flexible and mobile region. As result, even 
when these residues could be built they have also high B-values.  
The similarity of the temperature factor distribution of the 64 ! helices and 
24 " strands of the NheA structure suggest a similarity in the level of 
mobility of the eight monomers of NheA.   
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Figure 7.15: B-factors of NheA molecules.  
This figure shows a cartoon reproduction of the monomers of NheA 
coloured by B-factor. The thin blue lines indicate the lowest B-factors 
changing to thick red lines to indicate the highest B-factors. As expected, 
turns have B-factors higher than other parts of the structure. 
Produced using PyMol (DeLano and Lam, 2005).
A B C D 
E F G H 
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Table 7.4: The average B factors for main chain, side chain and overall 
value for each monomer of NheA.  !
 
Average B value for 
main chain (Å2) 
Average B value 
for side chain (Å2) 
Average B value for 
whole chain (Å2) 
Chain A 28.1 34 31 
Chain B 32.6 38.3 34.4 
Chain C 30.1 35.3 32.7 
Chain D 29.5 35.3 32.4 
Chain E 33.9 39.8 36.8 
Chain F 32.5 37.6 35 
Chain G 36.1 41.1 38.6 
Chain H 39.9 44.8 42.3 !!
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Figure 7.16: B-factors (Å2) of main and side chain residues of NheA molecules plotted against residue numbers (X-axis).  Red line 
represents B-factors of main chain and blue line represents B-factors of side chains. It is clear that the B-factors of side chains are higher than 
main chain. Zero side chain values correspond to Glycine or unbuilt side chain. 
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Chapter 8:  NheB Preparation and 
Crystallization  
 
This chapter will describe the work on the preparation, crystallization and 
attempts to solve the structure of the NheB component of the B. cereus Nhe 
toxin.  
 
8.1 Expression of NheB from Bacillus subtilis strain JH642 
Due to difficulties in the Oslo group in expressing the NheB in E. coli as a 
result of producing inactive protein (the reason for which was not clear, P. 
E. Granum and D. Phung, personal communication) the protein was instead 
expressed in B. subtilis.  
B. subtilis strain JH642 was used as the host cell of expression vector 
pDG148-Stu (Vector pDG148-nheB), which was supplied by Prof. Per Einar 
Granum, Norwegian School of Veterinary Science in Oslo.  
The primary culture was grown at 37 ˚C in LB media under the selection of 
kanamycin (5 µg/ml) with shaking (150 rpm) overnight.  
20 litres of LB liquid media containing kanamycin (5 µg/ml) in 20 flasks 
were prepared. The primary culture was added to the secondary culture 
medium in a ratio of 3:100 (primary: secondary). Therefore 30 ml of 
primary culture was added to each 1000 ml of secondary culture medium. 
The cells were then incubated at 37 °C whilst being shaken at 150 rpm for 5-
6 hours. When the cultures reached on optical density OD600 of 0.7 to 0.9, 
NheB expression was induced by the addition of IPTG to a final 
concentration of 200 !g/ml. The cells were left for a further 24 hours after 
induction.  The culture was then spun in a cold centrifuge (4 °C) for 20 
minutes at 15,344 g.  
 255 
It was assumed that the protein would be released from the cell into the 
media due to the presence of signal peptide that acts as a signal for 
transportation of the protein outside B. subtilis (Figure 8.1). 
The NheB was precipitated from the media using 65% (NH4)2SO4 overnight 
at 4 ˚C (Figure 8.2 A). After centrifugation the pellet was collected at 4 ˚C 
(70000 g ; 15 minutes) and dissolved in 50 mM Tris HCl at pH 8. Finally, 
the sample was dialyzed twice against 1 L of the same buffer to remove 
(NH4)2SO4.  
Western immunoblotting was carried out to check for the presence of NheB 
in the media (as explained in chapter 3 in section 3.4.4), and it is clear 
from  (Figure 8.2 B) that NheB was successfully expressed in LB media but 
with a low level of protein expression.  
 
8.2 Purification of NheB from Bacillus subtilis strain JH642 
 Purification of NheB is a complicated process and ideal protocol for 
purification has not yet been found.  
The following protocol was used to purify NheB from B. subtilis strain 
JH642, developed by Lindbäck et al, (2004). The dialyzed sample was 
loaded onto a DEAE sepharose fast flow ion exchange column pre-
equilibrated with loading buffer (50 mM Bis Tris at pH 8). Un-bound 
proteins were washed from the column using the same buffer. The bound 
proteins were eluted using a linear gradient of increasing 0–1 M NaCl in 
buffer. Most of the NheB was present in the unbound fractions (Figure 8.3).  
The unbound fractions that contained the largest amount of NheB were 
selected, and cut with 1.5 M (NH4)2SO4 and then the supernatant (NH4)2SO4 
was collected at 4˚C (15,344 g ; 20 minutes) and put through a 5 ml Phenyl 
Hp column pre-equilibrated with 25 mM Tris-HCl at pH8. The NheB was 
eluted using a linear gradient of increasing 1.5 M (NH4)2SO4 buffer.  
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        10         20         30         40         50         60  
MTKKPYKVMA LSALMAVFTA GNIMPAHTYA AESTVKQAPV HAVAKAYNDY EEYSLGPEGL  
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       250        260        270        280        290        300  
VATALGPIAI IGGAVVIATG AGTPLGVALI AGGAAAVGGG TAGIVLAKKE LDNAQAEIQK  
 
       310        320        330        340        350        360  
ITGQVTTAQL EVAGLTNIKT QTEYLTNTID TAITALQNIS NQWYTMGSKY NSLLQNVDSI  
 
       370        380        390        400  
SPNDLVFIKE DLNIAKDSWK NIKDYAEKIY AEDIKVVDTK KA  
 
 
Figure 8. 1: NheB amino acid sequence.  
The blue sequence colour shows a signal peptide, which functions as a 
signal for transportation of the protein. The bacterial cells cut off this signal 
peptide during expression, which means it is not a part of the mature NheB 
protein after purification. 
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Figure 8.2: The expression of NheB protein in B. subtilis strain JH642.  
(A) 12% SDS-PAGE analysis of NheB expression visualised by staining 
with Coomassie blue stain. Lane 1: Marker 12 from top to bottom: 200, 
116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: induction of NheB by 
200 !g/ml of IPTG in LB media for 24 h. The molecular weight of the 
protein should be around 36 kDa (red pointer).  
(B) Western immunobloting of 12% SDS-PAGE analysis of expression for 
NheB visualised by the colorimetric kit method. The primary antibody 
MAb 1C2 was used. Lane 1: Marker SeeBlue® Plus2 Pre-Stained Standard 
from top to bottom: 98, 64, 50, 36, 22, 16, and 6 kDa; Lane 2: the cell 
extract after induction of NheB by 200 !g/ml of IPTG in LB for 24 h; and 
Lane 3: the media after induction of NheB by 200 !g/ml of IPTG in LB for 
24 h.  It is clear that the protein is secreted in the media as it was expected.  
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Figure 8.3: 12% SDS-PAGE analysis of DEAE sepharose column 
purification for NheB from B. subtilis strain JH642.  
Visualised by staining with Coomassie blue stain.  Lane1: Marker12 from 
top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: 
DEAE sepharose column load; Lane3: unbound proteins; Lane 4: to lane 15 
the fractions collected from the DEAE sepharose column. 
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It can be seen from 12% SDS PAGE analysis the NheB is present in 
fractions 14 to 17 (Figure 8.4). The fractions were analyzed by Western Blot 
analysis, which confirmed the existence of the protein in those fractions 
(Figure 8.5).  
NheB fractions after the Phenyl HP column were applied to a calibrated Hi 
load superdex200 gel filtration column pre-equilibrated with 50 mM Tris 
HCl, at pH 8, and 0.5 M NaCl (Figure 8.6).    
 
8.3 Properties of pure NheB protein from Bacillus subtilis 
strain JH642 
Purified NheB had a band molecular mass of 36 kDa and was estimated to 
be !85% pure and heterogeneous by SDS-PAGE. There is a monomer and a 
dimer form of the protein (Figure 8.6). Western Blot analysis of the sample 
confirmed it was NheB and it has two forms (Figure 8.7).  
Protein concentration was estimated with the Bio-Rad protein assay protocol 
(Bradford method) and the concentration of the protein was performed using 
a 10 kDa molecular-weight cutoff Centricon centrifugal ultrafilteration 
device (Vivascience). NheB was concentrated to 8.5 mg/ml before 
crystallization trials. 
 
8.4 3D crystallization trials of NheB 
3D crystallization trials for NheB were preformed manually via vapour 
diffusion methods (sitting drop). Different crystallization screens from 
Hampton Research, Jena Bioscience and QIAGEN screens were utilized at 7 
ºC and 17 ºC with protein concentration (8.5 mg/ml).  
Small protein needles were observed in condition H10 of the JCSG [25% 
PEG500, 100 mM Bis-Tris at pH 5.5 and 200 mM CH3COONH4] after two 
days (Figure 8.8). 
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Figure 8.4: 12% SDS-PAGE analysis of a Phenyl HP column 
purification for NheB from B. subtilis strain JH642. 
Visualised by staining with Coomassie blue stain.  Lane 1: Marker12 
from top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; 
Lane 2: sample after DEAE sepharose; Lane 3: 1.5 M (NH4)2SO4 cut ; 
Lane 4: Phenyl HP column load; Lane 5: to lane 19 the fractions 
collected from Phenyl HP column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1     2   3     4     5     6      7     8      9     10   11  12    13    14    15     16     17   18    19     
31 
36v 
 
kDa 
97 
 
 261 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.5: Western immunobloting of 12% SDS-PAGE analysis of 
DEAE sepharose column and a Phenyl HP column purification for 
NheB from B. subtilis strain JH642 visualised by the 
chemiluminescence method.  
The primary antibody MAb 1C2 was used. 
Lane 1:  fraction 27 of Phenyl HP column; Lane 2: fraction 22 of Phenyl Hp 
column; Lane 3: Phenyl HP column load; Lane 4: fraction 11 of DEAE 
sepharose; lane 5: fraction 17 of DEAE sepharose; Lane 6: unbound proteins 
of DEAE sepharose; Lane 7: DEAE sepharose load; Lane 8: Marker Nexus 
View 20 kDa Dual Color from top to bottom: 140, 120, 100, 80, 60, 40, 30, 
and 20 kDa. 
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Figure 8.6: 12% SDS-PAGE analysis of gel filtration column 
purification for NheB from B. subtilis strain JH642.  
Visualised by staining with Coomassie blue stain.  Lane 1: Marker12 from 
top to bottom: 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: Gel 
filtration load; Lane 3: fraction 3 to 12 the fractions collected from gel 
filtration column. Red rectangle represents monomer form of NheB and 
yellow rectangle represents dimmer form of NheB.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.7: Western immunobloting of 12% SDS-PAGE analysis of gel 
filtration column purification for NheB from B. subtilis strain JH642 
visualised by chemiluminescence method. The primary antibody MAb 
1C2 was used. Lane 1: gel filtration load; Lane 2 to 8 fractions from gel 
filtration NheB. 
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This condition was optimized using the sitting-drop vapour-diffusion 
method in 24-well plates (Hampton Research). Protein drops were made up 
of 1 µl protein solution (8.5 mg/ml) mixed with 1 µl of various precipitants 
with varying PEG3350 concentration and pH.  
Further extensive trials were undertaken and finally rod crystals were 
obtained which were of sufficient size  (with dimensions of about 0.01 µm x 
0.01 µm x 0.3 µm) to attempt to collect data on. These crystals were 
obtained from optimized conditions 22% PEG500, 100 mM Bis-Tris at pH 
7.5 and 200 mM CH3COONH4, and took around one week to grow. An 
image of the crystals is shown in (Figure 8.9). Unfortunately no better 
crystals than these were grown for NheB. 
As can be seen from the 12 % SDS-PAGE analysis of the gel filtration 
column purification for NheB (Figure 8.6) the protein was not completely 
pure and to make sure that the crystal was NheB and not a contaminating 
protein, further experiments were carried out as summarized in Figure 8.10. 
These involved washing the crystals, dissolving them in water followed by 
12% SDS-PAGE and western blotting analysis. 
 
8.5 Data collection 
The crystals were soaked in mother liquor supplemented with 25% ethylene 
glycol, as cryo-testing in house had indicated that 25% ethylene glycol was a 
potential cryoprotectant for the crystals, and then the crystals were flash-
cooled in liquid nitrogen.  The crystal was tested for diffraction on our in-
house source at 100 K using the Rigaku X-ray generator with a Mar345 
detector. Data collection showed no diffraction, but this was potentially 
promising as it showed these crystals were not salt.  
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Figure 8.8: First hit for NheB crystals. The needles grow in 25% PEG500, 
100 mM Bis-Tris at pH5.5 and 200mM CH3COONH4, NheA 8.5 mg/ml, 17 
˚C. Scale bar: 100 !m 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.9: A cluster of crystals of NheB grown from 22% PEG500, 100 
mM Bis-Trisat pH7.5 and 200 mM CH3COONH4, NheB 8.5 mg/ml, 17 ˚C.   
Scale bar: 100 !m. 
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Figure 8.10: Summary of further experiment to make sure that the 
crystal was NheB.  
(A) The protein crystal. 
(B) 12% SDS-PAGE analysis of crystal visualised by staining with 
Coomassie blue stain.  Lane 1: Marker12 from top to bottom: 97, 66, 55, 36, 
31, 21, 14 and 10 kDa; Lane 2: NheB’s crystal.  
(C) Western immunobloting of 12% SDS-PAGE analysis of crystal 
visualised by colorimetric kit method. The primary antibody MAb 1C2 
was used. Lane 1: Marker SeeBlue® Plus2 Pre-Stained Standard from top 
to bottom: 98, 64, 50, 36, 22, 16, and 6 kDa; Lane 2: NheB’s crystal.  It is 
clear that the crystal is of NheB.  
A 
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The NheB crystal was stored in liquid nitrogen, and then tested with 
synchrotron X-ray beams at the Diamond Light Source where it diffracted to 
a final resolution of 3.5 Å (Figure 8.11). The diffraction images were 
collected on an ADSC Q315 CCD detector. A total of 240 images were 
collected with an oscillation angle of 0.5°. The exposure time was 0.8 
second per image with the detector distance set at 457.7 mm. 
 
 8.6 Space group determination, indexing and data processing 
Auto-indexing of NheB crystal was performed at the Diamond Light Source 
using the XDS program (Kabsch, 2010) using two images separated by 90°, 
with each image a 0.5° oscillation. The auto-indexing of NheB indicated that 
the crystal belongs to the hexagonal system and space group P62 or P64. 
Systematic absences were observed on all 00L reflections where h, k, l = 3n. 
Pseudo-precession pictures covering h, k, and l axes from NheB crystal are 
revealed in Figure 7.12 A, B, and C. 
The cell dimensions of the NheB crystal are a= 130.9 Å, b= 130.9 Å, c= 
61.9 Å, != 90°, "= 90°, and #= 120°.  The data were also processed at the 
Diamond Light Source using XDS (Kabsch, 2010). This data had an overall 
Rmerge of 0.14 with a value of 0.61 in the outermost resolution shell. The data 
were 99.7% complete with an I/$ of 10.4, overall. The statistics for X ray 
data processing are reported in (Table 8.1). 
 
S`8.7 Matthews number (Vm) calculation in space group P62 
The Matthews coefficient was calculated using the web page 
http://www.ruppweb.org/Mattprob/ (Kantardjieff & Rupp, 2003). This 
indicated the most probable number of NheB molecule in each a asymmetric 
unit is around two molecules, giving a crystal volume per protein mass (VM) 
of 2.07 Å3/Dalton and a solvent content of 44.55% (Matthews, 1968).  
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Figure 8.11: X-ray diffraction pattern of NheB crystal using beamline 
I02 of Diamond light source.  
A dataset was collected to 3.5Å resolution on the Diamond synchrotron. The 
exposure time was 0.8 s, the crystal-to-detector distance was 457.7 mm, 
wavelength 0.9796 Å and the oscillation range per image was 0.5°. The 
diffraction image was collected on an ADSC Q315 CCD detector 
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Figure 8.12 A: hkl view pseudo-precession image of zone hk0 from the 
NheB crystal. 
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Figure 8.12 B: hkl view pseudo-precession image of zone 0kl from the 
NheB crystal. See more details view in Figure 8.12 C. 
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Figure 8.12 C: Close up of hkl view pseudo-precession image of zone 0kl 
from the NheB crystal.  
The 00l axis is boxed and the only 006 and 009 are visible, corresponding to 
l= 3n.  
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To investigate the relationships of NheB molecules in the asymmetric unit, 
the self-rotation function using POLARRFN (CCP4: Supported Program) 
was run. The self-rotation function shows that there is no evidence for non-
crystallographic symmetry in 6-fold axis or 3-fold axis. However, in 2-fold 
axis there is appears to be additional pseudo-non-crystallographic symmetry 
(marked as X in figure 8.13), which more related to P6222 space group or 
P6422 space group. This result also confirms that there are two monomers of 
NheB in the asymmetric unit. However, examination of a self-Patterson 
synthesis shows there is no evidence for pseudo-translational symmetry in 
the NheB crystal. 
 
8.8 Attempts at NheB structure determination by molecular 
replacement 
The programme of choice for molecular replacement was PHASER (CCP4: 
Supported Program) (McCoy et al, 2007). The best solution in molecular 
replacement is indicated by: the Log likelihood gain which is show how good 
the solution is compared to a random solution and the "Z-score" which shows 
the number of standard deviations above the mean value. The successful hit 
that indicates the best solution should have a high Log likelihood gain (> 30) 
and a high Z-score (> 5) (Gubbi et al, 2007; McCoy et al, 2007; McCoy et al, 
2005; Storoni et al, 2004). 
 
8.8.1 Molecular replacement in space group P6 
Although the auto-indexing of NheB crystal showed that the crystal belongs 
to the hexagonal system and space group P62, for space group with 6-fold 
screw axes, the intensities do not give sufficient information to differentiate 
61/65, or 62/64 axes. Therefore, It was decided to try to determine the structure 
for the NheB protein by molecular replacement in space group P62 or one of 
alternative space group (P6, P61, P63, P64 or P65) using the B. cereus HblB 
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molecule (Madegowda et al, 2008), which has 27% amino acid similarity to 
NheB, as a search model.   
No satisfactory molecular replacement solution was found for NheB 
although the PHASER gives the single solution in space group P62. The Z-
scores were 3.8, and 5.9 for the rotation and translation functions 
respectively. The overall log likelihood gain was 44.54. However, 
examination of electron density map calculated with the PHASER gave no 
useful additional information. The space group P62 was expected to be 
correct for NheB crystal from the systematic absences and so was likely to be 
give best solution. 
 
8.8.2 Molecular replacement in space group P3, or P31, or P32 
Because the MR failed in space group P6, it was suggested to try 
determination of the structure of NheB in the lower symmetry space group, 
which is P3, P31 or P32. The data were re-processed again at the Diamond 
Light Source using XDS (Kabsch, 2010) in space group P3. Before running 
the molecular replacement it was important to know the number of molecules 
that were likely to be present in the asymmetric unit of space group P3.  This 
is estimated by the Matthews number (Matthews, 1968). The Matthews 
coefficient in space group P3 suggests that three or four molecules could be 
in the asymmetric, giving a crystal volume per protein mass (VM) of 2.75 
Å3/Dalton and a solvent content of 55.20% (Matthews, 1968). The 
reprocessed data had an overall Rmerge of 0.139 with a value of 0.65 in the 
outer resolution. The data were 99.7% complete with an I/! of 7.7 overall. 
The statistics for X ray data processing are listed in (Table 8.2).  The search 
model that was used was the same as that used for previous space group 
determinations - B. cereus HblB molecule (Madegowda et al, 2008). 
Unfortunately no convincing solution was suggested by PHASER in space 
group P3 or alternative space groups, P31 or P32 although the best solution  
(Z-score = 4.2 and 5.2 for the rotation and translation functions respectively) 
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was obtained for P32. However no additional information had been seen after 
examination of the electron density map that was calculated by PHASER. 
The reasons for this disappointing result and failure of the molecular 
replacement is probably because no search model with high sequence 
similarity to NheB was available. The general rules to make molecular 
replacement work is that sequence similarity of the model to the target 
should be >30% (Rupp, 2010). But the sequence identities of NheA, HblB, 
and ClyA are only 22%, 27%, and 19% respectively. In addition the X-ray 
data are of limited resolution, which does not add the interpretation the map 
and refinement. 
In the future it is hoped were to collect high-resolution data for NheB 
crystals or to find an alternative model with higher sequence similarity.  
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Figure 8. 13: Self-rotation function of NheB that was calculated using 
the program POLARRFN (CCP4: Supported Program). There is no 
evidence for non-crystallographic symmetry in 6- fold axis and 3- fold axis. 
There are 2-fold axes for pseudo- non-crystallographic symmetry (X 
labeling) that more related to P6222 space group or P6422 space group. 
 
 
 
x 
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Table 8.1: Data collection statistics from the NheB crystal processed in 
space group P6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.2: Data collection statistics from the NheB crystal processed in 
space group P3. 
 
 
 
 
 
 
 
 
 
 
Space group  P6 
Unit-cell parameters (Å, °) 
a= 130.89    b= 130.89   c= 61.86     
!=90   "=90   #=120 
Crystal system Hexagonal 
 Overall Inner Shell Outer Shell 
Low resolution limit (Å) 65.44 65.44 3.43 
High resolution limit (Å) 3.35 14.97 3.35 
Rmerge 0.140 0.045 0.614 
Total No. of observations 66236 727 5140 
Total No. Unique 8903 112 671 
Mean ((I)/sd(I)) 10.4 22.0 3.1 
Completeness 99.7 96.6 99.8 
Space group  P3 
Unit-cell parameters (Å, °) 
a= 130.69    b= 130.69   c= 61.76     
!=90   "=90   #=120 
Crystal system trigonal 
 Overall Inner Shell Outer Shell 
Low resolution limit (Å) 65.35 65.35 3.38 
High resolution limit (Å) 3.29 14.73 3.29 
Rmerge 0.139 0.044 0.654 
Total No. of observations 68831 741 5165 
Total No. Unique 17776 195 1295 
Mean ((I)/sd(I)) 7.7 20.2 2.0 
Completeness 99.0 96.2 100.0 
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8.9 Attempts to produce higher quality NheB crystals  
To obtain higher quality NheB crystals in order to acquire higher resolution 
data, we need more optimization of the NheB conditions.  Therefore, extra 
experiments of expression and purification of NheB were carried out.   
However, we noticed that the level of NheB expression from Bacillus 
subtilis strain JH642 decreased and became very low which did not allow to 
us to carry out the purification step. As the time for this project was running 
out, it was decided to make a trial to produce NheB from the pathogenic 
native strain, Bacillus cereus strain 0075/95.  
 
8.9.1 Expression of NheB from a native strain (Bacillus cereus 
strain 0075/95) 
8.9.1.1 Growth of Bacillus cereus strain 0075/95  
Our collaborator Danh Phung in Norway carried out the growth of the 
pathogenic B. cereus strain 0075/95, as our laboratory does not have 
facilities to grow pathogenic bacteria (D. Phung, personal communication). 
The cells were plated out from 70% glycerol stock of B. cereus strain 
0075/95 onto a Petri dish and incubated overnight at 37 °C. A single colony 
was transferred to a sterile flask with 50 ml LB liquid media and 0.4% 
glucose. The primary culture was grown at 32 °C whilst being shaken at 150 
rpm overnight. 
20 litres of LB liquid media in 20 flasks were prepared. The primary culture 
was added to the secondary culture medium in a ratio of 3:100 (primary: 
secondary). Therefore 30 ml of primary culture was added to each 1000 ml 
of secondary culture medium. The cells were then also incubated at 32 °C 
whilst being shaken at 100 to 150 rpm for 5-6 hours. The culture was then 
spun in a cold centrifuge (4 °C) for 20 minutes at 15,344 g.  
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The supernatant was transferred to a large flask and precipitated with 65% 
(NH4)2SO4 in a cold room overnight. The protein was kept in 65% 
(NH4)2SO4 and sent by post to our laboratory in Sheffield to carry out 
purification experiments. 
 
8.9.2 Trial purification of NheB from native strain, Bacillus cereus 
strain 0075/95 
The precipitated media were spin down at 4 °C for 15 minutes at 70000 g, 
and the pellet dissolved in 50 mM Tris-HCl buffer at pH 8. Then the sample 
was dialyzed twice against 3L of the same buffer to remove (NH4)2SO4. 
The protocol for purification of NheB from native strain, Bacillus cereus 
strain 0075/95, was essentially the same as the protocol for purification of 
NheB from Bacillus subtilis strain JH642  (section 8.2).  
The sample was applied onto a DEAE sepharose fast flow ion exchange 
column pre-equilibrated with loading buffer (25 mM Bis Tris at pH 8.0). It 
was assumed the protein would be found in the un-bound fractions, the un-
bound proteins were collected and loaded onto a 5ml Phenyl Hp column pre-
equilibrated with 25 mM Tris-HCl at pH 8. The NheB was eluted using a 
linear gradient of increasing 1.5 M (NH4)2SO4 buffer. The fewer 
contaminant fractions were applied to a calibrated Superdex200 gel filtration 
column and the final purification step is shown by 12% SDS PAGE in 
Figure 8.14. 
However, the purification of NheB from the native, Bacillus cereus strain 
0075/95 had very little success and the NheB obtained was not of a 
sufficient purity or quantity for more crystallization trials.  
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Figure 8. 14: 12% SDS-PAGE analysis of purification for NheB from 
native strain, B. cereus strain 0075/95.  
Visualised by staining with Coomassie blue stain.  Lane 1: Marker12 from 
top to bottom: 200, 116, 97, 66, 55, 36, 31, 21, 14 and 10 kDa; Lane 2: 
DEAE loading; Lane 3: Sample after DEAE; Lane 4: Sample after Phenyl 
Hp; Lane 5 to lane 15: fraction 16 to 26 the fractions collected from gel 
filtration column. Red rectangle represents monomer form of NheB and 
yellow rectangle represents dimer form of NheB.  
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8.10 Future work on NheB protein 
It is clear that, the knowledge of the crystallization conditions for NheB 
obtained  during this work should be useful in future.  However, the present 
data for NheB, which was collected to 3.5 Å, are of relatively low resolution 
and therefore it is important that more NheB crystals are obtained to provide 
high-resolution data.     
If the molecular replacement fails, there are two methods that may help to 
solve the phase problem, which are MIR or MAD. In general, incorporation 
of SeMet into protein, followed by structure determination using MAD data 
set could be easier than MIR method. However given the difficulties 
involved in obtaining native protein, and the lack of protocol for SeMe 
incorporation in B. subtilis or B. cereus, selenomethionine incorporation 
could be very challenging. If however this not works then heavy atom 
soaking may work, due to the huge range of heavy atoms that are available 
to the researcher. Unfortunately, there was not sufficient time to attempt to 
solve the structure of NheB by these methods during this project. 
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Chapter 9: Electron Microscopy Studies 
  
Electron microscopy is an important tool, which can provide essential low- 
and medium-resolution information on the size and quaternary structure of 
membrane proteins stabilized with detergent or in a lipid membrane. This 
Chapter describes the results from the electron microscopy studies on all the 
proteins, APEC ClyA, NheA and NheB, which have been worked on during 
this project.  In addition I present here the first observations of the bacterium 
B. cereus strain NHV 0075/95 by scanning electron microscopy (SEM) and 
transmission electron microscopy (TEM). In this work I am grateful for the 
help and guidance of Prof. Per Bullough and Dr Svetomir Tzokov. 
 
9.1 Electron microscopy of biological macromolecules 
Electron microscopy (EM) is a powerful tool to analyse the ultra-structure of 
cells and tissues. Over the last three decades, electron microscopy has also 
been used to elucidate the structures of biological macromolecules. Electron 
crystallography is a term that describes the use of electron diffraction data 
and electron microscope images to determine the structure 2D crystals of 
biological macromolecules (Glaeser  et al, 2007). 
Electron microscopy or crystallography is useful for the structure 
determination of two-dimensional (2D) crystals of membrane proteins and 
for single particle analysis of proteins.  Indeed electron microscopy is the 
only technique that has produced atomic structures of membrane proteins 
while embedded in their native biological lipids. In addition to the ability to 
determine membrane protein structures while contained in a native-like 
environment, electron microscopy can also measure phases, which are 
normally lost during X-ray crystallography. EM can also be used to 
determine structures by single particle analysis, which does not require 
proteins to be crystallised.  
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In addition to providing phases, electron microscopy has the great advantage 
that even samples that are only one molecule thick can be processed, 
something that is very difficult with X-ray crystallography. Indeed, electron 
microscopy requires very thin crystals. Electrons have 10000 times the 
scattering power of X-rays, and thus, thin samples that cannot diffract X-
rays are able to scatter electrons.   
All protein specimens in this project were prepared for EM by negative 
staining (see section 3.10.1 for protocol). In negative staining the sample is 
dried and embedded in a layer of electron-dense heavy metal salts, that 
provides high contrast for imaging in the electron microscope. The main 
advantage of negative staining is that it is quick and easy to use and does not 
require very specialized equipment 
 
9.2 Study of APEC ClyA by electron microscopy 
9.2.1 APEC ClyA pore formation by EM  
 Purified APEC ClyA was incubated with 1% ß-octylglucoside (ß-OG) in 
order to investigate APEC ClyA pore formation. Images of purified APEC 
ClyA protein were observed by transmission electron microscopy after 
staining in 0.75% uranyl formate, using a negative staining protocol (Ohi et 
al, 2004) as described in section 3. 10. 1. 
From (Figure 9.1), the majority of the pores were circular from the top view 
and bind together in complex but uniformly sized clusters. The pores can be 
seen as spikes from the side view. The clusters may well be spherical 
assemblies of pore, not unlike virus particles. Seen from above some appear 
to have a central pore surrounded by 6 others. This may be consistent with 
12- fold symmetry seen for K12 ClyA pores in the crystal structure (Mueller 
et al, 2009) or may reflect hexagonal close packing.  
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It is seen that different concentrations of APEC ClyA (0.1 mg/ml) and 
(0.025 mg/ml) in 25 mM Tris HCl at pH 6.8, 100 mM NaCl, 2.5mM CaCl2, 
0.05% NaN3 and 1% ß-OG mixed with 1% of ß-OG gave similar results. 
However, using a different detergent (0.1% DDM) with APEC ClyA (0.1 
mg/ml) produces more individual pores (Figure 9.2), which means in 
practice they should be easier to crystallize. For that reason, DDM was used 
in the 3D crystallization trials of APEC ClyA pores (See Chapter 4).  
APEC ClyA pores are homogeneous in size and the majority of the pores 
appear to have an external pore diameter of approximately 110 Å and are 
145Å long, measured from EM micrograph. These measurements were done 
by Digital Micrograph (GATAN software). The results presented here 
confirm earlier findings by Wyborn et al, (2004) who found the pores formed 
by APEC ClyA were more homogeneous than K-12 ClyA ones. Also the 
larger pore assemblies seen for the E. coli K-12 protein were absent (Wallace 
et al, 2000). This may be due to a higher variation of the number of ClyA 
subunits in the K-12 ClyA pore, like in some other toxins, e. g. the bacterial 
toxin pneumolysin?(Tilley et al, 2005).  
 
9.2.2 Two-dimensional crystallization trials of the trans-membrane 
APEC ClyA complex 
To understand the structure and function of APEC ClyA in its real context in 
the lipid bilayer of the cell membrane, I attempted two-dimensional (2D) 
crystallization trials of membrane protein complexes since the physiological 
state of the protein may not always be reflected by the 3D crystal structure 
of the protein in detergent.  
To attempt to obtain good 2D crystals APEC ClyA was combined with 
solubilized phospholipids and detergent, and then subsequently the detergent 
was removed. 
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Figure 9.1: Electron micrograph of negative stained APEC ClyA in the presence of detergent (1% ß-OG).  
(A) Using protein concentration of 0.1 mg/ml.  
(B) Using protein concentration of 0.025 mg/ml.  
The pore assemblies can be seen to be circular in the top views (1), while they are seen protruding spikes in the side view (2); (3) 
shows more isolated pores which were seen rarely.   
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Figure 9.2: Electron micrograph of negative stained APEC ClyA in the 
presence of detergent (1% DDM).  
(1) The top views of isolated pores. (2) The side view of the pores. 
 
 
 
 
 
 
 
 
 
 
1 
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There are a number of parameters affecting the results of a 2D 
crystallization trial such as the lipid-to-protein ratio (LPR), the type of lipids 
and detergent, concentration of detergent, salt concentration, temperature, 
and pH (Abeyrathne et al, 2010).    
In our trials, two kinds of lipids were used: Brain total lipid extract (BL) and 
E. coli total lipid extract (EL) which were prepared from lipid film (Avanti 
Polar lipids). We used method 1 for lipid preparation (see section 3.10. 4).  
APEC ClyA (0.5 mg/ml) in the presence of ß-OG was mixed with 
phospholipids in different ratios and dialyzed against ß-OG free buffer (25 
mM Tris HCl at pH 6.8, 100 mM NaCl, 2.5 mM CaCl2, 0.05 % NaN3) by 
the mini dialysis method for 20 days, changing the buffer every three days at 
25 °C. These trials were set up as follows: 
• Trial 1 (as control) 
12.5 !l of 4.5 mg/ml of APEC ClyA was mixed with 1% of ß-OG but no 
lipid to give an LPR= 0. The sample was diluted with 25 mM Tris HCl at pH 
6.8, 100 mM NaCl, 2.5 mM CaCl2, 0.05 % NaN3 buffer to obtain the final 
APEC ClyA concentration 0.5 mg/ml in 100 !l. of solution.  
• Trial 2 
The same as trial 1, except 5 !l of 4 mg/ml lipid was added. Thus, the LPR 
= 0.4. 
• Trial 3 
 The same as trial 1, except 10 !l of 4 mg/ml lipid was added. Thus, the LPR 
= 0.8. 
Electron micrographs in negative stain revealed that a possible small 
crystalline patch (Figure 9.3 A) was formed using an LPR = 0.4 with EL and 
an LPR = 0.8 with BL. This small crystal diffracted poorly (Figure 9.3 B). 
The small crystalline patch of APEC ClyA has approximate unit cell 
dimensions a=122.4 Å, b=114.0 Å, the cell angle (") =120.9° as measured 
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from the real EM micrograph of the crystal.  Unfortunately no large high 
quality 2D crystals suitable for electron data collection were found during 
this project.  
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Figure 9.3: Electron micrograph of negative stained APEC ClyA in the 
presence of lipid. 
(A) A small crystalline patch of APEC ClyA (0.5mg/ml) membrane 
complex (LPR = 0.4 with EL) in the red box. The protein may be starting to 
arrange itself in a flat lipid bilayer. 
(B) Electron diffraction pattern of the crystalline patch. 
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9.3 Studying Nhe pore formation by electron microscopy 
9.3.1 Study of Nhe pore formation in the presence of detergent by 
EM 
 Nhe proteins (NheA and NheB) were incubated with two types of detergent 
(ß-OG and DDM) in order to find evidence of pore formation. To examine 
the ability of each protein to form pores, each one was mixed separately 
with detergent. In addition both of them were combined together in the 
presence of detergent. The experiments are summarized as follows:  
• Trial 1: NheA (0.17 mg/ml) with 0.5% DDM.  
• Trial 2:  NheB (0.13 mg/ml) with 0.5% DDM 
• Trial 3:  NheA (0.17 mg/ml) and NheB (0.13 mg/ml) with 0.5% 
DDM 
• Trial 4: NheA (0.17 mg/ml) with 2% ß-OG 
• Trial 5: NheB (0.13 mg/ml) with 2% ß-OG 
• Trial 6: NheA (0.17 mg/ml) and NheB (0.13 mg/ml) with 2 % ß-OG 
From electron micrographs (Figure 9.4), it can be concluded that NheA on 
its own with detergent is largely aggregated but with some V-shaped objects 
that may correspond to pores. Some of these resemble the ClyA pores 
observed before. This result may support the previous study by (Fagerlund, 
2007), which stated that NheA on its own has a tendency to form pores.  
APEC ClyA is a homo-oligomeric pore forming toxin and needs only one 
protein to achieve maximum cytotoxic activity (Wallace et al, 2000). In 
contrast, the Nhe complex is a hetero-oligomeric pore forming toxin and 
requires three proteins to obtain maximum cytotoxic activity (Granum et al, 
1999). An initial measurement of one possible NheA pores indicated that the 
NheA pore might be a more tapered cone, longer and bigger than APEC 
ClyA pores (Figure 9.5).  
On the other hand, NheB on its own in the presence of detergent forms 
ribbon-like aggregates (Figure 9.6) with a thickness of about 50 Å.  The 
ribbon-like aggregates can be several hundred Å long. 
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A combination of the two proteins in the ratio 1 NheA: 1 NheB in the 
presence of 0.5% DDM produces network like aggregates (Figure 9.7).   
Here, it should be pointed out that in this experiment the third Nhe protein, 
NheC was not used. This was because it is known that NheA and NheB are 
necessary and sufficient for pore formation and cell lysis (Lindbäck et al, 
2010). However, NheC is necessary for full cytotoxicity in some cell types 
(Vero cells) (Lindbäck et al, 2010). It is believed that NheC may enhance 
pore formation, either by combining NheA and NheB together or by 
enhancing conformational changes (Lindbäck et al, 2004). 
 
9.3.2 Study NheA and NheB pore formation in the presence of 
lipids by EM 
In order to investigate the possibility of NheA and NheB forming pores in 
the presence of lipids, pore formation trials were carried out. In these trials, 
brain total lipid extract was used which was prepared from lipid film (Avanti 
Polar lipids). Method 1 was used for lipid preparation (see section 3.10. 4).   
NheA (0.5 mg/ml) and NheB (0.5 mg/ml) in the presence of DDM were 
mixed with phospholipids in different ratios and dialyzed against DDM free 
buffer (25 mM Tris HCl at pH 7.5, 100 mM NaCl, 2.5 mM CaCl2, 0.05% 
NaN3) by the mini dialysis method for 20 days, changing the buffer every 
three days at 19 °C.  The trials were set up as follows: 
• Trial 1: 
 6.4 !l of 7.8 mg/ml NheA was mixed with 0.15 % DDM. The sample was 
diluted to obtain the final NheA concentration of 0.5 mg/ml in 100 !l of 
solution, and then 10 !l of 2 mg/ml lipid was added. Thus, the LPR = 0.4. 
• Trial 2: 
 The same as trial 1, except 20 !l of 2 mg/ml lipid was added. Thus, the 
LPR = 0.8. 
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Figure 9.4: Electron micrograph of negative stained NheA and NheB in 
the presence of detergent (0.5% DDM).  
(A) 0.17 mg/ml NheA with 0.5% DDM. There are possible completed pores 
(yellow circle).  
(B) Side view of NheA pore (yellow arrow). 
 
 
 
Figure 9.5: Evaluation of the dimensions of NheA and APEC ClyA 
pores.  
A and B are electron micrographs of negative stained APEC ClyA and 
NheA respectively.  C and D show the approximate dimensions and length 
of the pores.  
A B 
C D 
A B 
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Figure 9.6: Electron micrograph of negative stained NheB in the 
presence of detergent (0.5% DDM). 0.13 mg/ml NheB with 0.5 % DDM 
produces ribbon-like aggregates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.7: Electron micrograph of negative stained a mixture of NheA 
and NheB in the presence of detergent (0.5% DDM). There are net work- 
like aggregates which may contain pore-like structures (yellow circles).
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• Trial 3: 
 89 !l of 0.5 mg/ml of NheB was mixed with 0.15 % of DDM, and then 10 
!l of 2 mg/ml lipid was added. Thus, the LPR = 0.4. 
•  Trial 4: 
 50 !l of trial 1 and 50 !l of trial 2 to get mixed NheA and NheB with the 
LPR = 0.4 
In the electron micrographs (Figure 9.8), it can be seen that NheA does not 
form a specific structure with the lipid bilayer of the membrane. On the 
other hand, NheB forms structures that look like boats and rings with 
different sizes (Figure 9.9), and it also forms structure that look like pores 
(Figure 9.10). The boats structures have a tiny lollipop like structures 
projecting from them. The end of lollipop is approximately 50 Å in diameter 
and the stick is about 60 Å in long (Figure 9.11).  These structures, which 
will simply be called “boats” in the rest of this Chapter are completely novel 
in view of two experienced electron microscopists (Prof. P. Bullough, and 
Prof. H. Saibil, personal communications). 
A combination of NheA and NheB in the presence of lipid gives unusual 
looking networks, which look like assemblies of pore-like structures (Figure 
9.12).  
 
9.3.3 NheA and NheB pore formation in the presence of liposomes 
by EM 
Method 2 for lipid preparation was used in these experiments (see section 
3.10.4) in order to find the optimal conditions for Nhe pore formation.  
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Figure 9.8: Electron micrograph of negative stained NheA in the 
presence of lipid preparation (method 1 was used for lipid preparation 
as described in section 3.10.4). NheA does not form a specific structure 
with lipid vesicles.  
Brain Lipid in LPR:0.4, NheA (0.5 mg/ml).
Lipid vesicles 
!  
!  
Lipid vesicles 
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Figure 9.9: Electron micrograph of negative stained NheB in the 
presence of lipid preparation (method 1 was used for lipid preparation 
as described in section 3.10.4).  
NheB forms boats (1) and rings (2). This result was observed using LPR:0.4; 
NheB (0.5 mg/ml).  
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Figure 9.10: Electron micrograph of negative stained NheB in the 
presence of lipid preparation (method 1 was used for lipid preparation 
as described in section 3.10.4).  
NheB forms boats (1) and rings (2) as well forms structure look like pores 
(red circles). This result was observed using LPR:0.4; NheB (0.5 mg/ml). 
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Figure 9.11: Electron micrograph of negative stained NheB in the presence of lipid preparation (method 1 was used for lipid 
preparation as described in section 3.10.4).  
NheB forms strange structures that look like lollipops that shown in a yellow box and close up of this structure is shown in black box. 
This result was observed by using LPR: 0.4 and LPR: 0.8 ; NheB (0.5 mg/ml).  
 
 
50 ! 
50 ! 
60 ! 
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Figure 9.12: Electron micrograph of negative stained a combination of 
NheA and NheB in the presence of lipid preparation (method 1 was 
used for lipid preparation as described in section 3.10.4). 
NheA and NheB form net-like assemblies of possible partial pore-like 
structures. This result was observed using LPR:0.4.  NheA (0.5 mg/ml) and 
NheB (0.5 mg/ml).  
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Liposomes from Brain Total Lipid Extract from Avanti Polar Lipids were 
mixed with the protein. The NheA (final concentration 0.1 mg/ml), NheB 
(final concentration 0.1 mg/ml) and NheC (final concentration 0.05 mg/ml) 
were mixed with liposomes in different ratios of protein to lipid and for 
different lengths of time. The experiments are summarized in (Table 9.1). 
The controls were made from liposomes (0.4 mg/ml) alone (Figure 9.13). 
From the electron micrographs it can be observed: 
NheA with liposomes shows the protein does not appear to form specific 
structures associated with the liposome (Figure 9.14).  However, NheB 
with liposomes preparation (in ratio 1:1) formed rings of different sizes and 
formed once again structures looking like boats with oars. As well, it can be 
seen NheB forms structure look like "hairy" or "spikey" ring- like structures 
in projection (Figure 9.15 A). This result confirmed our previous 
observations that mixing NheB with lipid leads to formation of boat like 
structures and rings (see section 9.2.2). After incubation of NheB with 
liposomes preparation (in ratio 1: 1) for 20 days, the big rings were 
observed as well as boats and smaller rings (Figure 9.15 B and C). 
Increasing the ratio of lipid to protein (3:1) apparently led to formation of 
more ring and boat structures (Figure 9.16 A and B). 
However it was also found NheB alone without liposomes was able to form 
rings and boats (Figure 9.17), but not as much as in NheB with liposomes. 
Since we were able to see NheB alone forming rings and boats, is possible 
some hydrophobic materials were co-purified with the NheB protein. It may 
also be that the protein formed boats and rings over time without the need of 
lipid.  
Incubation of NheA and NheB with liposomes in different ratios for one 
week showed formation of some small ring structures but the big rings were 
not seen (Figure 9.18 A, B, and C) which may be mean that some interaction 
between the two proteins was possibly happening. It was also possible to 
observe some boats but very rarely comparired to NheB with lipid alone 
(Figure 9.15 and 9.16).  However, significantly some pore structure with 
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internal diameter 7.5 to 10 nm could be seen (Figure 9.18 A, B and C). 
Similar results were observed when NheB and lipid were incubated 
overnight, and later mixed with NheA for 30 min. We saw some smaller 
rings, but most of the bigger rings were not seen. After incubation of NheA 
and NheB with liposomes, the formation of the pores increased (Figure 9.18 
D, E, and F). However, we found that mixing NheA with NheB without 
liposomes gave amorphous aggregates, with no formation of rings or boats 
or pores. 
- Incubation of NheA and NheB and NheC (in ratio 10:10:1 respectively) 
with liposomes gives similar result to NheA and NheB with liposomes, as 
there were some medium rings and pore- like structures (Figure 9.19 A, B, 
and C). This means that in our electron microscopy experiments the third 
component NheC did not appear to have any significant effect on the 
interaction of the other two proteins (NheA and NheB). This is consistent 
with (Lindbäck et al, 2010) who found that NheA and NheB are necessary 
and sufficient for pore formation and cell lysis. Nevertheless addition of 
NheC is important for full cytotoxicity in some cell types (Vero cells) 
(Lindbäck et al, 2010).  
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Table 9.1: Experimental conditions for Nhe pore formation by EM in 
the presence of liposomes. 
 
!"#$%&'()*)&'+$
 Lipid alone 
NheA (0.1mg/ml) + lipid (1L:1P) 
NheA  (0.1mg/ml) + lipid + 1A8 (1L:1P) 
NheB  (0.1mg/ml) + lipid (1L:1P) 
NheB (0.1mg/ml)  + lipid + (3L:1P) 
NheB  (0.1mg/ml) + lipid + 1E11 (1L:1P) 
NheB (0.1mg/ml)  + lipid + 2B11 (1L:1P) !"#$%%(0.1mg/ml) &'()(*%&%+#,-.*/01%/.2(3-*1(1L:1P) 
NheA (0.1mg/ml) + NheB (0.1mg/ml) + lipid (1L:1P) 
NheA (0.1mg/ml) + NheB (0.1mg/ml)  + lipid (1L:2P) 
NheA (0.1mg/ml) + NheB (0.1mg/ml) + lipid (1L:3P) 
NheA (0.1mg/ml) + NheB  (0.1mg/ml) + lipid (3L:1P) 
NheA (0.1mg/ml) + NheB (0.1mg/ml)  + NheC  (0.05 mg/ml) + lipid 
(1L:1P) 
NheA  (0.1mg/ml) + NheB (0.1mg/ml) 
NheA (0.1mg/ml) + NheB (0.1mg/ml) + 1A8 
NheA (0.1mg/ml) + NheB (0.1mg/ml) + lipid +1A8(1L:1P) 
NheA (0.1mg/ml) + NheB (0.1mg/ml) + lipid +1E11(1L:1P) 
NheA (0.1mg/ml) + NheB (0.1mg/ml) + lipid +2B11(1L:1P) 
NheB (0.1mg/ml) + lipid + Crosslinking by Glutaraldehyde + 1E11 
NheB (0.1mg/ml) + lipid + Crosslinking by Glutaraldehyde + 2B11 
NheB (0.1mg/ml) + lipid + Crosslinking by Glutaraldehyde + NheA 
NheB (0.1mg/ml) + lipid + Crosslinking by Glutaraldehyde (control) 
NheB alone 
NheB (0.1mg/ml)  + 2B11 
NheB (0.1mg/ml)  + 1E11 
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Figure 9.13: Electron micrograph of negative stained control electron 
micrograph shows liposome vesicles (method 2 was used for lipid 
preparation as described in section 3.10.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.14: Electron micrograph of negative stained NheA in the 
presence of liposomes preparation (method 2 was used for lipid 
preparation as described in section 3.10.4). 
NheA does not form a specific structure with liposome vesicles. This result 
was observed using the protein to lipid ratio (1:1), (0.1 mg/ml).  This was 
observed after one week and the same result was observed after 20 days.  
 
Liposomes 
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Figure 9.15 A: Electron micrograph of negative stained NheB in the 
presence of liposomes preparation (method 2 was used for lipid 
preparation as described in section 3.10.4).  
NheB forms ring structures of different sizes in projection (1) and forms 
boats (2). NheB forms structure look like "hairy" or "spikey" ring (3). This 
result was observed using the protein to lipid ratio (1:1), NheB (0.1mg/ml). 
This was observed after one week.  
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Figure 9.15 B and C: Electron micrograph of negative stained NheB in 
the presence of liposomes preparation (method 2 was used for lipid 
preparation as described in section 3.10.4).  NheB forms rings structures 
of different sizes (1). Some rings look like "hairy" or "spikey" spheres (2). 
Structures looking like a boat (3). Small rings and pore-sized assemblies 
with protein densities protruding out from the central body (red circles) were 
also observed. This result was observed using the protein to lipid ratio (1:1), 
NheB (0.1mg/ml). This was observed after 20 days.  
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Figure 9.16 A and B: Electron micrograph of negative stained NheB in the presence of liposomes preparation (method 2 was 
used for lipid preparation as described in section 3.10.4).  
NheB forms ring of different sizes (1) and form boats (2). This result was observed using the protein to lipid ratio (1:3); NheB (0.1 
mg/ml). This was observed after one week and similar results were observed after 20 days
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Figure 9.17: Electron micrograph of negative stained NheB.  
Without liposomes preparation NheB forms rings in different sizes (1) and 
forms boats (2). This result was observed using NheB 0.1mg/ml. 
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Figure 9.18 A, B, and C: Electron micrograph of negative stained a 
combination of NheA and NheB in the presence of liposomes 
preparation (method 2 was used for lipid preparation as described in 
section 3.10.4). NheA and NheB form pore structures (red circles). There 
are some small rings (1) but no big rings. Some boats (2) can be seen very 
rarely. This result was observed using the protein to lipid ratio (1:1); NheA 
(0.1 mg/ml) and NheB (0.1 mg/ml). This result was seen after one week.  
2 
1 
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Figure 9.18 D, E, and F: Electron micrograph of negative stained a 
combination of NheA and NheB in the presence of liposomes 
preparation (method 2 was used for lipid preparation as described in 
section 3.10.4). NheA and NheB form pore like structures (red circles). Few 
rings and the boats are seen. This result was observed using the protein to 
lipid ratio (1:1); NheA (0.1 mg/ml) and NheB (0.1 mg/ml). This result was 
seen after 20 days.  
Liposome 
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Figure 9.19 A and B: Electron micrograph of negative stained a 
combination of NheA, NheB and NheC in the presence of liposomes 
preparation (method 2 was used for lipid preparation as described in 
section 3.10.4). Pore-like structures can be observed (red circles). This 
result was observed using the protein to lipid ratio (1:1); NheA (0.1 mg/ml) 
and NheB (0.1 mg/ml) and NheC (0.05 mg/ml). This result was seen after 
one week.  
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Figure 9.19 C: Electron micrograph of negative stained a combination 
of NheA, NheB and NheC in the presence of liposomes preparation 
(method 2 was used for lipid preparation as described in section 3.10.4).  
Pore structures can be observed (red circle). This result was observed using 
the protein to lipid ratio (1:1); NheA (0.1 mg/ml) and NheB (0.1 mg/ml) and 
NheC (0.05 mg/ml). This result was seen after 20 days. 
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9.3.4 Immuno-gold labelling 
The aim of immuno-gold labelling is to allow identification of the proteins 
by labelling them with specific antibodies which are themselves labeled with 
a gold conjugated antibody which is highly visible in EM.  We used three 
antibodies in our EM studies: MAb 1A8 (0.2 mg/ml) against NheA, MAb 
2B11 (0.2 mg/ml) and MAb1E11 (0.2 mg/ml) against NheB. These 
antibodies have been kindly given from Dr. Erwin Märtlbauer (Ludwig-
Maximilians-Universitat, (Dietrich et al, 2005), see table 3. 1 and section 
3.10.2 for the protocol. The secondary antibody was Anti-Mouse IgG–Gold 
antibody produced in goat with the particle size of 5 nm (from SIGMA 
ALDRICH): 
 NheA with liposomes was incubated with primary antibody 1A8 and 
secondary immunogold antibody for 20 min and 1 h but give no specific 
binding of the secondary antibody. However, there was a strong 
immunogold labeling to the amorphous background material, which was 
everywhere  (Figure 9.20). 
NheB and liposomes were incubated for 20 min and 1h with primary 
antibody 1E11 and and secondary immunogold antibody. This did not 
produce any clear structures and no specific immunogold labeling (Figure 
9.21). However, NheB and liposomes after incubation for 20 min and 1h 
with primary antibody 2B11 and secondary immunogold antibody showed 
formation of rings and the boats (Figure 9.22 A, B, C, and D). On the other 
hand, NheB alone with either 1E11 or 2B11 did not produce clear structures 
or specific binding of immunogold (Figure 9.23). However, for NheB and 
liposomes after incubation for 20 min with secondary antibody, clear ring 
formation and boats were seen.  It therefore appears that the primary 
antibody 1E11 had a neutralising effect, possibly disrupting the ring and 
boat structures when added to NheB. 2B11 might have the same effect, 
although some rings can see after the addition of 2B11.  
NheA and NheB and liposomes with either with 1A8 or 1E11 and secondary 
immunogold antibody did not form specific structure or show any specific 
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binding (Figure 9.24 A and B). NheA and NheB with liposomes and 2B11 
and secondary immunogold antibody form pores look like structure but 
without specific binding (Figure 9.25 A and B) did do so. 
In order to investigate the disruptive effect of the primary antibodies on 
NheB structure formation, cross-linking experiments using 50 mM 
glutaraldehyde solution were carried out (see section 3.10.3 for the 
protocol). Glutaraldehyde solution has revealed to be an effective 
crosslinking agent for the stabilization of biomaterials (Damink et al, 1995). 
The controls were made for NheB with liposomes cross-linked by 50 mM 
glutaraldehyde solution (Figure 9.26). When NheB with liposomes was 
cross-linked, then incubated with primary antibodies 1E11 or 2B11, the 
boats and rings can be seen (Figure 9.27 A and B) without specific 
immunogold labeling to them. When NheB liposomes were cross-linked and 
then incubated with NheA, we were also able to see some the big ring 
formation (Figure 9.28).  
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Figure 9.20: Electron micrograph of negative stained immunogold 
labeled NheA in the presence of liposomes preparation (method 2 was 
used for lipid preparation as described in section 3.10.4). The primary 
antibody 1A8 (after incubation for 20 min) was used. There is no formation 
of clear structures and there is a random labeling (black spots) to the to the 
amorphous background material. NheA (0.1 mg/ml). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.21: Electron micrograph of negative stained immunogold 
labeled NheB in the presence of liposomes preparation (method 2 was 
used for lipid preparation as described in section 3.10.4). The primary 
antibody 1E11 (after incubation for 20 min) was used. There is no formation 
of clear structures and there is a random labeling (black spots) to the to the 
amorphous background material. NheB (0.1 mg/ml). 
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Figure 9.22 A and B: Electron micrograph of negative stained 
immunogold labeled NheB in the presence of liposomes preparation 
(method 2 was used for lipid preparation as described in section 3.10.4). 
(A) The primary antibody 2B11(after incubation for 20 min) was used. 
There is still a random labeling (black spots). (B) There is formation of rings 
of NheB (0.1 mg/ml; red circle). 
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Figure 9.22 C and D: Electron micrograph of negative stained 
immunogold labeled NheB in the presence of liposomes preparation 
(method 2 was used for lipid preparation as described in section 3.10.4). 
The primary antibody 2B11 (after incubation for 1h) was used. There is 
formation of rings with possible specific immunogold labeling (black spots) 
to them (red circles). However, still there is also strong labelling of the 
amorphous background material. NheB (0.1 mg/ml).  
C 
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Figure 9.23: Electron micrograph of negative stained immunogold 
labeled NheB without liposomes preparation (method 2 was used for 
lipid preparation as described in section 3.10.4).  The primary antibody 
1E11 (A) and 2B11 (B) after incubation for 1h were used. There is no 
formation of specific structures. However, still there is also random labelling 
(black spots) of the amorphous background material. NheB (0.1 mg/ml).  
A 
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Figure 9.24 A and B: Electron micrograph of negative stained 
immunogold labeled NheA and NheB in the presence of liposomes 
preparation (method 2 was used for lipid preparation as described in 
section 3.10.4). (A) The primary antibody 1A8 (after incubation for 1h) was 
used. (B) The primary antibody 1E11 was used (after incubation for 1h). 
There is no formation of any clear structures and no specific labeling (black 
spots). NheA (0.1 mg/ml) and NheB (0.1 mg/ml). 
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Figure 9.25 A and B: Electron micrograph of negative stained 
immunogold labeled NheA and NheB in the presence of liposomes 
preparation (method 2 was used for lipid preparation as described in 
section 3.10.4). The primary antibody 2B11(after incubation for 1h) was 
used. There are some structures that look like rings (red circles). However, 
there is also a strong labeling (black spots) to amorphous background 
material. NheA (0.1 mg/ml) and NheB (0.1 mg/ml). 
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Figure 9.26: Electron micrograph of negative stained NheB with 
liposomes preparation (method 2 was used for lipid preparation as 
described in section 3.10.4), cross-linked by 50 mM glutaraldehyde.  
There is formation of rings (1) and boats (2). NheB (0.1 mg/ml).
1 
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Figure 9.27 A: Electron micrograph of negative stained NheB with 
liposomes preparation (method 2 was used for lipid preparation as 
described in section 3.10.4), cross-linked by 50 mM glutaraldehyde and 
then incubated in 1E11. There is formation of rings (1). There is no 
specific immunogold labeling.  However, still there is a random binding to 
amorphous background material. NheB (0.1 mg/ml). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.27 B: Electron micrograph of negative stained NheB with 
liposomes preparation (method 2 was used for lipid preparation as 
described in section 3.10.4) cross-linked by 50 mM glutaraldehyde and 
then incubated in 2B11. There is formation of rings (1). There is no 
specific immunogold labeling.  However, still there is a random binding to 
amorphous background material. NheB (0.1 mg/ml). 
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Figure 9.28: Electron micrograph of negative stained NheB with 
liposomes preparation (method 2 was used for lipid preparation as 
described in section 3.10.4) cross-linked by 50 mM glutaraldehyde and 
then incubated in NheA. There is formation of rings (1). NheB (0.1 
mg/ml). 
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9.4 The first observation of B. cereus strain NHV 0075/95 by 
SEM & TEM 
B. cereus is a gram-positive bacteria, and causes many food poisoning cases 
in humans due to the formation of spores which survive inadequate cooking.  
By using scanning electron microscopy (SEM) and transmission electron 
microscopy (TEM) the first experiments were carried out to observe B. 
cereus strain NHV 0075/95.  This was in order to find more information 
about this strain, which does not carry the hbl genes and just produces the 
Nhe pore forming toxins. No other toxins have been recognized and secreted 
by B. cereus strain NHV 0075/95 (Lund & Granum, 1996).  
The specimen was prepared according to the techniques of (Bozzola & 
Russell 1999) techniques using the Philips XL-20 SEM and the FEI Tecnai 
G2 Spirit TEM in the Department of Biomedical Science, University of 
Sheffield, UK. This work was done with the assistance of Dr. Christopher J 
Hill. 
 
In (Figure 9.29) the surface structures of B. cereus strain NHV 0075/95 can 
be seen by SEM. The bacterium is a rod shaped structure, about 3 µm long 
and 0.7 !m wide and appears very similar to other strains of B. cereus. 
 
Internal cellular structures of B. cereus strain NHV 0075/95 can be observed 
by TEM (Figure 9.30 A). The cell wall and many organelles such as the 
genetic material, mesosome, and ribosomes can be seen.  
 Studying internal structures of B. cereus strain NHV 0075/95 revealed a 
strange ring- shaped structure located behind the cell wall (Figure 9.30 B). 
This structure has never been noticed in any strains of B. cereus or other 
bacteria before (Prof. Anne Moir, Prof. Jeff Green and others, personal 
communication). So what is it and what is function? If you look closely, you 
can see evidence for secreted materials around this structure and it is 
tempting to speculate that this structure may be related to a new secretion 
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system in the bacterium. This observation could be open a new research 
window for microbiologists in the future. 
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Figure 9.29:  Scanning electron micrograph of B. cereus strain NHV 
0075/95. B. cereus strain NHV 0075/95 is rod shaped strcuure and , about 
3µm long and 0.7 !m wide.  
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Figure 9.30: Transmission electron micrograph of B. cereus strain NHV 
0075/95: (A) showing various organelles.   
(B) and (C) There is a ring-like structure has never been seen in B. cereus 
before. It looks like a ring in shape and has   unknown structure and function 
(blue pointer). The red stars show the secretion material around this 
structure.   
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Chapter 10: Summary, Conclusion and Future 
work  
 
This chapter summarizes and describes the major findings of this thesis on 
the APEC ClyA protein from E. coli and the Nhe proteins from B. cereus. 
 
Pore Forming Toxins (PFTs) are one of the major groups of bacterial toxins 
and have been classified into two divisions according to the category of the 
secondary structure utilized to insert into the phospholipid bilayers of plasma 
membrane (Gilbert, 2002; Tilley et al, 2005):  
1) ! PFTs  
These form !-helical channels.  Pore formation by !–PFTs involves three 
steps: binding to a specific receptor, formation of the pore and insertion in 
the membrane. e.g Colicins, and Diphtheria toxin (Tilley et al, 2005). 
 
2) " PFTs  
These can form " sheet structures such as " barrels. This type of toxin 
requires an important refolding step during insertion in the membrane so they 
can form trans-membrane " barrels.  e.g. the  !-Hemolysin family, which are 
also known as repeat in toxin (RTX) toxins, Aerolysin toxins, Anthrax toxin, 
and Cholesterol-dependent cytolysins (Tilley et al, 2005). 
E. coli K12 ClyA revealed the first structure of a novel family of cytolytic 
toxins (Wallace et al, 2000) and it is classified as !-helical pore-forming 
(Mueller et al, 2009). APEC ClyA protein is a cytolytic toxin with similar 
characteristics to K-12 ClyA. Having successfully optimized the conditions 
for expression and purification of APEC ClyA, crystals of probable APEC 
ClyA pore form were grown in different concentrations of PEG400 (10- 
15%), 50 mM Tris HCl at pH 8.5, 100 mM MgCl2 and detergent in different 
forms, which diffracted poorly to >10Å resolution. Further methods to 
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improve the diffraction of APEC ClyA pore form crystals were attempted 
and the best diffraction obtained was only to 7 Å by synchrotron radiation in 
the presence EMP. Using hemolytic activity experiments we were able to 
prove that the APEC ClyA is in active form and in folded conformation.  
Recently, the X-ray crystal structure of the E. coli K-12 ClyA pore form was 
published (Mueller et al, 2009) and this structure had a 12-meric pore. High 
sequence homology (about 75% identity) between E. coli K-12 ClyA and 
APEC ClyA, suggested that they would share the same large conformational 
changes on pore formation. 
Bacillus cereus is gram-positive, rod shaped bacterium, widespread in the 
environment, which can be isolated from soil and contaminated food. Due to 
the ability of B. cereus to form spores it is involved in two types of food 
poisoning: the emetic and diarrheal types. B. cereus bacteria have three 
putative enterotoxins: hemolysin BL  (Hbl), non-hemolytic enterotoxin 
(Nhe) and cytotoxin K (CytK).  Both Hbl (HblL1, HblL2, HblB) and Nhe 
(NheA, NheB, NheC) are tripartite pore forming toxins.  Hbl and Nhe are 
encoded by three genes cotranscribed as operons: hblCDA encodes Hbl 
proteins L2, L1 and B, and nheABC encodes NheA, NheB and NheC.  There 
is sequence similarity between the three components in each complex and 
between the proteins of Nhe and Hbl (Fagerlund et al, 2008).  
Despite low sequence similarities between Hbl and ClyA, the 3D crystal 
structure of Hbl component B from B. cereus shared significant structural 
homologies with E. coli ClyA (Madegowda et al, 2008).   
This thesis presents the first structure of an Nhe protein, component A from 
B. cereus. NheA and a SeMet-derivative have been expressed successfully 
and purified to homogeneity using several purification protocols including 
an anion exchange column, hydroxylapatite chromatography and gel 
filtration. NheA and SeMet NheA were successfully crystallized using 
PEG3350 as a precipitant by the sitting-drop vapour-diffusion method.  A 
full diffraction data set was collected using synchrotron facility to 2.05 Å 
resolution from a single crystal of NheA. The Matthews coefficient 
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suggested that 8 molecules could be in the asymmetric unit, giving a VM of 
2.20 Å3/Dalton and a solvent content of 44.52% (Matthews, 1968). The 
structure of NheA was solved using SeMet MAD data sets, which was 
collected from a SeMet NheA crystal.  
NheA has mostly an !-helical bundle architecture. It is an elongated, rod 
shaped structure with dimensions 95 Å X 40 Å X 20 Å.  It consists of seven 
!-helices, known as ! A, ! B, ! C, ! F, ! G, ! D, ! E. NheA has two sub-
domains the "Tail" domain, and the "Head" domain, which includes the "ß 
tongue" which contains two strands ß1 and ß 2. A third ß strand, ß3, forms 
the C-terminal and forms hydrogen bonds to the ß tongue.  
The structure of NheA reveals a strong similarity in tertiary structure with 
HblB from B. cereus and ClyA from E. coli. The major interesting 
differences between them are in the orientation of head domains of the 
proteins. The head domain is turned downward and interacts with the tail 
domain in NheA and HblB (the interdomain angles are ~20° and ~30°, 
respectively), however it is turned upward in ClyA with only small 
interactions with its tail domain (~120° interdomain angle).  
 The structural and functional similarities among Nhe, Hbl and ClyA appear 
to indicate that they belong to a superfamily of pore-forming toxins.  
Furthermore, the different orientations of the head domains in ClyA, NheA 
and HblB may suggest a degree of flexibility in the " tongue region but 
could also represent different conformations in these toxins. As more 3D 
crystal structures of other toxins from different species are determined, it is 
likely that the number of ClyA homologues identified will increase and so it 
will become apparent if ClyA, Hbl and Nhe are really member of a novel 
superfamily of pore-forming toxins. 
The elongated amphipathic beta sheet of NheA molecules is reminiscent of 
transmembrane sequences in some toxins for which structures have been 
reported, such as !HL (Song et al, 1996), and LukF (Olson et al, 1999). 
However, these are based on " sheet rather than ! helical architectures. 
Therefore could Nhe form a transmembrane "-barrel like S. aureus !-toxins 
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and could the Nhe be considered as a possible link between the ! and " pore 
forming toxins? 
This project also involved the successful expression, purification and 
crystallization of the second, NheB, component of Nhe toxin from B. subtilis 
strain JH642. A full diffraction data set was collected under cryoconditions 
using synchrotron radiation to 3.5 Å resolution from a single crystal of 
NheB. The space group was determined to be primitive hexagonal (P62 or 
P64) with unit cell dimensions a = 130.89 Å, b = 130.89 Å, c=61.86Å and 
#=120°. However, the attempts within this thesis to determine the structure 
of NheB by molecular replacement in space group P62 and P32 or one of 
their alternative space groups were unsuccessful. There are two 
considerations, which may explain the unsuccessful results: The first is the 
lack of a homology model with high sequence similarity with NheB, and the 
second is the lack of a major high- resolution data.  
Observations of NheA and NheB by electron microscopy show that NheA 
does not form specific structures with lipid.  NheB can form different size of 
rings and structure that looks like a boat. It can form long sticks in the 
presence of detergent. NheA and NheB together give strange network 
materials, which looks like an assembly of pores in the presence of 
detergent, and form small rings and a pore like structure with internal 
diameter 7.5 to 10 nm.  However, adding NheC not did change that result 
which was not surprising as it found that NheA and NheB are sufficient for 
pore formation and cell lysis (Lindbäck et al, 2010). However, addition of 
NheC is important for full cytotoxicity in some cell types (Vero cells) 
(Lindbäck et al, 2010).  
Many questions concerning the mechanism of Nhe pore formation remain 
unanswered and require extensive biochemical and structural studies. 
Future work should focus on further expression, purification and 
crystallization trials of the NheB protein.  The main goal of future study on 
Nhe toxin should be the obtaining of detailed, high-resolution data which 
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will enable description of the transmembrane assembly of the Nhe pore 
complex by X-ray crystallography or cryo-EM.  
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